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ABSTRACT
THE CARDIOVASCULAR EFFECTS OF TOBACCO PRODUCT-DERIVED
ALDEHYDES: ROLE OF TRPA1

Lexiao Jin

03-02-2020

Background
Cardiovascular diseases (CVD) are the leading cause of death in most
countries and are a significant health and financial burden worldwide (Bhatnagar,
2004; Ramana et al., 2006). Smoking contributes to more than 480,000
premature deaths annually -- accounting for one of every five deaths in the
United States each year (Centers for Disease Control and Prevention, 2018; U.S.
Department of Health and Human Services, 2014). Numerous studies have
shown that smoking increases the risk of factors including endothelial
dysfunction, thrombosis, and atherosclerosis, that may lead to incidence of
myocardial infarction, coronary artery disease, and stroke (Srivastava et al.,
2011; U.S. Department of Health and Human Services, 2014). Electronic
cigarettes (e-cigarettes) are a new kind of tobacco product, and some studies
show that e-cigarettes also could induce CVD since both e-cigarettes and
conventional tobacco products release many aldehydes. Extensive
v

epidemiological and experimental data show that aldehydes contribute to
cardiovascular morbidity and mortality. However, whether these aldehydes
contribute to the adverse effects of emerging tobacco-products such as ecigarettes are unknown. The transient receptor potential ankyrin1 (TRPA1)
channel is a receptor of unsaturated aldehydes that mediates tobacco smokeinduced lung injury in some animal models (Andre et al., 2008; Cheah, Burcham,
Mann, & Henry, 2014; D. J. Conklin, 2016; D. J Conklin, Haberzettl,
Jagatheesan, Kong, & Hoyle, 2017; Simon & Liedtke, 2008). Thus, our central
hypothesis is that aldehydes derived from e-cigarettes or conventional tobaccos
contribute to vascular toxicity through the activation of TRPA1 pathway.
Methods
Both in vivo and in vitro studies were performed using male and female
C57BL/6J mice. For in vivo studies, mice were exposed to aldehyde gas (1-5
ppm, 6 h/day) for 4 days or 12 weeks (6 h/day, 5 days/week). Non-invasive blood
pressure and heart rate were measured weekly for 12 weeks by tail cuff system.
Measure real-time blood pressure and heart rate by telemetry system. After
exposures, we collected aortas and examined vascular function ex vivo,
specifically, testing for any changes in sensitivity and efficacy of the aorta in
response to pharmacological agents: phenylephrine (PE; contractions),
acetylcholine (ACh; relaxation) and sodium nitroprusside (SNP; relaxation). PEinduced isometric contractions (mN) were normalized by segment length and/or
volume to compare aortic contractility. Relaxations were calculated as a
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percentage reduction in PE-induced tension. Sensitivity of each agent was
calculated as the effective concentration producing 50% response (EC50).
In our in vitro studies, we examined the effects and underlying
mechanisms of action (relaxation) of aldehydes in both isolated mouse superior
mesenteric artery (SMA) and aorta. To test specific pathways, we used
pharmacological inhibitors of nitric oxide synthase (NOS), guanylyl cyclase,
TRPA1, and K+ channels as well as mechanical injury of the endothelium.

Results
In our in vivo studies, C57BL/6J (wild type, WT) mice were exposed to
HEPA-filtered room air (control), formaldehyde (FA; 5 ppm) or acetaldehyde (AA;
5ppm) for 4 days. There were no differences in the relaxations of ACh and SNP
or in the PE-induced contractility of between control and aldehyde-exposed
groups. So, short-term exposure to FA or AA at levels present in tobacco product
aerosols did not alter aortic function. Mice were exposed to crotonaldehyde (CR)
or filtered room air for 12 weeks (1 ppm, 6h/day, 5 d/week). Non-invasive blood
pressure was measured by tail cuff (once a week) for 12 weeks. Blood pressures
(systolic, mean, diastolic) were significantly lower in the CR group than in the air
group over the last several weeks, yet there was no difference in heart rate
between these two groups. Blood pressure changes were accompanied by
changes in aortic vasoreactivity ex vivo. Following 12-wk CR chronic exposure,
the sensitivity of ACh-induced relaxation was significantly increased in the CR
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group, however, there was no change in aortic response to PE. Similarly, aortic
sensitivity to SNP relaxation was enhanced by CR compared with air control
group. To dissect the mechanism of CR-induced vascular changes, we
performed acute 4-day exposures (1 and 3 ppm). Similarly, CR exposure also
altered aortic responses to ACh and slightly to SNP. Because a 4-day CR
exposure was sufficient to alter aortic reactivity, we tested whether the transient
receptor potential ankyrin 1 (TRPA1) channel was involved. In TRPA1-null mice
exposed to CR (4-days, 1ppm), there were no changes in aortic reactivity to any
agonist (PE, ACh, and SNP) compared with air group, indicating a distinct role of
TRPA1 in CR-induced changes. Interestingly, there also were no differences in
any aortic responses in CR- (1 ppm 4 days) versus air-exposed female WT mice.
For the in vitro studies, we explored the direct effects of FA, AA and CR in
isolated murine superior mesenteric artery (SMA) and aorta. FA (30-1,200 mM)
and AA (1-100 mM) strongly and reversibly relaxed agonist-induced contractions
of SMA including phenylephrine (PE), thromboxane A2 analog (U46,619) and
high potassium (high K+, 60 mM) without toxicity. The sensitivity but not the
efficacy of AA-, FA- and CR-induced relaxations was dependent on blood vessel
(wherein SMA was more sensitive than aorta) and contractile agonist (PE;
U46,619; high K+) yet independent of circadian cycle and sex. All three aldehydeinduced relaxations were significantly inhibited (at low concentrations) in the
presence of: 1) mechanically-impaired endothelium; 2) Nω-Nitro-L-arginine
methyl ester hydrochloride (L-NAME); and 3) guanylyl cyclase (GC) inhibitor
(ODQ). Positive immunofluorescent staining for TRPA1 was co-localized in
viii

endothelium of isolated SMA and the TRPA1-specific gene sequence was
detected in SMA. The relaxations of FA and CR but not AA at low concentrations
were all inhibited in the presence of TRPA1 antagonist (A967079).
Conclusion
These studies indicate that short-term exposure of mice to FA or AA have
limited direct toxicity in aorta, however, CR exposure (acute and chronic) leads to
altered vascular function that may lead to vascular disease. Moreover, we
describe direct effects of FA, AA, and CR that are dependent on an EDRF/NO
and VSMC GC/PKG pathway in SMA, with FA- and CR-induced relaxations also
dependent on an endothelium-localized TRPA1 receptor. From our vitro study,
we conclude that aldehydes play a key role in the regulation of blood flow in the
gastrointestinal (GI) tract to augment digestion and nutrient absorption and
induce postprandial hyperemia, and TRPA1 receptor plays an important role in
the aldehyde-induced vasodilation in vasculature. Future studies are required to
better understand how CR exposure modifies cardiovascular pathophysiology,
and the specific roles of TRPA1 and sex play in contributing to burden of
tobacco-related CVD including pathophysiological processes of atherosclerosis.
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CHAPTER I

INTRODUCTION

Background and Rationale
Conventional tobacco smoking and cardiovascular disease (CVD)
Cardiovascular diseases (CVDs) are the leading cause of death in most
countries and it kills 1 million people per year; accounting for over 40% of all
deaths (Levy D, 2000). More than 900 000 deaths for the reason of CVD in the
United States in 2016 (Roth et al., 2018). It is a significant health and financial
burden worldwide (Bhatnagar, 2004, 2006). In 2011, the United States spent
$316.6 billion directly and indirectly on CVD, more than the cost of other
diagnostic group (Writing Group et al., 2019), and the total cost of CVD is
increased exponentially over the past two decades (Heidenreich et al., 2011).
Based on these data, looking for the reason and the way of prevention for the
CVD showed to be urgent to humans.
Smoking has been used for thousands of years in the worldwide and has
been studied for several decades. In 2017, the number of smoker exceeded 1
billion globally and the Centers for Diseases Control and Prevention (CDC)
reported that 14% of U.S. adults were current smokers (Centers for Disease
Control and Prevention, 2017). In 2018, 27.1% of high school students and 7.2%
1

middle school students were current tobacco users (Centers for Disease Control
and Prevention, 2018). In 2017, the World Health Organization (WHO) reported
that tobacco caused about 8 million global deaths each year (World Health
Organization, 2019). In the United States, Smoking kills more than 480,000
deaths annually and accounted for one of every five deaths in the United States
each year (Centers for Disease Control and Prevention, 2018; U.S. Department
of Health and Human Services, 2014). Numerous studies showed that smoking
increased the risk of thrombosis, atherosclerosis, etc. which narrowed the
vascular lumen and caused myocardial infarction, coronary artery disease and
stroke (Srivastava et al., 2011; U.S. Department of Health and Human Services,
2014). Cigarette smoking also is a cause of peripheral arterial disease (PAD),
aortic aneurysm, and cerebrovascular disease. Over 90% of patients with
symptomatic PAD have a chronic smoking history (Hughson, Mann, & Garrod,
1978; Powell et al., 1997). About 11% of Americans are affected by PAD, 11.08%
developed to limb ischemia (Nehler et al., 2014). PAD affects 22.7% of those
aged > 80 years, especially 59% in male African American are affected
(Benjamin et al., 2019; Writing Group et al., 2019).

Electronic-cigarette smoking and CVD
Except for conventional tobacco smoking, there are more and more new
forms of smoking, such as electronic cigarette, hookahs, JUUL, etc… Electronic
cigarette is a new kind of tobacco product that was introduced to the commercial
market in 2004. E-cigarette includes aerosol delivery devices and a battery, the
2

cartridge contains e-liquids that contain a mixture of glycerol and propylene
glycol, flavors, and most commonly with variable concentrations of nicotine (T.
Cheng, 2014; Hutzler et al., 2014) .
As e-cigarettes initially were exclaimed to be less toxic for the smoker’s
health, there has been a steady increase in e-cigarette users especially among
high school students, wherein e-cigarette users increased from 1.5% in 2011 to
20.8% in 2018 (Cullen et al., 2018; Gentzke et al., 2019). More and more
research shows the potential harm to e-cigarette users (Benowitz & Fraiman,
2017; Bhatnagar et al., 2019). In animal studies, Olfert et al. (2018) showed that
mice were caused cardiovascular dysfunction such as impaired vascular function
and increased arterial stiffness after had been exposed to e-cigarette aerosol for
8 months (Olfert et al., 2018). Another study showed that e-cigarette exposure
induces cardiac dysfunction and atherosclerosis in apolipoprotein-E-null mice
(Espinoza-Derout et al., 2019). Two human studies showed that sympathetic
activity and oxidative stress significantly increased in e-cigarette users
(Carnevale et al., 2016; Moheimani et al., 2017). Another one clinical study
showed that e-cigarette aerosol could suppress the immune system and
inflammatory response genes in nasal epithelial cells similar to cigarette smoke
(Martin et al., 2016).
E-cigarettes do not induce combustion as in conventional tobacco
smoking. During heating of e-cigs, the humectants (VG, PG) are thermally
decomposed and oxidized into short, toxic aldehydes including formaldehyde,
acetaldehyde, and acrolein (D. J. Conklin et al., 2018; Ogunwale et al., 2017).
3

These aldehydes are well associated with endothelium dysfunction of cigarette
smoking (Anderson, Majeste, Hanus, & Wang, 2016; G. E. Hill et al., 1998; S. E.
Lee & Park, 2013; Lino-dos-Santos-Franco et al., 2011; Lino-dos-Santos-Franco
et al., 2010; Park & Taniguchi, 2008). What’s more, different brands of ecigarettes contain varying amounts of nicotine along with multiple other elements
in the smoke of the e-cigarette (Hahn et al., 2014). Numerous studies showed
the cardiovascular effects of nicotine. During smoking, nicotine stimulates the
release of catecholamines, thereby increases heart rate and blood pressure
(Benowitz & Gourlay, 1997; Benowitz, Hansson, & Jacob, 2002). Nicotine could
also increase platelet aggregation (Hom et al., 2016), induce vascular smooth
muscle cell proliferation (Egleton, Brown, & Dasgupta, 2009), and increase
atherosclerosis (Santanam et al., 2012).
We still do not know much about the risks of e-cigarettes to the smoker or
second-hand smoker or the extent of harm. Many health care providers continue
to urge people to be cautious in considering this as an alternative to cigarette
smoking.

Aldehydes and CVD
Aldehydes are toxic components of automobiles exhaust and smoke, and
have been detected in high concentrations in cigarette, cotton, wood, and coal
smoke. Aldehydes are even present in drinking water. Cooking and frying further
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would increase aldehydes concentration in foods. The metabolism of several
pollutants and toxicants also generates aldehydes.
Extensive epidemiological and experimental data show that aldehydes
contribute to cardiovascular mortality and morbidity. Lots of our previous studies
showed the effects of aldehydes on lipid metabolism, atherosclerosis, platelet
activation, thrombosis, myocardial function, and sensitivity to ischemiasuggesting that environmental aldehydes could increase CVD (D. J. Conklin, R.
A. Prough, et al., 2011; B. G. Hill, Haberzettl, Ahmed, Srivastava, & Bhatnagar,
2008; Makia, Bojang, Falkner, Conklin, & Prough, 2011; O'Toole et al., 2014;
Sithu et al., 2010; Srivastava et al., 2011; Srivastava et al., 2009). Some
aldehydes, such as acrolein, acetaldehyde, and formaldehyde are considered the
most significant cardiovascular and pulmonary toxins in tobacco smoke
(Haussmann, 2012). Wheat et al. found acrolein inhalation exposure suppressed
circulating endothelial progenitor cell (EPC) levels, indicating that EPC depletion
might be a significant contributory factor linking pollutant exposure to CVD risk
(Wheat et al., 2011). Other studies showed that e-cigarette aerosol including α,βunsaturated aldehydes and saturated aldehydes led to inflammatory changes
such as induction of cyclooxygenase-2 and cytokines, interacted with
endothelium–leukocyte, increased lung vascular permeability, induced reactive
oxygen species, DNA damage, apoptosis and programmed necrosis pathways in
vascular endothelial cells (Anderson et al., 2016; S. E. Lee & Park, 2013; Linodos-Santos-Franco et al., 2011; Lino-dos-Santos-Franco et al., 2010). However,
whether these aerosolized aldehydes contribute to the adverse effects of e-
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cigarette that could induce endothelium dysfunction via its produced aldehydes is
still unclear.
The metabolism of several industrial pollutants such as butadiene, vinyl
chloride, benzene, and allylamine, generate aldehydes that may be the common
metabolite responsible for the cardiotoxicity of these pollutants. For example,
acrolein and crotonaldehyde are also formed during the metabolism of 1,3butadiene (Nauhaus, Fennell, Asgharian, Bond, & Sumner, 1996; Richardson et
al., 1998), which is used in the rubber industry. Butadiene is also a reactive
constituent of cigarette smoke (Himmelstein, Acquavella, Recio, Medinsky, &
Bond, 1997). Occupational exposure to butadiene is associated with a significant
risk of death from arteriosclerotic heart disease (Matanoski, Santos-Burgoa, &
Schwartz, 1990). Moreover, butadiene exposure has been shown to increase
atherosclerosis in cockerels (Penn & Snyder, 1996a, 1996b) and generation of
hemangiosarcomas in the heart (Solleveld, Miller, Banas, & Boorman, 1988).
Aldehydes are metabolized in cardiac myocytes, smooth muscle cells and
endothelial cells by glutathione-S-transferases (GSTP) and aldehyde
dehydrogenase (ALDH) (D. J. Conklin et al., 2004; D. J. Conklin, Haberzettl, et
al., 2015b; D. J. Conklin, Haberzettl, Prough, & Bhatnagar, 2009b).
Formaldehyde is metabolized to formate, and acetaldehyde is metabolized to
acetate. Those two metabolites are extremely high in the urine (D. J. Conklin et
al., 2018; D. J. Conklin, S. Schick, et al., 2019). Our preliminary data showed that
formate had no relaxation in precontracted aorta, formate and acetate had some
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relaxation in superior mesenteric artery (SMA), but significantly lower than
formaldehyde and acetaldehyde (Jin, Jagatheesan, et al., 2019).
Toxic metabolites of aldehydes and other environmental pollutants may actually
be contributing to cardiovascular effects in vivo. Since many environmental
pollutants are metabolized to aldehydes, research into the mechanisms of how
aldehydes induce CVD could help study the mechanisms of these environmental
pollutants as parent compounds. Rewrite. However, there was still a long way to
study how aldehydes impair cardiovascular function or enhance cardiovascular
diseases.

Endothelium Dysfunction and CVD
Endothelium is important in the regulation of vascular tone through the
production of a variety of mediators such as NO, ROS, prostanoids, and
endothelin. It acts as an active signal transducer instead of as a barrier (Vita &
Loscalzo, 2002). Bunches of studies showed that smoking could directly damage
to endothelial cells and affect endothelial function (Barua, Ambrose, Srivastava,
DeVoe, & Eales-Reynolds, 2003; Messner & Bernhard, 2014; Raij, DeMaster, &
Jaimes, 2001). Alteration in endothelial function causes the initiation of
prothrombotic, proinflammatory and proliferative states and induces the
development of morphological atherosclerotic changes. Endothelial dysfunction
is the first step in vascular disease, since it leads to vascular inflammation, cell
proliferation, and thrombosis, seems to be the most notable indicator of the
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progression of cardiovascular disease (CVD), leading to high morbidity and
mortality from CVD (Daiber et al., 2017; Huveneers, Daemen, & Hordijk, 2015;
Lerman & Zeiher, 2005; Schachinger, Britten, & Zeiher, 2000; Yannoutsos, Levy,
Safar, Slama, & Blacher, 2014). Evaluation of endothelial function is crucial to
our study about the vascular effects of aldehydes.
Endothelial dysfunction refers to the impairment of endotheliumdependent vasodilatation, which implies abnormalities in endothelial integrity and
homeostasis and usually occurs at an early stage of hypertension (Deanfield,
Halcox, & Rabelink, 2007). The imbalance between the dilator and constrictor
forces in the vasculature leads to injurious changes in the endothelium, these
changes are considered as an evidence of dysfunction and as a sign of
unhealthy vasculature (Kolluru, Bir, & Kevil, 2012).
Endothelial cells synthesize and secrete a broad of anti-atherosclerotic
substances, the principal of which is nitric oxide (NO) that is generated from the
metabolism of L-arginine by endothelial NO synthase (eNOS), constitutively
expressed in endothelial cells (Luscher, 1990). Endothelial dysfunction is defined
as a reduced NO bioavailability. Endothelial progenitor cells (EPCs) have
multiple different cell types that play roles in the regeneration of the endothelial
lining of blood vessels. They are released from the bone marrow to the sites of
endothelial damaged blood vessels and promote an angiogenesis, which play an
important role in the proper endothelial function (Asahara et al., 1999; Pelosi,
Castelli, & Testa, 2014). The levels of endothelial progenitor cells might be a
surrogate biologic marker for vascular function and cumulative cardiovascular
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risk (Vasa et al., 2001). An increase in EPC levels was also shown to correlate
with the occurrence of ischemic stroke (Liao et al., 2017).

Transient receptor potential ankyrin1 (TRPA1) and CVD
Despite this high disease burden, we still know little about the
mechanisms by which smoking causes CVD. The transient receptor potential
family is a large family of cation selective ion channels that are extensively
expressed in the sensory nerves, endothelium and vascular smooth muscle cells.
Transient receptor potential ankyrin1 (TRPA1) is a promiscuous sensory receptor
that is activated by a variety of environmental and endogenous noxious
compounds, including α,β-unsaturated aldehydes such as acrolein (Bautista et
al., 2006; Cheah et al., 2014; D. J. Conklin, 2016; D. J Conklin et al., 2017),
cinnamaldehyde (Bandell et al., 2004; Bodkin & Brain, 2011; Pozsgai et al.,
2010), and 4-hydroxynonenal (4HNE) (Trevisani et al., 2007). TRPA1 mediates
pain-reception/transmission (nociceptors). Recently, the distribution of TRPA1
receptor has been expanded to include non-neuronal locations, such as the
heart, endothelium, and urothelium (Bautista et al., 2006; Earley, Gonzales, &
Crnich, 2009a; Kolluru et al., 2012; Pelosi et al., 2014), it is also present in
vasculature (Earley et al., 2009a; Sinharoy et al., 2017).
Activation of peripheral sensory fiber TRPA1 leads to pain signaling and
likely triggers the opening of the cation channel, allowing calcium entry, neuronal
activation, and release of vasoactive peptides, substance P (SubP) and
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calcitonin gene-related peptide (cGRP) (Macpherson et al., 2007; Trevisan et al.,
2016), which may contribute to increased vasodilation. These peptides increase
local tissue inflammation, blood flow, vascular permeability, edema and leukocyte
binding and extravasation (Andrade, Meotti, & Calixto, 2012). Thus, activation of
the TRPA1 channel by acrolein is linked with inflammation, which could
contribute to acute tobacco smoking- or acrolein-induced injury in the airways
and the cardiovascular system (Bautista et al., 2006; Earley et al., 2009a; Inoue
et al., 2006). Our previous study showed that pre- and post-exposure TRPA1
antagonism significantly protected against acrolein-induced mortality showed a
complex role of TRPA1 in cardiopulmonary injury (D. J Conklin et al., 2017). The
airway-located TRPA1 triggers an irritant response (e.g., coughing and
“respiratory braking”) that alters the rate and depth of breathing to reduce
exposure, what’s more, the morbidity and mortality significantly increased in the
TRPA1-null mice might be for the reason that these TRPA1-null were deficient in
this “respiratory braking” (D. J Conklin et al., 2017). Cinnamaldehyde-induced
dose-dependent blood vessel relaxation, blood pressure, heart rate and local
blood flow was significantly less potent in TRPA1-null compared with wide type
arteries (Pozsgai et al., 2010). However, the relationship between TRPA1 and ecigarettes aerosol induced endothelial dysfunction and CVD risk is still unclear.
In summary, voluntary and involuntary exposures to cigarette smoke (and
perhaps e-cigarette aerosols) are major causes of CVD such as CHD, stroke,
aortic aneurysm, and PAD. Smoking releases aldehydes, and numerous studies
show that aldehydes can also induce CVD. The risk is seen both as an increased
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risk of endothelial dysfunction and acute thrombosis of narrowed vessels and as
an increased of atherosclerosis in the blood vessels involved. The cardiovascular
risks attributable to cigarette smoking increase with the number of cigarettes
smoked and the duration of smoking. The mechanisms of the smoking induce
endothelial dysfunction are still unclear. TRP family play important roles in the
development of CVD, especially TRPA1 receptor. It is important to clarify this
mechanism in order to decrease the impact that cigarette products exposure has
on the incidence of endothelial dysfunction and CVDs. Once this mechanism has
been better clarified, and the toxicity of cigarette smoking or e-cigarette smoking
has been identified, we can begin to develop health guidelines and
pharmaceutical interventions to reduce the frequency of CVD both nationally and
globally. A decreased rate of cigarette smoking and a decreased incidence of
CVDs would have a significant impact on the cost of medical treatment and the
worldwide financial burden and, more importantly, on the global quality of life.

B. Specific aims in this study
The primary goal of the proposed research is to determine whether the
aldehydes derived from tobacco products (electronic cigarettes, conventional
tobacco) may be harmful to the vasculature, and, if so, what is the underlying
mechanism. Over-exposure to aldehydes is known to produce cardiovascular
toxicity. However, whether these aldehydes contribute to the adverse effects of
tobacco-products such as electronic cigarettes are unknown. The transient
receptor potential ankyrin1 (TRPA1) channel is a receptor of aldehydes and
11

mediates tobacco smoke-induced lung injury in some animal models. Thus, our
central hypothesis is that tobacco product-derived aldehydes contribute to
vascular toxicity through activation of the TRPA1 pathway. To test this
hypothesis, we explored the following aims:
Aim 1. Determine the direct vascular effects of tobacco-product derived
aldehydes in vitro.
We explored the possible pathways of vascular effects of aldehydes, and
found that the relaxation of formaldehyde (FA), acetaldehyde (AA) and
crotonaldehyde (CR) were all endothelium dependent, nitric oxide dependent,
and cGMP dependent. We also showed that the relaxation of FA and CR was
TRPA1 dependent. Furthermore, we tested the vascular effects of aldehydes
metabolites. Formate (main metabolite of FA; up to 1 mM) nor methanol (a
stabilizer in formalin, up to 1 mM) induced a weak relaxation in SMA indicating
that FA-induced relaxation was not a result of formate or methanol. Ethanol and
acetate could dilate blood vessels but much lower than AA and were all nitric
oxide dependent. Because smoking is often inhaled with nicotine, we tested if
nicotine modified aldehyde effects, but nicotine [1μM] had no effect on
subsequent FA, AA and CR-induced vasorelaxation.
Aim 2. Determine the vascular effects (endothelium dysfunction) of
tobacco-product derived aldehydes exposures in vivo.
We hypothesize that the of electronic cigarettes or conventional tobacco
could cause cardiovascular injury through its aldehydes. Mice were exposed to
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FA (5ppm) or AA (5ppm) for 4 days, there was no significant change in aorta
function after FA or AA exposure. Mice were exposed to CR or air for 12 weeks
(1 ppm, 6h/day, 5 d/week). Blood pressure was significantly lower in the CR
group than in the air group for the last several weeks, but there was no difference
in the changes of heart rate between these two groups. Hemodynamic changes
were accompanied by changes in aortic vasoreactivity ex vivo. Following 12-wk
CR chronic exposure, there was no change in aortic response to phenylephrine
(PE), however, the sensitivity of ACh-induced relaxation was significantly
increased in the CR group. Similarly, aortic sensitivity to SNP relaxation was
enhanced by CR. To dissect the mechanism of CR-induced vascular changes,
we performed acute 4-day exposures (1 and 3 ppm). Similarly, CR exposure also
altered aortic responses to ACh and somewhat to SNP.
Aim 3. Are vascular effects of aldehydes mediated by TRPA1?
We hypothesize that the aldehydes derived from tobacco products induce
vascular injury might through the TRPA1 pathway. In our vivo study, since a 4day CR exposure was sufficient to alter aortic reactivity, we tested whether the
transient receptor potential ankyrin 1 (TRPA1) channel was involved. In TRPA1null mice exposed to CR (4-days, 1ppm), there were no changes in aortic
reactivity to any agonist (PE, ACh, and SNP) compared with air group, indicating
a distinct role of TRPA1. In our vitro study, since histology staining showed there
were a lot of TRPA1 proteins in endothelium in superior mesenteric artery (SMA).
We tested whether the relaxation of FA, AA or CR via TRPA1 pathway. TRPA1
antagonist (A967079) has significantly inhibited the relaxation of FA and CR at
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low concentrations in SMA. The relaxation of CR significantly decreased in
TRPA1-null mice. We concluded that the relaxation of FA and CR are TRPA1
dependent.
We also have tested the sex dependence in the cardiovascular effects of
aldehydes. In our vivo study, we tested a 4-day CR exposure to female mice,
Interestingly, there were also no differences in any aortic responses in CR versus
air-exposed female mice. For the in vitro study, there was no difference in the
relaxation of FA and AA between male and female mice. The mechanism of
female-dependent protection in mice is not clear.
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CHAPER II

A SIMPLE METHOD FOR NORMALIZATION OF AORTA CONTRACTILITY

Vascular contractile function changes in proliferative vascular diseases,
e.g., atherosclerosis, and is documented using isolated blood vessels, yet, many
laboratories differ in their approach to quantification. Some use raw values (e.g.,
mg, mN); others use a ‘percentage of control agonist’ approach; and, others
normalize by blood vessel characteristic, e.g., length, mass, etc. A lack of
uniformity limits direct comparison of contractility outcomes. To address this
limitation, we developed a simple 2-step normalization method: 1) measure blood
vessel segment length (mm) and volume (mm3); and, 2) normalize isometric
contraction (mN) by segment length and/or volume. Normalization reduced
variability, and thus, normalized aortic contractions but not raw values were
statistically different between normal chow (NC) and high fat diet-fed (HFD) mice
supporting the practical utility and general applicability of normalization. It is
recommended that aortic contractions be normalized to segment length and/or
volume to reduce variability, enhance efficiency and to foster universal
comparisons across myography platforms, laboratories and experimental
settings.
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1. Introduction
Cardiovascular disease is the leading cause of death worldwide.
Atherosclerosis is the primary form of cardiovascular disease that increases the
risk of myocardial infarction, stroke and peripheral arterial disease. An underlying
mechanism of atherosclerosis involves a ‘phenotypic switch’ in vascular smooth
muscle cells (VSMC) that transcriptionally moves VSMC from a contractile to a
proliferative or “synthetic phenotype” (Li et al., 2013; Z. Zhang et al., 2012). Thus,
(D. J. Conklin, Haberzettl, et al., 2009b) phenotypic change reflective of the
underlying local cellular and biochemical alterations such as in atherosclerosis.
Thus, laboratories around the world measure vascular contractile function in vitro
wherein an isolated blood vessel, e.g., aorta, is contracted with an agonist, e.g.,
phenylephrine (PE), endothelin-1, U46,619 – a thromboxane A2 analog, etc…
and data reported (D. J. Conklin & Boor, 1998; D. J. Conklin, Boyce, Trent, &
Boor, 2001b; D. J. Conklin, Haberzettl, et al., 2009b). The widespread use of in
vitro vascular contractility assays is revealed in PubMed search using the terms
“vascular” and “dysfunction,” which netted 214,358 hits, indicating a sizeable
research investment.
Although raw isometric data reflect vessel contractility, raw values (e.g., mg
or mN tension)(Reynolds et al., 2012) cannot be compared across different
laboratories due to obvious differences in the size of the blood vessel segment
(e.g., length, diameter), species, animal size, age, diet, and disease state as well
as the specific blood vessel or blood vessel location (e.g., thoracic vs abdominal
aorta). Additionally, different platforms or myography systems (e.g., DMT) are used
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to assess isometric force production. So, even if two laboratories use the same
system, the reporting of data can make it difficult to compare contractility due to
dissimilar units (mg vs mN) or a different data normalization procedure, e.g., % of
control agonist such as % contraction of high potassium solution)(Kim, Avila, &
Massett, 2016; Schepelmann et al., 2016) or differential normalization, e.g., mg
tension/cross-sectional area; mg tension/mg wet weight; mN/mm length (D. J.
Conklin & Boor, 1998; D. J. Conklin et al., 2004; D. J. Conklin, Haberzettl, et al.,
2009b). To address this obvious limitation and to foster more across-study and
laboratory comparisons, aortic contractions were normalized by several easily
measured parameters.
Several criteria need to be met to establish a universal normalization
method. For example, the method needs to be accessible, and thus, it should not
require costly equipment that may exclude users. It should be simple enough that
all users can implement the method. Moreover, the method should be cost
effective in that the time spent performing should be worth the effort. Because
current laboratories already use some form of normalization (e.g., as “% of control
agonist”) (Kim et al., 2016), a new approach must be cost effective and enhance
data quality over an existing practice. Finally, the method should foster data
comparisons for both cross-laboratory fertilization and greater biological
understanding. To this end, we offer a simple and cost-effective method for
normalization of vascular contractility that requires minimal equipment and effort
on the user’s behalf, yet refines the measurement of aortic contraction to a degree
wherein even modest changes in contractility (e.g., due to a treatment, aging, diet,
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etc…) are more readily discerned. Universally-normalized contractility data can be
shared and compared by laboratories around the globe. Adoption of this approach
may improve assessment of the biological actions of drugs, for example, and thus,
minimize the overall use of resources.

2. Materials and Methods
Rodents:
Male C57BL/6 mice were purchased from The Jackson Laboratory (Bar
Harbor, ME) or raised in house. Mice were fed normal chow (NC; 13% kcal fat,
Rodent Diet 5010, LabDiet; St. Louis, MO) or high fat (HFD; 42% kcal fat,
TD.88137, Harlan Teklad, Madison, WI) diet from 8 to 20 weeks of age. Male
Sprague-Dawley rats (wild type and low-density lipoprotein receptor deficient;
LDLR-null) were obtained from SAGE (Sigma-Aldrich) and fed normal chow diet
up to 1 yr of age (Sithu et al., 2017). Rodents were treated according to APS’s
Guiding Principles in the Care and Use of Animals and all protocols were approved
by University of Louisville IACUC. All rodents were anesthetized with sodium
pentobarbital (i.p., 150 mg/kg) and exsanguinated via right ventricle blood draw.
Equipment:
Digital handheld microscope (zORB, Carson, New York); scientific ruler (1
mm increments; Fine Science Tools); 10% neutral buffered formalin solution (NBF;
Sigma); Falcon® 12-well, clear, flat bottom plate (Corning Costar); ImageJ (NIH
free imaging software); razor blades; dental wax (Z Pink); general surgical tools
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(scissors, forceps); microfuge tubes; organ bath myography system; and,
microbalance.
Aorta Isolation and Organ Bath Systems:
Aortas were isolated via ventral thoracotomy and placed into cold
phosphate buffered solution (PSS) containing (in mM): NaCl, 130; KCl, 4.7;
MgSO4·7H2O, 1.17; KH2PO4, 1.18; NaHCO3, 14.9; CaCl2, 2.0; glucose, 5.0; pH
7.4. Distal thoracic aorta (located 0.8-1 cm from aortic arch apex) segments were
cut from each aorta (2-4 mm), cleaned of perivascular adipose tissue, and
mounted in one of two systems: 1) horizontal pin (DMT, Ann Arbor, MI); or, 2)
vertical wire system. In the horizontal pin system, a short, aortic segment (≈2 mm)
was mounted on stainless steel pins in a 5-ml heated (37 ºC) organ bath. One pin
was connected to an isometric strain gauge transducer, and the other was
attached to a micrometer. Transducer signals were fed directly into a PC with
LabChart software (v. 7 or 8; ADI). In the vertical wire system, an aortic segment
(3-5 mm) was placed on wire hooks (100 µm dia. tungsten wire) with a hook
connected to an isometric strain gauge transducer (Kent Scientific, Litchfield, CT)
and the other attached to a fixed support glass rod in a 15-ml heated (37 ºC) organ
bath. Transducer signals were fed into an 8-channel PowerLab A/D converter and
recorded on a PC using LabChart software (v. 4.3.2; ADI). Prior to each use, each
system was calibrated using standardized weights. In both systems, after 10 min
without tension, aortic rings were equilibrated to ≈9.81 mN (≈1 g) loading tension
over 30 min before agonist stimulation (D. J. Conklin, Haberzettl, Prough, &
Bhatnagar, 2009a).
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Statistics.
Values are expressed as mean ± SD or ± SE (where appropriate).
Comparisons between 2 groups (e.g., horizontal vs vertical system; User 1 vs User
2; etc…) were done with a paired or unpaired t-test as appropriate. P<0.05 was
considered significant.

3. Results and Discussion
Acquisition of Aortic Segment Parameters:
Normalization of contractions was done using a simple, sequential, multistep process that is described pictorially in Fig. 1, and described here as a general
protocol: 1) immediately formalin-fix a blood vessel segment; 2) obtain wet weight
(to 0.1 mg; dab extra fluid on tissue paper); 3) image segment lengthwise with
scientific ruler (Fig. 1a); 4) cut (with razor blade) and image (with handheld digital
microscope) a thin (0.5 mm) blood vessel cross-section (x-sec) with a ruler in the
image (Fig. 1b); 5) using ImageJ, quantify segment length (mm) and x-sec area
(mm2)(Fig. 1c); and, 6) calculate segment volume (mm3) as the product of length
(mm) and x-sec area (mm2), and the normalize isometric contractions by segment
length (mN/mm), x-sec area (mm2), and volume (mN/mm3).
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Figure 1. Images of method for aortic parameter data acquisition. a) Digital
images of blood vessel segment length (mm) acquired with digital minimicroscope camera. b) Digital image of blood vessel cross-section over-laid with
digital outlines of outer and inner circumferences (NIH ImageJ). The outer area
(OA) minus the inner area (IA) is the segment cross-sectional area (mm2). c)
Calculation of blood vessel segment volume ( volume = cross-section area *
length = mm3). (Permission with S. Karger AG, Basel.)
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Aortic Function:
Aortic vascular contractile function was assessed using both a horizontal
and a vertical isometric tension organ bath system as reported previously (D. J.
Conklin, Haberzettl, et al., 2009a). To illustrate the utility of the normalization
protocol, the distal thoracic aorta of a mouse was sectioned into 2 obvious,
unequal lengths. A shorter piece (1.5-2.5 mm) was mounted in the horizontal pin
system and a longer piece (3-4 mm) was mounted in the vertical system. Both
segments were equilibrated similarly (≈9.81 mN tension). As intended in this
‘proof of principle’ example, the absolute (raw) tension of aortic contractions (mN)
induced either by cumulative concentrations of PE (1 nM-10 µM; Fig. 2a) or by
high potassium solution (100 mM; Fig. 2b) was significantly different between the
two due to the intentional difference in blood vessel segment size (≈2x).
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Figure 2. Normalization of vascular contractility data. Contraction data (Raw, mN)
and data normalized by aorta cross-sectional area (mN/mm2), length (mN/mm),
and volume (mN/mm3) were plotted. To generate tension data, two aortic
segments were exposed to contractile agents: a) phenylephrine (PE, 1 nM-10 μM);
and, b) high potassium (100 mM) buffer; in a horizontal pin (DMT; 1, filled symbols),
or a vertical wire (2, open symbols) organ bath system. After experimentation,
length and cross-sectional area of the blood vessel segments were measured and
the segment volume calculated from these values (volume = cross-section area *
length; see Fig. 1). (Permission with S. Karger AG, Basel.)
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Normalization of Aortic Contraction:
After acquisition of aortic parameters, cumulative PE and high potassiuminduced contractions were normalized to x-sec area, length, and volume (Fig. 2).
Normalization of raw tension by segment volume (mN/mm 3) resulted in the most
similar PE-induced tension curves (see curves of “Volume 1” and “Volume 2”; Fig.
2a). Whereas normalization of raw values to either x-sec area or length were
beneficial in reducing the difference between “Raw 1” and “Raw 2” values, but
neither was superior to normalization by volume. Notably, in a separate study, a
group used a standardized mouse aorta segment length (3 mm) to normalize
contractility and arrived at values similar to ours, thus, supporting the idea that
normalized contractions even to one dimension (e.g., length; mN/mm) likely is
better than no normalization (Fig. 2a) (Silva et al., 2016). Normalization efficacy
was independent of the contractile agonist because a similar effect was observed
when high potassium-induced maximal tension was normalized to x-sec area,
length and volume (Fig. 2b). As for PE, normalization to volume appeared to
perform better than using either length or area alone.
In a second, real-world example, contractility was measured in aortas isolated from
C57BL/6 mice fed either a normal chow (13% kcal fat) or high fat diet (42% kcal
fat) for 12 weeks. As all aorta segments had similar lengths, x-sec areas, and thus,
volumes (Table 1), direct comparison of raw contractility values revealed that 12
weeks of HFD appeared to decrease PE-induced contractions relative to aortas of
NC-fed mice yet there were no statistically significant differences (Fig. 3a). To
assess whether normalization would unmask differences in contractility, raw
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values were normalized by area (Fig. 3b), length (Fig. 3c) and volume (Fig. 3d).
When normalized to aortic segment length or volume, contractions were
statistically different between NC and HFD mice (Fig. 3c, d). Regression analyses
revealed that aortic length (mm; Fig. 3e) and volume (mm3; Fig. 3f) were
correlated with contractility (mN) more strongly in aorta of NC- than in HFD-fed
mice. Moreover, volume appeared to perform better as a denominator than did
length in both NC- and HFD-fed mice (Fig. 3e, f). Overall, these data indicate that
normalization of aortic contractility enhanced detection of statistically significant
changes induced by HFD (Fig. 3d). Another real world example was performed
using aortas isolated from 1-year old Sprague-Dawley rats that were wild type or
deficient of LDLR (LDLR-KO). As all aorta segments had similar lengths, x-sec
areas, and thus, volumes (Table 2), direct comparison of raw contractility values
revealed that genetic deletion of LDLR increased PE-induced contractions relative
to aortas of WT rats (Fig. 4a). To assess whether normalization would alter the
difference in contractility based on raw values, values were normalized by length
(Fig. 4b), x-sec area (Fig. 4c) and volume (Fig. 4d). Normalization of raw
contractility data to aortic segment length, area or volume only enhanced the
statistically significant differences between WT and LDLR-KO rats (Fig. 4b, c, d).
Overall, these data indicate that normalization of aortic contractility improves
detection of statistically significant changes induced by genetic deletion of LDLR
in rats.
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Table 1. Thoracic aorta segment parameters from C57BL/6 mice fed normal chow (n=9)
or high-fat diet (n=10) for 12 weeks.
Parameter

Diet
Normal chow

High-fat diet

Wall area, mm2

0.246±0.024

0.225±0.020

Length, mm

3.96±0.56

4.37±0.41

Volume, mm3

0.976±0.178

0.990±0.171

Values = means ± SE; n = 9,10 mice, respectively.
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Figure 3. Normalization of vascular contractility of aortas from C57BL/6 mice fed
normal chow (NC; n=9 mice) or high fat diet (HFD; n=10 mice) for 12 weeks.
Phenylephrine (PE)-induced raw contraction data (a, mN) and raw data normalized
by aorta length (b, mN/mm), x-sec area (c, mN/mm2), and volume (d, mN/mm3).
Values = mean ± SE. n = 9 or 10 aortas (1 aorta per mouse). *, P<0.05 between
NC and HFD. (Permission with S. Karger AG, Basel.)
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Table 2. Normalization of high potassium-induced (100mM) isometric
contractions in thoracic aortas isolated from male mice fed either normal chow
(NC) or high fat diet (HFD) for 12 weeks.
Group
mN
mN/mm
mN/mm2
mN/mm3
NC
8.26±1.03
2.08±3.32
33.16±3.32
8.37±0.71
HFD
5.54±0.61
1.26±0.13
24.61±2.60
5.66±0.57
p value
0.0330
0.0047
0.0562
0.0079
Value = means ± SE; n = 9,10 mice, respectively; p values shown are results of
unpaired t tests between NC and HFD groups.
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Table 3. Thoracic aorta segment parameters from wild-type (WT) and LDLR-null
(LDLR-KO) 1-year-old Sprague-Dawley rats.
Parameter

Strain
WT
1.251±0.213
3.07±0.49
3.90±1.055

Wall area, mm2
Length, mm
Volume, mm3
Values = means ± SE. n = 5,6 rats, respectively.
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LDLR-KO
1.168±0.224
2.74±0.48
3.269±1.138

Table 4. Normalization of PE-induced (10 μM) isometric contractions in thoracic
aortas isolated from wild-type (WT) and LDLR-null (LDLR-KO) 1-year-old
Sprague-Dawley rats.
Group
mN
mN/mm
mN/mm2
mN/mm3
NC
15.10±2.55
4.85±0.66
12.09±1.59
3.98±0.52
HFD
22.29±2.34
8.36±1.09
19.57±2.35
7.50±1.27
p value
0.0680
0.0283
0.0327
0.0413
Value = means ± SE; n = 5,6 rats, respectively; p values shown are results of unpaired
t tests between WT and LDLR-KO groups.
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Figure 4. Normalization of vascular contractility of aortas from Sprague-Dawley
wild type (WT; n=5 rats) and LDLR-KO rats (n=6 rats) fed normal chow for 1 year.
Phenylephrine (PE)-induced raw contraction data (a, mN) and raw data normalized
by aorta length (b, mN/mm), x-sec area (c, mN/mm2), and volume (d, mN/mm3).
Values = mean ± SE. n = 5 blood vessels. *, P<0.05 between WT and LDLR-KO
rats. (Permission with S. Karger AG, Basel.)
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Method Validation:
The ‘proof of principle’ tests (i.e., platforms; NC vs HFD; WT vs LDLR-KO)
support the general applicability of our normalization approach, so we also
performed four validation tests. These were: 1) two different ‘users’ quantified the
same ring images using ImageJ; 2) two different users quantified the same image
multiple times (e.g., 10 times); 3) two different users imaged and then quantified
multiple sections from a single aorta; and, 4) normalization was performed using
segment volume calculated by 2 different methods: a) our image analysis
approach; and, b) volume estimated from segment weight (in mg) and density
(mg/l; mg/mm3).
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Reproducibility.
Image analysis for length and x-sec area proved highly reproducible (Fig.
5). It appeared that users vary in their first attempt to quantify length, but users
rapidly adjusted and subsequently made consistent measurements of the same
image. These data support the robust and cost-effective nature of our approach.
Images were made with an inexpensive microscope camera (<$50) and were
analyzed with free imaging software (NIH ImageJ). The approach was independent
of the user because measurements made by 2 users of both area (Fig. 6a) and
length (Fig. 6b) using the same 5 blood vessel segments were similar. Although
noticeable divergence in volumes between users was present (Fig. 6c), both
variability and directionality of values were preserved -- indicating both robustness
and consistency. Our approach also compared favorably to using blood vessel
volume estimated as the quotient of blood vessel mass and reported aortic density,
i.e., 0.86 mg/L (Weind, Ellis, & Boughner, 2002) (Fig. 6d). We think that there is
inherently more difficulty in accurately measuring the mass of a wet blood vessel
than our image-based approach. First, it should be recognized that a short,
cleaned segment of mouse aorta weighs approximately 0.1-0.2 mg, and a highquality balance capable of such a measurement is costly. Second, much smaller
blood vessels, e.g., mesenteric, may be difficult to weigh accurately because of
lumen fluid retention that is difficult to remove without rapidly “drying out” the blood
vessel segment (Murphy, 1980). Thus, our low-cost approach is more practical and
avoids these pitfalls.
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We also tested whether a single blood vessel segment would yield different
x-sec areas along its length and whether this was dependent on user evaluation.
Although variation in x-sec area was apparent, it appeared less dependent on user
and more on image quality and segment location (Fig. 7). These data further
emphasize that specific user-based analysis of an image is a less important
determinant of x-sec area than is the image quality and blood vessel location (e.g.,
thoracic aorta tapers proximal to distal). Of course, quality control of image
analysis needs to be established in each laboratory adopting this approach. We
purposefully used a low cost, highly portable ‘hobby’ or classroom-style digital
camera/microscope to emphasize that even rudimentary optics are sufficient to
perform blood vessel analysis yet practice is required.
Resiliency to Prolonged Formalin Fixation.
Formalin fixation for 1 week (Fig. 8a), 1 month (Fig. 8b) and up to 2 months
(Fig. 8c) had little effect on quantified aortic segment volume, so it is feasible to
formalin fix a blood vessel and still obtain reliable and robust measurements for
normalization long after contractility experiments were performed. Additionally,
fixed blood vessel segments can be processed, embedded, sectioned and stained
for more refined morphometry of the blood vessel wall (D. J. Conklin, Kong, &
Committee, 2015).
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Figure 5. Reproducibility of aorta parameter data acquisition: intra-assay variation.
The same images of a blood vessel lengthwise and in cross-section (ring) were
repeatedly examined for length and cross-sectional area (x-sec area), respectively,
as described above using ImageJ a total of 10 times by two different observers.
Blood vessel volume (mm3) was calculated by multiplying length (mm) × x-sec area
(mm2). Values = mean ± SD. (Permission with S. Karger AG, Basel.)
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Figure 6. Reproducibility of aorta parameter data acquisition: inter-assay variation.
a) Aorta cross sectional area (mm2) measured in five separate aortas
independently by two users (User 1; User 2). b) Aorta segment length (mm)
measured independently by two different users in five separate aortas. c) Volume
(mm3) calculated five times by two users. d) Aortic volume calculated from image
analysis compared with volume derived from segment weight and aorta density
(0.86 mg/L). Values = mean ± SD. (Permission with S. Karger AG, Basel.)
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Figure 7. Intra-aortic variation in cross-sectional area. A single thoracic aorta
segment was cut into five cross-sections (“donut”) and each cross-section was
imaged and the area measured by two independent users (User 1; User 2). Values
= mean ± SD. (Permission with S. Karger AG, Basel.)
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Figure 8. Resiliency of aorta parameter data acquisition over time. Comparison of
aorta volumes measured after formalin fixation of the blood vessel. A) Aorta
volume measured 1 week after formalin fixation. B) Aorta volume measured 1
month after formalin fixation. C) Aorta volume measured 2 months after formalin
fixation. Values = mean ± SD. (Permission with S. Karger AG, Basel.)
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Major Advantages and Limitations:
The current study describes a novel method for normalization of vascular
contractility in vitro, and highlights 4 major advantages: 1) the method is simple
and low cost, and thus, accessible world-wide; 2) the method is validated and is
reproducible across different platforms and users; 3) the method is resilient to the
chronic storage of blood vessels in formalin; and, 4) if adopted, normalized
vascular contraction data with a ‘universal unit’ (either mN/mm or mN/mm 3) will
allow for more across study and across laboratory comparisons, and thus, more
efficient use of research resources.
There are several caveats to this method. This method does not define the
optimal state of contractility or the mechanisms of change in contractility. It is
expected that laboratory conditions likely will vary in many ways that meaningfully
contribute to real differences in contractility (e.g., buffer composition, loading
tension, temperature, inhibitors, denuding, etc…), but “all things being equal,” this
approach provides a common denominator, which currently is not used by most
laboratories. As indicated above, the method reduces variability in raw values by
correcting for differences that arise as a function of blood vessel segment size.
Blood vessel segments differ in size simply because two different laboratories use
different platforms. An obvious limitation is that we only tested the protocol using
aortas from mice and rats, however, the method will likely work in other blood
vessels because there is an inherit reliance of vascular contraction on smooth
muscle that makes up the bulk of the media in aorta and other arteries as well. In
any case, we predict that normalization (with segment length and/or volume) is
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superior to using only raw contraction values. In our real-world example, we detect
significant changes in aortic contractility with HFD feeding (vs NC) only when we
normalized contractions (see Fig. 3). This outcome has value because importantly
it reduces the overall cost of a study by reducing the number of animals needed in
a study. Finally, our approach is validated to be robust, consistent, reproducible
and resilient. It is recommended that isometric vascular contractions be normalized
to either blood vessel segment length (mN/mm) or volume (mN/mm 3) to foster both
improved quantitative assessment of contractility changes and across study
comparisons.
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CHAPTER III
FORMALDEHYDE INDUCES MESENTERIC ARTERY RELAXATION VIA A
SENSITIVE TRANSIENT RECEPTOR POTENTIAL ANKYRIN-1 (TRPA1) AND
ENDOTHELIUM-DEPENDENT MECHANISM

Introduction Formaldehyde (FA), the smallest aldehyde, is generated
endogenously, and is widespread in the environment in foods, beverages and as
a gas phase product of incomplete combustion. Methods and Results The main
metabolite of FA, formate, was increased significantly in murine urine (3x) after
overnight feeding. Because feeding increases mesenteric blood flow, we explored
the direct effects of FA in isolated murine superior mesenteric artery (SMA). Over
the concentration range of 30-1,200 μM, FA strongly and reversibly relaxed
contractions of SMA induced by three different agonists: phenylephrine (PE),
thromboxane A2 analog (U46,619) and high potassium (high K+, 60 mM K+).
Formate (to 1.5 mM) did not induce relaxation. FA (>1,500 μM) irreversibly
depressed vascular function in SMA indicating vasotoxicity. The sensitivity (EC 50)
but not the efficacy (% relaxation) of FA-induced relaxations was dependent on
blood vessel type (SMA << aorta) and contractile agonist (PE, EC50=52±14 μM;
U46,619, EC50=514±129 μM; 60K, EC50=1,093±87 μM). The most sensitive
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component of FA vasorelaxation was within physiological levels (30-150 μM) and
was inhibited significantly by: 1) mechanically-impaired endothelium; 2) Nω-NitroL-arginine methyl ester hydrochloride (L-NAME); 3) transient receptor potential
ankyrin-1 (TRPA1) antagonist (A967079); 4) guanylyl cyclase (GC) inhibitor (ODQ);
and, 5) K+ channel inhibitor (BaCl2). A similar mechanism of SMA vasorelaxation
was stimulated by the TRPA1 agonist cinnamaldehyde. Positive TRPA1
immunofluorescent staining and gene-specific sequence were present in SMA but
not in aorta. Conclusion These data indicate FA, but not formate, robustly relaxes
SMA via a sensitive TRPA1- and endothelium-dependent mechanism that is
absent in aorta. Thus, as FA levels increase with feeding, FA likely contributes to
the physiological reflex of post-prandial hyperemia via SMA vasodilatation.

1. Introduction
Formaldehyde (FA) is the smallest aldehyde and the concentration of FA in
the blood ranges from 0.0127 to 2.28 μg/mL (1.9 to 5.4 mg/L; or 63-179
µM)(Kleinnijenhuis, Staal, Duistermaat, Engel, & Woutersen, 2013; Y. S. Wang et
al., 2011). FA is in food and beverages (likely the largest quantitative source of
exogenous FA) and is metabolically-derived (D.J. Conklin, P. Haberzettl, J. Lee,
& S. Srivastava, 2011). Exogenous FA is a volatile indoor and outdoor pollutant
emitting from building materials (e.g., plywood, glues, carpet, drapery), and
present in cosmetics, vehicle exhaust, photochemical smog and tobacco-derived
aerosols (D. J. Conklin, P. Haberzettl, J. Lee, & S. Srivastava, 2011; Ogunwale et
al., 2017). Endogenous FA is generated by breakdown of L-methionine, histamine,
50

methanol and methylamine, and may contribute to biological methylation of folic
acid (Yu & Zuo, 1996). Thus, blood levels of FA are in constant flux due to rapid
changes in exposure, absorption, distribution, metabolism (to formate and CO2)
and excretion.
Although direct effects of FA on cardiovascular targets are described, the
role of FA in cardiovascular physiology is not well explored. For example, intraarterial or intravenous FA reduces heart rate (bradycardia), decreases arterial
pressure (hypotension) and causes arrhythmias in animals (Strubelt, Brasch,
Pentz, & Younes, 1990; Tani & Horiguchi, 1990; Tani, Kogi, & Horiguchi, 1986;
Tani, Satoh, & Horiguchi, 1978), but these are considered toxicological effects due
to high doses administered directly into the blood. Because FA is toxic in cultured
endothelial cells (inhibition of mitosis, increased apoptosis), vascular smooth
muscle cells and cardiomyocytes (D. J. Conklin, Langford, & Boor, 1998), it is, thus,
speculated that endogenously-generated FA induces endothelium dysfunction by
which it accelerates diabetic complications such as atherosclerosis (Deng & Yu,
1999). However, FA induces a concentration-dependent relaxation in isolated
blood vessels (D. J. Conklin et al., 2004; Tani, 1981; Q. Zhang et al., 2018) yet the
relevance of this effect in vascular physiology is unclear.
Despite myriad sources of FA and its provoked cardiovascular effects, few
studies address the vascular effects of physiological levels of FA. Formate is a
stable metabolite of FA generated from a 2-step enzymatic process involving
glutathione-dependent formaldehyde dehydrogenase (FALDH2) hemi-thioacetal
formation and aldehyde dehydrogenase 2 (ALDH2) mediated oxidation (Conklin et
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al., 2006). In the current study, we measured urine levels of formate, the primary
metabolite of FA, to estimate changes in endogenous FA levels. As murine urine
levels of formate increased 3 times overnight (with feeding) compared with levels
after daytime fast, we think feeding increased endogenous FA levels (directly or
indirectly). As such, the gastrointestinal vasculature represents a likely target of
changes in FA levels following feeding when reflexively blood flow increases in the
gut (Takagi, Naruse, & Shionoya, 1988). Thus, to address potential FA-induced
vascular effects, isolated superior mesenteric artery (SMA) and aorta were
exposed to FA across a physiologic to toxic range (30-1,500 µM). Although an FAinduced vasorelaxation was present in both blood vessels, the most sensitive
relaxation was present in SMA indicating that physiologic levels of FA likely
stimulate dilation in SMA before aorta. Thus, we identified the mechanisms of the
FA-induced relaxation (30-150 µM) as dependent on: a functional endothelium,
TRPA1 activation, NO formation, guanylyl cyclase activation, and potassium
channels. Formate, though, had no effect in blood vessels up to 1,500 µM. These
data collectively support the idea that feeding increases FA levels, and that FA
(and not formate) likely contributes to increased gastrointestinal blood flow of
feeding (i.e., postprandial hyperemia) through a sensitive, robust and reversible
TRPA1- and endothelium-dependent mechanism.

2. Material and Methods
Chemicals and Solutions.
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Reagent grade chemicals were purchased from Sigma-Aldrich or other
commercial sources as indicated: A967079 (AdooQ); acetylcholine chloride (ACh);
4-aminopyridine (4-AP); barium chloride (BaCl2); cinnamaldehyde ( %); formalin
(formaldehyde, 37% and methanol, 10-15%); formate; 1h-[1,2,4]oxadiazolo[4,3a]quinoxalin-1-one (ODQ); N-nitro-L-arginine methyl ester hydrochloride (LNAME); L-phenylephrine hydrochloride (PE); sodium nitroprusside (SNP);
tetraethylammonium chloride (TEA); and, U46,619 (thromboxane A2 analog).
Krebs physiological salt solution (PSS) for SMA was (in mM): NaCl, 119; KCl, 4.7;
CaCl2, 2.5; MgCl2, 1.2; KH2PO4, 1.2; NaHCO3, 24; glucose, 7.0; pH 7.4. Krebs
PSS for aorta was (in mM): NaCl, 118; KCl, 4.7; CaCl2, 2.5; KH2PO4, 1.2; MgSO4,
1.2; NaHCO3, 12.5; and, glucose, 5.5; pH 7.4. High K+ PSS (60K; 60 mM)
substituted equimolar K+ for Na+.
Animals.
Wild type C57BL/6J mice from in house breeding pairs or purchased (The
Jackson Laboratory, Bar Harbor, ME) (12-20 weeks old; 25-35g) were used in
these studies. Mice were treated according to American Physiological Society
Guiding Principles in the Care and Use of Animals, and all protocols were
approved by University of Louisville Institutional Animal Care and Use Committee.
Mice were housed under pathogen-free conditions in the University of Louisville
vivarium under controlled temperature and 12h light:12h dark cycle. Mice were
provided a standard chow diet (Rodent Diet 5010, 4.5% fat by weight, LabDiet; St.
Louis, MO).
Urine Collection and Formate Measurement.
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Urine samples were collected, centrifuged (2,500 RPM, 10 min, 4 C),
decanted, and stored at -80 °C until analysis (D. J. Conklin et al., 2017). In brief,
each mouse was briefly exposed to D-glucose/saccharin solution (w/v;
3.0%/0.125%; Sigma) immediately prior to a 6h fast after which each was placed
singly in a metabolic cage (Harvard Apparatus) with glucose/saccharin solution in
drinking water without food to collect urine (in 4°C water-jacketed organ baths) for
3h. In total, mice were fasted for 9-h. After fasted urine collection, mice were
provided food along with glucose/saccharin solution for an overnight urine
collection (O/N). Urine samples were collected, centrifuged, decanted, and stored
at -80 °C (D. J. Conklin et al., 2017).
The primary urinary metabolite of FA is formate and it was measured using
GC-MS as described previously (Kage, Kudo, Ikeda, & Ikeda, 2004; Lamarre et al.,
2014) with minor modifications. Briefly, urine (50 µL) was mixed with sodium
phosphate (20 µL 0.5M, pH 8.0) containing internal standard (13C-formate, 2.3 mM).
Samples were incubated with PFBBr (130 µL, 0.1M) for 15 min at 60°C, extracted
with hexane (330 µL), and analyzed by GC-MS in electron ionization (EI) mode.
Six-point calibration curve was used to calculate the concentration of formate.
Results were corrected for the natural abundance of

13C

isotope. Formate level

was normalized to urinary creatinine (mg) to account for urine dilution.
Isolated Superior Mesenteric Artery (SMA) and Aorta.
Mice were anesthetized with sodium pentobarbital (0.1 ml, 150 mg/kg, i.p.),
and SMA and aorta were removed via mid-ventral thoracotomy. Thoracic aorta
rings (3-4 mm) were hung on stainless steel hooks in 15-ml water-jacketed organ
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baths and SMA rings (2 mm) were hung on tungsten wire (75 µm dia.) in 5-ml
heated organ baths (MultiWire Myograph System 620M, DMT, Denmark) in PSS
bubbled with 95% O2: 5% CO2 at 37 °C. After 10 min without tension, aorta rings
were equilibrated to ≈1g loading tension over 30 min and SMA rings were
equilibrated to ≈0.25g loading tension over 1h. All rings were stimulated with high
K+ to test for viability, washed 3 times with PSS over 30 min, and re-equilibrated
to appropriate resting tension.
FA-Induced Relaxation in Isolated Superior Mesenteric Artery (SMA) and
Aorta:
Formaldehyde (30-1,500 µM) was added to organ baths containing either
aorta or SMAs pre-contracted with 1 of 3 contractile agonists: phenylephrine (PE,
10 µM), U46,619 (0.1 µM), or high K+ (60 mM). The efficacy of FA-induced
relaxation was calculated as the % reduction in agonist-induced contraction. The
sensitivity of FA-induced relaxation was calculated as the effective concentration
producing 50% response (EC50), i.e., cumulative concentration responses were
normalized to 100% with interpolation of EC50. To assess whether time of day
affected SMA response to FA, mice were euthanized both in day and in night cycle.
Sensitivity to a known TRPA1 agonist, cinnamaldehyde (1-100 µM), were
conducted, and because cinnamaldehyde is immiscible in aqueous solution,
dilutions were vigorously vortexed immediately prior to addition to organ baths.
Effects of Formate (FA metabolite) and Methanol: FA is oxidized to formate
(primary urinary metabolite), and thus, we tested whether formate could induce
vasorelaxation or vascular toxicity (50 to 1,500 µM) in PE pre-contracted aorta and
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SMA. Because formalin (a source of FA) contains 10-15% methanol (as a
stabilizer), we also tested whether formalin or methanol alone (to 0.001%,
equivalent to amount present in 1,200 µM formalin) contributed, in part, to FAinduced relaxation.
Role of Endothelium, Nitric Oxide Synthase (NOS), and cGMP:
To evaluate the role of NOS, L-NAME (0.1 mM) was added prior (15 min)
to addition of PE (10 µM), U46,619 (0.1 µM) or High K+ (60 mM). Pre-contracted
SMA rings were then relaxed with cumulative concentrations of FA (50, 150, and
300 µM). The role of the endothelium was assessed as vasorelaxation to
increasing FA concentrations (50, 150, 300, and 600 µM) in aorta and in SMA with
intact and injured endothelium. The endothelium was mechanically-injured by air
perfusion, and effective impairment was confirmed by near complete abolition
(>95%) of ACh-induced dilation of PE pre-contracted blood vessels. To assess
whether cGMP was involved in FA-induced vasorelaxation, isolated blood vessels
were pre-incubated with ODQ (3 µM) to inhibit guanylyl cyclase (GC) and
subsequent formation of cGMP (Jiang, Wan, Wang, & Wu, 2015).
Role of TRPA1 Channel:
The role of the TRPA1 channel was assessed by addition of TRPA1
antagonist (A967079, 1 µM; 10 min; Cat. #: A12353, AdooQ, Invine, CA) or DMSO
(vehicle) in PE-precontracted aorta and SMA followed by cumulative addition of
FA (30-300 µM).
Role of K+ Channels:
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The role of K+-channels in FA-induced responses were interrogated using
KIR channel inhibitor (BaCl2, 1 mM) and the non-specific Kv channel inhibitor
(tetraethylammonium, TEA, 10 mM).
Role of nicotine:
Because most cigarette and e-cigarette contains nicotine, we tested
whether nicotine would affect FA-induced relaxation in PE-precontracted SMA.
Histology and TRPA1 Immunofluorescence.
Thin sections (4 µm) of formalin-fixed, paraffin-embedded SMA and dorsal
root ganglia (DRG; positive control) of WT mice were stained with H&E and TRPA1
antibody (1:200; Alomone Labs, Israel; Cat. #: ACC-037)(N. Green, Weech, &
Walters, 2005). Images of SMA sections were made using a digital Spot camera
mounted on an Olympus microscope. Immunofluorescence microscopy was
performed with rabbit polyclonal antibody against TRPA1 without or with a blocking
peptide of the TRPA1 antibody and Alexa Fluor 647 goat anti-rabbit secondary
antibody (1:400 dilution; Invitrogen; Cat. #: 21244). To label endothelial cells,
sections were co-stained with isolectin GS-IB4 Alexa Fluor 594 conjugate (1:200
dilution; Invitrogen; Cat. #: I21413). Briefly, the slides were deparaffinized, and
heat-mediated antigen retrieval was performed in 10 mM citrate buffer (pH 6.0) for
20 min at 95 ºC. The slides were cooled to room temperature and then incubated
with blocking buffer (10% goat serum, 1% BSA, 0.025% triton X-100 in 1X TBS)
for 2h at RT and then incubated with either TRPA antibody in blocking buffer
without and with blocking peptide against TRPA1 (the TRPA1 antibody and the
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blocking peptide at 1:1 ratio; µg/µg) was mixed and pre-incubated for 1h at RT
before adding on top of the tissue sections) in blocking buffer overnight at 4 o C.
The slides were incubated with anti-rabbit Alexa Fluor 647 secondary antibody in
the dark for 1h at RT. The slides were washed 3 X 5 min with 1X TBST after each
step. Tissue sections incubated with secondary antibody only served as a negative
control. Slides were covered with DAPI containing Slow Fade ® Gold anti-fade
reagent (Invitrogen; Cat. #: S36938) and fluorescence was visualized on a Nikon
eclipse Ti fluorescence Microscope using NIS-Elements (Nikon; Japan) at 200X.
A DAPI filter was used for nuclear staining and a Cy5 Red filter for TRPA1 staining.
TRPA1 qRT-PCR.
Total RNA was isolated from approximately 10 mg of SMA (8 arteries
pooled) and DRG (positive control) from WT mice with Trizol (Invitrogen) and
RNeasy MiniKit (QIAGEN) according to manufacturer’s instructions. RNase-free
DNase (QIAGEN; Cat. # 79254) was used to remove any contaminating DNA.
RNA was eluted from RNeasy mini-columns into 30 μL of RNAse-free water and
the concentration measured using NANODROP 2000C (Thermo Scientific). Total
cDNA was synthesized using iScript cDNA synthesis Kit (BIO-RAD; Cat. # 1708891) according to manufacturer’s instructions. Briefly, 15 μL denatured RNA
(250 ng), 4 μL 5X iScript reaction mix and 1 μL of iScript reverse transcriptase
were mixed (total volume, 20 μL) and cDNA synthesis was carried out in a BioRad mycycler Thermocycler using the following conditions: 42 °C for 60 min and
94 °C for 5 min. The resultant cDNA was target amplified using TRPA1 specific
primers. (Forward 5’-GAT GCC TTC AGC ACC CCA TTG- 3’; Reverse 5’-CAC
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TTT GCG TAA GTA CCA GAG TGG- 3’). Real-time quantitative PCR was done
using a murine specific TaqMan gene expression assays. Briefly, the following
were added to each well of a 384-well plate sequentially: 5.0 μL of 2X TaqMan
Fast Universal PCR Master Mix (Cat.no. 4440040), 2 μL undiluted cDNA from
target specific PCR and 3 μL of murine primers for mTrpa1, (Mm01227447_m1,
Cat. # 4351372) or β-actin (Mm00607939_m1, Applied Biosystems, Cat. #
4331182) for TaqMan assays (total = 10 μL final volume), and then subjected to
qRT-PCR using standard protocols on an Applied Biosystems 7900 HT Real-Time
PCR system. For each RNA sample, the cDNAs were run in duplicate for each
assay set in the same plate along with β-actin. The expression level of TRPA1 in
both SMA and DRG are expressed as ct values.
DNA Sequencing and Agarose Gel Electrophoresis.
PCR products from TRPA1 TaqMan assay were run on 1.5% agarose gel
and stained with ethidium bromide to visualize the expected 101 bp band in WT
SMA and DRG. Also, the PCR product from Target specific TRPA1 amplification
(309 bp) of SMA and DRG were sequenced on Illumina NextSeq 500 by the Center
for Genetic and Molecular Medicine (CGEMM University of Louisville) sequencing
service core.
Statistical Analyses.
Data are expressed as means ± SE. When comparing two groups, a t-test
was used (paired or unpaired as appropriate), and statistical significance was
assumed where P<0.05 (SigmaPlot, ver. 11).

59

3. Results
Formate: the primary FA metabolite is increased with feeding.
Formate is the primary metabolite of FA, and formate in the urine is a
consequence of endogenous FA metabolism, so we measured urinary formate by
GC-MS. We found that feeding significantly increased the urinary levels of formate
indicating a major source of endogenous FA is either directly from food or related
to feeding, e.g., metabolism of food constituents, intermediary metabolism, etc...
In male C57BL/6J mice, a daytime fast (9 h) resulted in a basal level of urinary
formate that was tripled with overnight feeding (Table 5). A similar pattern occurred
in female C57BL/6J mice (data not shown). Thus, we infer that feeding increased
FA levels that subsequently increased formate excretion in urine.
FA-induced relaxation.
FA (from 30 µM to 1.2 mM) induced a robust, repeatable and concentration- and
agonist-dependent relaxation in isolated SMA and aorta of both male and female
mice (Fig. 9 A-D; Table 6). Regardless of agonist (PE, U46,619, high K+), FA
relaxed agonist-induced tension by >90% in SMA and aorta (Table 7), yet when
added to an uncontracted vessel, FA did not affect basal tone (myogenic tone;
data not shown). FA-induced relaxation up to 1.2 mM (SMA) and 1.5 mM (aorta)
did

not

alter

subsequent

agonist-induced

contractions or ACh-induced

(endothelium-dependent) relaxation indicating no overt vasotoxicity. Irreversible
toxicity was, however, detected following exposure to high levels of FA (>1.2 mM
in SMA; >1.5 mM in aorta) with vasotoxicity defined as near loss of contractility
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even after multiple bath changes (e.g., 3 washouts, <10% tension production of
first agonist-induced contraction; data not shown).
FA: formate and methanol.
Because FA is metabolized to formate, it is possible that vascular effects of
FA (and its precursors) are the result of FA metabolism to formate. To address this
possibility, formate was cumulatively added up to 2.1 mM in PE pre-contracted
SMA. Formate induced a weak relaxation indicating that FA-induced relaxation
was not a result of formate production (Table 7). Formalin, a mixture of FA (37%)
and methanol (10-15% as stabilizer), induces TRPA1-dependent vasodilation and
pain (McNamara et al., 2007), yet it is unknown if this is due to either FA or
methanol (or both). Because FA also is a product of methanol metabolism, we
tested whether methanol alone (at levels comparable with those present in formalin)
had any effect in PE pre-contracted SMA.

Methanol also induced a weak,

modestly concentration-dependent relaxation in SMA. Thus, neither formate nor
methanol appears responsible for the efficacy of FA- or formalin-induced
relaxations, respectively. These data also implicate real time metabolism of FA (to
formate) as a relevant vaso-regulatory step because it converts an active agent
(FA) into an inactive metabolite (formate). Thus, alterations in FA metabolism in
the vascular wall may be a targetable process to promote or diminish feedinginduce hyperemia.
Role of endothelium, nitric oxide synthase (NOS), and GC in FA-induced
vasorelaxation.
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To investigate the mechanism of the most sensitive component of the FAinduced relaxation, we used PE-precontracted SMA (PE<U46,619<60K). Because
the SMA has a robust ACh-induced, endothelium-dependent relaxation that was
impaired significantly by air perfusion (Fig. 10), we tested for the role of
endothelium in FA-induced relaxation. Air perfusion significantly shifted FAinduced relaxation rightward in SMA (Fig. 11 A, B). Similarly, the sensitivity (EC50)
but not the efficacy of FA-induced vasorelaxation in PE-pre-contracted SMA was
affected by L-NAME (100 µM) (Fig. 11 C, D). However, L-NAME had no effect on
sensitivity or efficacy of FA-induced relaxation in either U46,619 (514±129 vs
569±98 µM) or High-K+ (1,093±87 vs 984±92 µM) pre-contracted SMA (Fig. 10 C,
D). The rightward shift due to L-NAME indicated a role of NO (e.g., eNOS) as part
of the most sensitive component of the FA-induced relaxation in PE-precontracted
SMA. Because NO stimulates guanylyl cyclase (GC) to generate cGMP in smooth
muscle cells, we tested ODQ, an irreversible inhibitor of GC, and ODQ also
rightward shifted the FA-induced relaxation (Fig. 11 E, F). The endothelium
contributes to overall contractility in SMA (Fig.10 B, E). Collectively, these data
show that the most sensitive component of the FA-induced relaxation is dependent
on a functional endothelium, NOS and an NO-mediated activation of GC.
Role of TRPA1 channel.
Because formalin-induced pain is associated with activation of TRPA1
channel as well as an increase in blood flow (McNamara et al., 2007), we
hypothesized that the TRPA1 channel may contribute to the FA-induced,
endothelium-dependent relaxation in SMA. In support, the TRPA1 antagonist
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A967079 (1 µM) significantly inhibited the most sensitive portion of the FA-induced
relaxation (30 µM) in PE-contracted SMA (Fig. 12 A, B). In paraffin-embedded,
thin cut sections of mouse SMA, TRPA1 (green) was co-localized with isolectin
(red) in endothelium (Fig. 12 C). More modest yet specific TRPA1 staining was
present in SMA media and adventitia as well. Positive and selective TRPA1
staining was confirmed by inclusion of a blocking peptide and by using dorsal root
ganglion (DRG; Fig. 12 D) as a positive control. A PCR product specific to TRPA1
exons 23-25 mRNA (Fig. 12 Ei) matched both the predicted fragment size (101 bp;
Fig. 12 Eii) and by gene sequence (Fig. 12 Eiii) -- confirming TRPA1 presence in
SMA. These image and molecular data support that TRPA1 contributed to the FAinduced, endothelium-dependent relaxation in SMA.
Cinnamaldehyde is a known TRPA1 agonist, and, unsurprisingly, it induced
a concentration- and TRPA1-dependent relaxation in SMA (Fig. 13 A). This
relaxation, like FA, this sensitive cinnamaldehyde-induced relaxation in SMA was
dependent on a functional endothelium (Fig. 13 B), TRPA1 (Fig. 13 C), NOS (Fig.
13 D) and GC (Fig. 13 E).
Role of K+-channels.
In SMA pre-contracted with High K+ (60mM), FA induced an insensitive
(rightward-shifted) relaxation (compared with both PE and U46,619). From these
data, we surmised that alteration of smooth muscle membrane potential, likely due
to K+ channel activation, contributed to FA-induced vasorelaxation in PEcontracted SMA. In confirmation, BaCl2 (1 mM), which blocks inward rectifier K+
channels, significantly inhibited FA-induced relaxation in PE-contracted SMA (Fig.
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14 A, B) and also in aorta (Fig. 14 C). However, we observed no effect of the nonselective K+ channel inhibitor, TEA (tetraethylammonium, 10 mM), on FA-induced
relaxation in SMA (Tables 7, 8). Collectively, these results indicate that the
activation of KIR channels but not of other K+ channels was involved in FA-induced
vasorelaxation in PE-precontracted SMA. The endothelium also contributed to FAinduced relaxation in aorta (Fig. 14 D)
Nicotine and FA:
In tobacco users, FA may be present in blood simultaneously with nicotine,
so we also tested whether nicotine altered FA-induced relaxation in SMA. Nicotine
alone (1 µM) had no effect in PE-contracted SMA, and also had no effect on
subsequent FA-induced vasorelaxation.
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Fig. 9. Formaldehyde (FA) induced relaxation in superior mesenteric artery (SMA).
A) Representative traces of concentration-dependent relaxation induced by
cumulative addition of FA (50-1,200 µM) in isolated SMA contracted by one of three
different contractile agonists: phenylephrine (PE); thromboxane A2 analog
(U46,619); or, high potassium (60K). B) Summary data of the efficacy (%
relaxation) of FA-induced relaxation in isolated pre-contracted SMA. Summary
data of the efficacy (% relaxation; C) and of the sensitivity (D) of FA-induced
relaxation in isolated PE-precontracted SMA from male and female mice isolated
either during day time or night time. Values are means ± SE of 3-10 preparations.
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Table 5. Levels of urinary formate following either a daytime fast or overnight
feeding in male C57BL/6J mice.

Urine Metabolite
Formate (g/ml)
Creatinine (mg/dl)

Condition
Daytime Fast
Overnight Feeding
(9h, no food, 3h water)
(16h, food & water)
0.72±0.03
2.73±0.95*
6.88±0.32
7.23±0.66

10.54±0.74
36.82±10.30*
Formate (g/mg
creatinine)
Values = means ± SE. N = 3-5 per group. *, P<0.05 vs fasting.
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Table 6. The effective concentration inducing 50% relaxation (EC 50; in µM) of
formaldehyde-induced vasorelaxation in isolated murine superior mesenteric
artery (SMA; male and female; day and night) and thoracic aorta precontracted
with different agonists.
Blood Vessel
(sex, time of day)

EC50 by precontraction agonist
PE

U46,619

High K+

SMA (male, night)

53±3
43±2

514±129*
--

1,093±87*
--

SMA (female, day)

77±9

--

--

SMA (male, day)

261±22*
--Aorta (male, day)
Values = means ± SE. Abbr.: PE, phenylephrine, [10 µM]; U46,619, thromboxane
A2 analog, [0.1 µM]; High K+, high potassium solution, [60 mM K+]; --, did not
perform experiment. N=3-10 per group. *, P<0.05 vs EC50 of “SMA (male, day)”
PE agonist (i.e., baseline control).
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Table 7. Efficacy of formaldehyde and associated compounds in relaxation of PEprecontracted superior mesenteric artery (SMA) and aorta without and with
selective treatments (inhibitors).
[mM]
% Relaxation
Treatment
SMA Aorta
SMA
Aorta
Formaldehyde
0.3
0.6
-94.3±1.3
-99.6±1.2
Formate
2.1
-25.7±6.7
Methanol
2.1
-34.1±11.7
Formaldehyde
0.3
0.6
ED
-90.4±2.3
-94.0±2.6
Formaldehyde
0.6
+LNAME
-96.7±2.2
Formaldehyde
0.3
0.6
+A967079
-96.4±1.1
-100.7±1.2
Formaldehyde
0.6
+ODQ
-99.7±0.5
Formaldehyde
0.6
0.6
+BaCl2
-99.5±0.5
-81.7±3.7
Formaldehyde
0.2
0.6
+TEA
-90±1.8
-94.4±1.3
Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; ED, endothelial
dysfunction induced by mechanical air perfusion; LNAME, N -nitro-L-arginine
methyl ester hydrochloride, 100 M; A967079, TRPA1 antagonist, 3 M; ODQ, 1h[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, BaCl2, barium chloride, 1 mM; TEA,
tetraethylammonium. N=3-6 per group.
Compounds
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Fig. 10. Regulators of agonist-induced tension in superior mesenteric artery (SMA).
A) Phenylephrine (PE), U46,619- and 60K-induced tension (mN) in SMA in the
absence and presence of LNAME. B) FA-induced relaxations (%) in PE, U46,619and 60K-precontracted SMA in the absence and presence of LNAME. C) FAinduced relaxations (converted to 100 %) in PE, U46,619- and 60K-precontracted
SMA in the absence and presence of LNAME. D) Representative tracings of PEinduced tension and ACh-induced relaxation in SMA with intact and mechanicallyimpaired endothelium (ED). E) Summary data of PE-induced tension in SMA in the
absence and presence of LNAME, BaCl2, ED, and ODQ. Values are means ± SE
of 3-4 preparations. *, P<0.05 vs Control.
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Fig. 11. Role of the endothelium and nitric oxide (NO) in the most sensitive
component of formaldehyde-induced relaxation of phenylephrine (PE) precontracted superior mesenteric artery (SMA). A) Representative traces of FAstimulated relaxation of PE-induced contraction without and with endothelium
impairment due to 5 min of air perfusion. B) Summary data of FA-induced
relaxation in isolated SMA pre-contracted with PE in the presence and absence of
functional endothelium. C) Representative traces of FA-stimulated relaxation of
PE-induced contraction in the presence and absence of LNAME. D) Summary data
of FA-induced relaxation in isolated SMA pre-contracted with PE in the absence
and presence of LNAME. E) Representative traces of FA-stimulated relaxation of
PE-induced contraction in the presence and absence of the guanylyl cyclase (GC)
antagonist, ODQ (3 µM), added to bath after PE-induced contraction plateaued
and prior to cumulative addition of FA. F) Summary data of FA-induced relaxation
in isolated SMA pre-contracted with PE in the absence and presence of ODQ.
Values are means ± SE of 3-4 preparations. *, P<0.05 vs Control.

72

73

Fig. 12. Role of the TRPA1 channel in formaldehyde (FA)-induced relaxation in
phenylephrine (PE) pre-contracted superior mesenteric artery (SMA). A)
Representative traces of FA-stimulated relaxation of PE pre-contracted SMA in the
absence (Control) and presence of the TRPA1 antagonist, A967079 (3 µM), which
was added after PE-induced contraction plateaued and prior to cumulative addition
of FA in wild type (WT) SMA. B) Summary data of FA-induced relaxation in isolated
SMA pre-contracted with PE in the absence and presence of TRPA1 antagonist.
Immunofluorescence localization of TRPA1 in SMA (C) and in dorsal root ganglion
(DRG; D). Formalin-fixed and paraffin-embedded sections of murine organs were
stained with H&E (Ci, Di); TRPA1 only (green; Cii) or DAPI only (blue, nuclear
stain; Dii); TRPA1 antibody (green), isolectin (red, endothelium) and DAPI (Ciii) or
TRPA1 antibody (red) and DAPI (Diii); and, TRPA1 antibody, TRPA1 blocking
peptide, isolectin and DAPI (Civ) or TRPA1 antibody, TRPA1 blocking peptide, and
DAPI (Div). L, lumen of SMA. All images were at 200x magnification (scale bar =
100 µm). Ei) Schematic depicting mouse mTrpa1 gene exons (E) 23 to 25 (with
introns, I) and their length (in base pairs, bp). TRPA1 mRNA with the spliced exons
23 to 25 makes a 309 bp product as indicated by TRPA1 specific primers used.
Eii) Agarose gel electrophoresis of PCR amplified product from 309 bp cDNA by
qRT-PCR (101 bp product from SMA or DRG of WT mouse using TaqMan Assay
for TRPA1; ct values indicated). Eiii) DNA sequence of 309 bp PCR product
identified as TRPA1. Sequence of DRG PCR product (309 bp) was used as
validation (data not shown). Values are means ± SE of 3-4 preparations. *, P<0.05
vs Control.
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Fig. 13. Role of the endothelium and nitric oxide (NO) in the most sensitive
component of cinnamaldehyde-induced (CA) relaxation of phenylephrine (PE) precontracted superior mesenteric artery (SMA). A) Representative traces of
concentration-dependent CA-stimulated relaxation of PE-induced contraction. B)
Summary data of CA-induced relaxation in isolated SMA pre-contracted with PE
in the presence and absence of functional endothelium. C) Summary data of CAinduced relaxation in isolated SMA pre-contracted with PE in the absence and
presence of TRPA1 antagonist. D) Summary data of CA-induced relaxation in
isolated SMA pre-contracted with PE in the absence and presence of L-NAME. E)
Summary data of CA-stimulated relaxation of PE-induced contraction in the
presence and absence of the guanylyl cyclase (GC) antagonist, ODQ (3 µM),
added to bath after PE-induced contraction plateaued and prior to cumulative
addition of CA. Values are means ± SE of 3-4 preparations. *, P<0.05 vs Control.
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Fig. 14. Role of potassium channel (KIR) in formaldehyde (FA)-induced relaxation
in phenylephrine (PE) pre-contracted blood vessels. A) Representative and B)
summary curves of FA-induced relaxation in superior mesenteric artery (SMA) in
the absence and presence of BaCl2. Summary curves of FA-induced relaxation in
aorta in the absence and presence of C) BaCl2 or D) endothelium damage (ED).
BaCl2 (1 mM) was added to PSS after stable PE-induced contraction and prior to
cumulative addition of FA. ED was induced by 5 min of air perfusion. Values are
means ± SE of 3-4 preparations. *, P<0.05 vs Control.
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Table 8. The sensitivity of formaldehyde-induced vasorelaxation measured as the
effective concentration inducing 50% relaxation (EC50; in µM) in isolated murine
superior mesenteric artery (SMA; male) pre-contracted with PE in the absence and
presence of functional endothelium and selective inhibitors of mediators of
vasorelaxation.
SMA
(+treatment)
+ED

EC50
(Control, PE+vehicle)
61±8

EC50
(ED or PE+inhibitor)
142±14*

+LNAME

52±8

207±10*

+A967079

52±6

95±18*

+ODQ

76±15

182±16*

+BaCl2

63±10

248±56*

+TEA

75±3

93±15

Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; ED, endothelial
dysfunction induced by mechanical air perfusion; LNAME, N -nitro-L-arginine
methyl ester hydrochloride, 100 M; A967079, TRPA1 antagonist, 3 M; ODQ, 1h[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, BaCl2, barium chloride, 1 mM; TEA,
tetraethylammonium. N=3-6 per group. *, P<0.05 vs Control (PE+vehicle).
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4. Discussion
To our knowledge, this is the first study to propose that FA may contribute
to postprandial hyperemia via a TRPA1- an endothelium-mediated SMA
vasodilation. Because rodents feed at night and sleep (fast) during the day, we
measured and observed a circadian difference in urinary formate levels indicating
endogenous FA level likely increases with feeding. As far as we know, this is a
novel observation. Furthermore, we show that SMA is sensitive to FA significantly
more so than aorta, and that FA not its metabolite, formate, stimulates a robust
and reversible vasorelaxation. The SMA is a major arterial blood supply to the GI
tract and it dilates postprandially in response to many stimuli e.g., nutrients, vagovagal reflex, NO, substance P, etc... (Chou & Coatney, 1994; Lucchini, Saumet,
Mei, & Garnier, 1996). Although FA is oft considered a toxicant, its natural
abundance in food, water and beverages (Committee on, 1981; D. J. Conklin, P.
Haberzettl, et al., 2011) and as an abundant metabolic product make it a plausible
stimulus of GI blood flow. As this is the first suggestion of this physiological role,
more research will be needed to establish FA as a bona fide contributor to
postprandial hyperemia in vivo.
We show that there are 3 distinct pathways of FA-induced vasorelaxation in SMA
(Fig. 15) and while this is fascinating in its own right, we focused on the mechanism
of the most sensitive, and thus, most likely physiological pathway. FA-induced
vasorelaxation requires a functional endothelium, TRPA1 channels, NOS
(presumably eNOS), guanylyl cyclase (GC/cGMP) and KIR channels. Likely, the
TRPA1 and NOS components are in endothelial cells, whereas the latter two
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components are likely present in vascular smooth muscle cells (VSMC). From
these collective data, we propose a model featuring a stepwise sequence of events
that is quite typical of agonists that elicit EDRF/NO such as ACh (see model in Fig.
15). That FA activates a TRPA1 channel likely present on the SMA endothelium is
paralleled by FA action in rat aorta (Q. Zhang et al., 2018) and by systemically
administered propofol – a general anesthetic that induces TRPA1-dependent
hypotension (Sinha, Sinharoy, Bratz, & Damron, 2015). Similarly, TRPA1 is a
known target of formalin (solution of FA and methanol) that increases blood flow
and pain (McNamara et al., 2007). With regard to formalin, we show that it is likely
the FA in formalin and not the methanol, which can be metabolized to FA, that
elicits vasorelaxation.
TRPA1 is a well-known target of unsaturated aldehydes, such as acrolein
and crotonaldehyde (Andre et al., 2008; Bessac et al., 2008; D. J. Conklin, 2016)
and cinnamaldehyde (Pozsgai et al., 2010), but its activation by FA is somewhat
surprising given the proposed mechanism of unsaturated aldehyde-mediated
activation via conjugation with TRPA1 N-terminal free cysteines (Macpherson et
al., 2007). In addition, several unsaturated aldehydes including acrolein,
cinnamaldehyde and 4HNE induce sensitive and robust vasodilation in mesenteric
arteries (Awe, Adeagbo, D'Souza, Bhatnagar, & Conklin, 2006; Romero et al.,
1997) and other blood vessels (Yanaga et al., 2006) and smooth muscle (Cheah
et al., 2014) indicating perhaps a shared (universal) aldehyde-TRPA1 pathway.
In any case, TRPA1 is a cation (calcium) channel and a promiscuous
receptor concentrated in sensory fibers (unmyelinated C-fibers) that mediate pain
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reception/transmission (nociceptors), and it is also are present in vasculature
(Earley et al., 2009a; Sinharoy et al., 2017). Activation of peripheral sensory fiber
TRPA1 leads to pain signaling and release of vasoactive peptides, substance P
(SubP) and cGRP (Trevisan et al., 2016), which may contribute to increased
vasodilation. We confirm localization of TRPA1 in mouse DRG and show specific
staining in the endothelium of murine SMA but not in aorta. Functionally, the
specific TRPA1 antagonist, A967079 (IC50 = 289 nM), significantly blocks the most
sensitive component of the FA-induced relaxation and shifts the EC50 to the right
quantitatively similar to that of endothelium disruption but less so than LNAME
treatment -- further supporting a role of endothelial cell TRPA1. Above 150 µM FA
-- likely an unphysiological level of FA -- the TRPA1 antagonist did not affect FA
relaxation reflecting a non-TRPA1 pathway(s), yet perhaps via TRPV1 or TRPV4
channels (Ma et al., 2008). We cannot rule out the possibility that additional
components in the vascular wall (perivascular nerves, SubP, CGRP, etc...) also
may contribute to overall FA-induced relaxation (Nilius, Appendino, & Owsianik,
2012).
FA-induced vasorelaxation is well-documented for over 4 decades, yet the
complex mechanisms of this phenomenon are only now becoming clearer. In
contrast to the idea that FA induces endothelial dysfunction (Yu & Deng, 1998),
our data indicate that endothelial dysfunction itself likely would block only the
physiological (sensitive) component of FA-induced vasorelaxation. We did not
observe evidence of FA-induced endothelial dysfunction even after exposing SMA
to 1,000 µM FA. Moreover, in isolated human CABG blood vessels with endothelial
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dysfunction, FA still induces relaxation but in a far less sensitive manner (EC 50,
315±0 µM) (D. J. Conklin et al., 2004) than that present in healthy mice (65 µM;
this study).
It is clear that the vascular effects of FA ex vivo are not a result of FA
metabolism into formate (primary metabolite). For example, formate addition (up
to 2.1 mM) fails to evoke a strong vascular response, and thus, oxidative
metabolism of FA regulates FA levels and subsequently any FA-evoked
physiological vascular responses. Similarly, formate fails to recapitulate formalininduced vasodepressor response in rats in vivo (Strubelt et al., 1990). Because FA
metabolism involves a reduced glutathione (GSH)- and FALDH-dependent (aka
ADH3) hemi-thioacetal formation (Kaiser, Holmquist, Vallee, & Jornvall, 1991), this
process may be more affected by changes in oxidant load and GSH depletion in
the vascular wall or in neurons, for example (Materazzi et al., 2012). As shown
previously, deficiency in glutathione-dependent metabolism of acrolein (i.e.,
GSTP-null mice) increases susceptibility to

acrolein-induced endothelial

dysfunction in vivo and in vitro (D. J. Conklin, Haberzettl, et al., 2009a). Whether
or not FALDH deficiency or GSH depletion likewise alters vascular sensitivity to
FA-induced relaxation (or toxicity) remains to be tested.
In conclusion, we describe a sensitive mechanism of FA-induced
vasorelaxation that is sequentially dependent on an endothelium-localized TRPA1
receptor (EDRF/NO) and a VSMC GC/PKG/KIR pathway in SMA. We hypothesize
that this sensitive pathway is only a part of the postprandial hyperemia reflex that
increases blood flow to the GI tract to augment digestion and nutrient absorption.
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Fig. 15. A cartoon depicting the mechanisms by which formaldehyde (FA) induces
vasorelaxation in SMA precontracted by phenylephrine (PE), thromboxane A 2
analog (U46,619) and 60 mM potassium solution (60K). FA appeared to induce a
sensitive and sequential mechanism that begins with opening of Transient
Receptor Potential Ankyrin 1 (TRPA1) cation channels, Ca2+ entry into endothelial
cell, eNOS activation, NO formation, GC activation and cGMP formation with
Protein Kinase G (PKG) mediated opening of KIR channels leading to VSMC
hyperpolarization and relaxation. Several of these steps were significantly
impaired by a selective antagonist or treatment, including TRPA1 (A967079),
eNOS (LNAME), endothelium (impaired by air perfusion), guanylyl cyclase (GC;
ODQ) and KIR channel (BaCl2). As demonstrated, this sequential pathway was
sensitive to exogenous FA (30-150 µM) in the physiological range that was altered
at least 2-3x during feeding. Other less sensitive yet equally efficacious pathways
of vasorelaxation included VSMC hyperpolarization and a voltage-insensitive
mechanism that reversed 60K-induced contraction implicating closure of VSMC
Ca2+ channels.
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CHAPTER IV

ACETALDEHYDE INDUCES AN ENDOTHELIUM-DEPENDENT RELAXATION
OF SUPERIOR MESENTERIC ARTERY:
POTENTIAL ROLE IN POSTPRANDIAL HYPERMIA

Acetaldehyde (AA) is a small, ubiquitous compound present in foods,
beverages, as a gas phase combustion product, and also endogenouslygenerated from metabolism as from ethanol (EtOH). Acetate is a short chain fatty
acid derived from AA oxidation, and acetate levels were significantly higher in urine
collected overnight with food provided ad libitum compared with urine collected
after 9h fasting. Because feeding increases gastrointestinal blood flow, we
explored the direct effects of AA (and acetate) in isolated murine superior
mesenteric artery (SMA). Over the concentration range of 1-100 mM, AA strongly
and

reversibly

relaxed

agonist-induced

contractions

of

SMA

including

phenylephrine (PE), thromboxane A2 analog (U46,619) and high potassium (High
K+) without toxicity. The sensitivity (EC50) but not the efficacy (>90% relaxation of
PE-precontraction) of AA-induced relaxations was dependent on blood vessel
(SMA was 3x more sensitive than aorta) and contractile agonist (PE EC50=3.3±0.4
mM; U46,619 EC50 =14.9±1.5 mM; High K+ EC50 = 17.7±0.5 mM) yet
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independent of circadian cycle and sex. The most sensitive component of the AAinduced relaxation was inhibited significantly by: 1) mechanically-impaired
endothelium; 2) nitric oxide synthase (NOS) inhibitor (L-NAME); and, 3) a guanylyl
cyclase (GC) inhibitor (ODQ). Both acetate and EtOH stimulated much weaker
relaxations in SMA than did AA, yet these relaxations were significantly inhibited
by L-NAME as well. Neither EtOH nor acetate relaxed pre-contracted aorta.
Although neither cyanamide, a non-specific aldehyde dehydrogenase (ALDH)
enzyme inhibitor, nor Alda-1, a specific activator of ALDH2 activity, had any effect
on either sensitivity or efficacy of AA-induced relaxation in SMA, cyanamide
significantly blocked both EtOH- and acetate-induced relaxations in SMA
implicating a role of ALDH activity in vasorelaxation. These data show that AA
relaxes SMA via an endothelium- and NO-dependent mechanism supporting the
idea that AA may contribute to the physiological reflex of post-prandial hyperemia
via vasodilatation of mesenteric vasculature.

1. Introduction
Acetaldehyde (AA) is the second smallest aldehyde, and the concentration
of AA in the blood is typically low due to high levels of aldehyde dehydrogenase
(ALDH) activity throughout the body. AA is present in food and beverages and is
from ethanol (EtOH) metabolism, which can be a major exogenous source of
systemic AA and AA may also enter via inhalation of vehicle exhaust-derived
aerosols (D. J. Conklin, P. Haberzettl, et al., 2011; Ogunwale et al., 2017).
Typically, AA levels range in the blood from 1-100 µM, and can reach >1 mM with
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excessive alcohol ingestion especially in individuals with an aldehyde
dehydrogenase 2, ALDH2*2 mutation, e.g., common in SE Asians (Tsukamoto et
al., 1991; Vasiliou & Nebert, 2005). Blood levels of AA are constantly changing
due to metabolism and exposures (eg., feeding and inhilation) (Hobara et al., 1985)
and thus, what physiological role AA plays in vascular control has remained
uncertain.
A variety of direct effects of exogenous AA on cardiovascular targets have
been described, yet a distinct role of AA in cardiovascular physiology is missing.
For example, intra-arterial or intravenous AA reduces heart rate (bradycardia),
decreases arterial pressure (hypotension) and causes arrhythmias in animals, but
these are considered toxicological effects due to exceedingly high doses
administered directly into the blood (Egle, Hudgins, & Lai, 1973; M. A. Green &
Egle, 1983). Nonetheless, AA is ubiquitous, and, it is thought that AA generated
from EtOH contributes to alcohol-induced cardiomyopathy (Ren & Brown, 2000;
Tan et al., 2012). Recently, it was shown that perfusion of a low level of AA (50
µM) into an isolated rat heart induces a cardioprotective effect against ischemiareperfusion indicating that endogenous AA levels likely are bioactive (Ueta et al.,
2018). It is well-known that AA induces concentration-dependent relaxation in
many different isolated blood vessels (Altura & Altura, 1982, 1987), yet the
relevance of this relaxation to vascular physiology is unclear.

Yet, AA is

considered relevant to the well-known phenomenon of EtOH-induced ‘flushing’
(increased blood flow and redness in facial skin flushing) in people with an
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ALDH2*2 mutation that reduces ALDH2 activity, and thus, limits the rate of
metabolism of AA to acetate (Scarino, Tardif, & Charbonneau, 2009).
Despite myriad sources and well-known cardiovascular effects of AA, few
studies address the physiological role of AA in vascular control. To address this
gap in knowledge, we measured urine levels of acetate, the primary metabolite of
AA, to assess fluctuations in endogenous AA levels in mice. Urine levels of acetate
increased 2-3 times overnight after feeding compared with urine levels during a
daytime fast, and thus, it appeared that feeding increased endogenous AA levels
(directly or indirectly). The gastrointestinal vasculature, thus, represents a likely
target of AA levels after feeding when gut blood flow reflexively increases (Chou &
Coatney, 1994; Takagi et al., 1988). To test this idea, isolated superior mesenteric
artery (SMA) and aorta were exposed to AA across a physiological to supraphysiological range (1-100 mM). The most sensitive AA-induced relaxation was in
the SMA (1-30 mM), and it was dependent on: a functional endothelium, NO
formation, and guanylyl cyclase activation. Because EtOH is metabolized to AA by
alcohol dehydrogenases, and AA is metabolized by ALDH to acetate, the vascular
effects of EtOH and acetate in the absence and presence of an ALDH inhibitor
(cyanamide) and ALDH2 activator (Alda1) were also assessed. EtOH and acetate
(up to 30 mM) elicited less robust relaxations (less than 50% of AA-induced
relaxation), yet these relaxations were NO- and ALDH-dependent in SMA
indicating intrinsic overlap with AA’s mechanism of action. For many reasons,
tobacco and EtOH are often consumed together, so effect of nicotine on AAinduced relaxation also was tested (Abreu-Villaca, Manhaes, Krahe, Filgueiras, &
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Ribeiro-Carvalho, 2017). Collectively, these findings support the idea that
increased levels of AA due to feeding (and associated drinking of EtOH) likely
contribute to reflex-driven increased gastrointestinal blood flow after feeding (aka
‘postprandial hyperemia’) through a sensitive, robust, reversible, endothelium- and
NO-dependent process.

2. Material and Methods
Chemicals and Solutions.
Reagent grade chemicals were purchased from Sigma-Aldrich or other
commercial sources as indicated: A967079 (AdooQ); acetaldehyde; acetate;
acetylcholine chloride (ACh); Alda1 and cyanamide (gift of Dr. B.G. Hill, Univ.
Louisville); 1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ); ethanol (100%);
N-nitro-L-arginine methyl ester hydrochloride (L-NAME); L-phenylephrine
hydrochloride (PE); sodium nitroprusside (SNP); U46,619 (thromboxane A 2
analog); and, 2,3,4,5-pentafluorobenzyle bromide (PFBBr).
Krebs physiological salt solution (PSS) for SMA was (in mM): NaCl, 119;
KCl, 4.7; MgCl2, 1.2; KH2PO4, 1.2; NaHCO3, 24; glucose, 7.0; pH 7.4. Krebs PSS
for aorta was (in mM): NaCl 118, KCl 4.7, CaCl2 2.5, KH2PO4 1.2, MgSO4 1.2,
NaHCO3 12.5, and glucose 5.5; pH 7.4. High K+ PSS (High K; 60 mM) was
prepared by substituting equimolar K+ for Na+.
Animals.
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Wild type C57BL/6J mice from in house breeding pairs or purchased (The
Jackson Laboratory, Bar Harbor, ME) (12-20 weeks old; 25-35g) were used in
these studies. Aldose reductase (AR) null mice were from a breeding colony at
Univ. of Louisville (Wetzelberger et al., 2010). Mice were treated according to
American Physiological Society Guiding Principles in the Care and Use of Animals,
and all protocols were approved by University of Louisville Institutional Animal
Care and Use Committee. Mice were housed under pathogen-free conditions in
the Univ. of Louisville vivarium under controlled temperature and 12h light:12h dark
cycle. Mice were provided a standard chow diet (Rodent Diet 5010, 4.5% fat by
weight, LabDiet; St. Louis, MO).
Urine Collection and Acetate Measurement.
Urine samples were collected, centrifuged (2,500 RPM, 10 min, 4 C),
decanted, and stored at -80 °C until analysis (D. J. Conklin et al., 2017). Each
mouse was held (<5 sec) and the mouth was gently touched with the sipper tube
of a water bottle filled with D-glucose/saccharin solution (w/v; 3.0%/0.125%; Sigma)
immediately prior to a 6h fast. After 6h fast, each mouse was placed in a metabolic
cage (Harvard Apparatus) with ab libitum access to glucose/saccharin solution in
water without access to food for 3h to collect urine (in 4°C water-jacketed organ
baths). In total, mice were fasted during daytime for 9-h. After fasted urine
collection, mice then were provided food and glucose/saccharin solution ab libitum
for an overnight urine collection (O/N). For urine samples, volumes were recorded,
samples centrifuged to sediment food/feces, decanted, and stored at -80 °C until
analysis (D. J. Conklin et al., 2017).
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The primary urinary metabolite of AA is acetate, and it was measured using
GC-MS as described previously (Kage et al., 2004; Lamarre et al., 2014) with
minor modifications (Conklin et al., 2018). Briefly, urine (50 µL) was mixed with
sodium phosphate (20 µL 0.5M, pH 8.0) containing internal standard (13C-acetate,
2.3 mM). Samples were incubated with PFBBr (130 µL, 0.1M) for 15 min at 60°C,
extracted with hexane (330 µL), and analyzed by GC-MS in electron ionization (EI)
mode. Six-point calibration curve was used to calculate the concentration of
acetate. Results were corrected for the natural abundance of

13C

isotope. Acetate

level was normalized to urinary creatinine (mg) to account for urine dilution
(Lorkiewicz et al., 2019).
Isolated Superior Mesenteric Artery (SMA) and Aorta.
Mice were anesthetized with sodium pentobarbital (0.1 ml, 150 mg/kg, i.p.),
and SMA and aorta were removed via mid-ventral thoracotomy. Thoracic aorta
rings (3-4 mm) were hung on stainless steel hooks in 15-ml water-jacketed organ
baths and SMA rings (2 mm) were hung on tungsten wire (75 µm dia.) in 5-ml
heated organ baths (MultiWire Myograph System 620M, DMT, Denmark) in PSS
bubbled with 95% O2: 5% CO2 at 37 °C. After 10 min without tension, aorta rings
were equilibrated to ≈1g loading tension over 30 min and SMA rings were
equilibrated to ≈0.25g loading tension over 1h. All rings were stimulated with 60K
to test for viability, washed 3 times with PSS over 30 min, and re-equilibrated to
appropriate resting tension (Jin, Jagatheesan, et al., 2019).
AA-Induced Relaxation in Isolated Superior Mesenteric Artery (SMA) and Aorta:
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Acetaldehyde (1-100 mM) was added to organ baths containing either aorta
or SMAs pre-contracted with 1 of 3 contractile agonists: phenylephrine (PE, 10
µM), U46,619 (0.1 µM), or High K+ (60 mM). The efficacy of AA-induced relaxation
was calculated as the maximal % reduction in agonist-induced contraction (Emax).
The sensitivity of agonist-induced relaxation was calculated as the effective
concentration producing 50% response (EC50), i.e., cumulative concentration
responses were normalized to 100% with interpolation of EC50 (D. J. Conklin,
Haberzettl, et al., 2009b). To assess whether time of day affected SMA response
to AA, mice were euthanized both in day and in night cycle (Jin, Jagatheesan, et
al., 2019).
Role of AA Metabolism and Effects of EtOH and Acetate (AA metabolite):
Because EtOH is a known source of AA, we tested whether EtOH alone (up
to 1%, equivalent to amount present in 100 mM AA) mimicked AA-induced
relaxation. Because AA is oxidized to acetate (primary urinary metabolite), we
tested whether acetate (1-100 mM) alone could induce vasorelaxation in PE precontracted aorta and SMA. To test the specific role of ALDH to AA-induced
vasorelaxation, we used a non-specific ALDH enzyme inhibitor (cyanamide, 1 mM)
and an activator of ALDH2 (Alda-1, 25 µM) (Chen et al., 2008; Srivastava et al.,
2001). In addition, to test for role of acetaldehyde reductive metabolism, SMA and
aorta were isolated from aldose reductase (AR) null mice.
Role of Endothelium, Nitric Oxide Synthase (NOS), and cGMP:
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To evaluate the role of NOS, L-NAME (0.1 mM) was added prior (15 min)
to addition of PE (10 µM), U46,619 (0.1 µM) or High K+ (60 mM). Pre-contracted
SMA rings were then relaxed with cumulative concentrations of AA. The role of the
endothelium was assessed as vasorelaxation to increasing AA concentrations in
aorta and in SMA with intact and injured endothelium. The endothelium was
mechanically-injured by air perfusion, and effective impairment was confirmed by
near complete abolition (>95%) of ACh-induced dilation of PE pre-contracted blood
vessels (Jin, Jagatheesan, et al., 2019). To assess whether cGMP was involved
in AA-induced vasorelaxation, isolated blood vessels were pre-incubated with
ODQ (3 µM) to inhibit guanylyl cyclase (GC) and subsequent formation of cGMP
(Jiang et al., 2015).
Role of Transient Receptor Potential Ankyrin 1 (TRPA1):
Because formaldehyde induces a sensitive TRPA1-dependent relaxation in
isolated SMA, we tested whether the TRPA1 antagonist (A967079, 3 µM) would
alter AA-induced relaxation in PE-precontracted SMA (Jin, Jagatheesan, et al.,
2019).
Role of nicotine:
Because most cigarette and e-cigarette contains nicotine, we tested
whether nicotine would affect AA-induced relaxation in PE-precontracted SMA.
Statistical Analyses.
Data are expressed as means ± SE. When comparing two groups, a t-test
was used (paired or unpaired as appropriate). Multiple groups were compared
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using Kruskal-Wallis ANOVA followed by Bonferroni post-hoc tests. Statistical
significance was assumed when P<0.05.

3. Results
Acetate: the primary metabolite of acetaldehyde (AA) is increased with feeding.
Acetate is the primary oxidation metabolite of AA, and thus, urinary acetate
is a product of endogenous AA metabolism. We measured urinary acetate using
GC-MS, and we found that feeding (overnight) significantly increased urinary levels
of acetate indicating that a major source of endogenous AA likely is either directly
from food or related to feeding, e.g., metabolism of food constituents, intermediary
metabolism, etc... In female and male C57BL/6J mice, a daytime fast (9 h) resulted
in a basal level of urinary acetate that overnight feeding was increased by 2-3 times
(Table 9). Thus, we infer that feeding overnight increased AA levels that resulted
in increased acetate excretion in urine.
AA-induced relaxation.
Because feeding increases gastrointestinal (GI) blood flow, we investigated
whether AA would relax superior mesenteric artery (SMA) – a major conduit for
increased GI blood flow with feeding (Chou & Coatney, 1994; Lucchini et al., 1996).
In fact, AA (1 to 100 mM) induced a concentration-dependent, robust, repeatable
and agonist-dependent relaxation in isolated SMA and aorta of female and male
mice (Fig. 16; Table 10). Regardless of agonist (PE, U46,619, High K+), AA
relaxed precontraction tension by >90% in SMA (Fig. 16A, B) and in aorta (Table
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10; PE only), yet when added to an uncontracted blood vessel, AA did not affect
basal tone (aka myogenic tone; data not shown). Blood vessels sensitivity of male
SMA was circadian-independent, and sensitivity of female SMA in daytime was
less sensitive to male SMA sensitivity (either day or night cycle) (Fig. 16 C, D;
Table 10), and thus, subsequent experiments to probe the mechanisms of AAinduced relaxation were conducted using only SMA isolated from male mice in the
daytime (lights on). Collectively, AA-induced relaxation was repeatable (even up
to 100 mM) without any loss of efficacy or any induced change in endotheliumdependent ACh-induced relaxation indicating little overt vasotoxicity of AA even at
supra-physiological levels (data not shown).
Role of endothelium, nitric oxide synthase (NOS), and GC in AA-induced
vasorelaxation.
The sensitivity of AA-induced relaxation (but not efficacy) was agonist-dependent
(PE<U46,619=High K+; Fig. 16 A, B; Table 10) and indicated at least 2 distinct
mechanisms were operative. We showed the most sensitive component of the AAinduced relaxation was significantly rightward-shifted by mechanical disruption of
endothelium in SMA (air perfusion impaired >90% of ACh-induced relaxation) (Fig.
17 A, B; Tables 11, 12). This effect was similar to the effect of L-NAME incubation,
which further implicated endothelium-derived NO (Fig. 17 C, D; Tables 11, 12).
Because NO stimulates guanylyl cyclase (GC) to generate cGMP in smooth
muscle cells, we used ODQ, an irreversible inhibitor of GC, and it also rightwardshifted the AA-induced relaxation (Fig. 17 E, F; Tables 11, 12). Collectively, these
data show that the most sensitive component of the AA-induced relaxation was
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dependent on a functional endothelium, NOS (likely eNOS) and an NO-mediated
activation of GC, but at high concentrations, the relaxation of AA was not affected
(Table 11). Thus, L-NAME shifted the sensitivity of AA-induced relaxation in SMA
pre-contracted with PE (3.3±0.3 vs 6.3±0.6 mM), but did not alter efficacy (Emax).
Similarly, it neither affected the sensitivity nor efficacy of AA-induced relaxation in
U46,619- (17.2±0.3 vs 14.9±1.5 mM) or High K- (18.4±0.4 vs 17.7±0.5 mM) precontracted SMA (Fig. 18A, B; Table 10). These data support a role of
endothelium-derived NO in the most sensitive component of AA-induced relaxation
in PE-precontracted SMA.
Ethanol-, acetaldehyde- and acetate-induced relaxations.
Because AA is formed from EtOH by alcohol dehydrogenase (ADH), and
AA is metabolized by ALDH to acetate, it is possible that the vascular effects of
EtOH or acetate are due to AA. To address this possibility, EtOH and acetate were
cumulatively added (up to 100 mM) in PE pre-contracted SMA and aorta. Ethanol
is known to induce vasodilation in several blood vessels, yet it is unclear if the
effect is due to formation of AA. Ethanol relaxed PE-precontracted SMA weakly
(Emax about 40% of PE precontraction) compared with AA (Fig. 19A, B). Ethanol
did not relax PE pre-contracted aorta even at 100 mM, in fact, it increased tension
primarily at 100 mM (Fig. 20A). Acetate also induced weak relaxation and a slight
contraction at 100 mM in PE-precontracted SMA (Fig. 19A, B, C). L-NAME
treatment significantly reduced both EtOH- and acetate-induced relaxations of
SMA (Fig. 19D, E; Table 11). Although both EtOH- and acetate-induced
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significantly weaker relaxations in SMA than did AA, the NO dependence of these
relaxations was a shared mechanism of action with AA.
Role of AA metabolism: Effects of Cyanamide and Alda1 and AR.
To investigate the possible role of metabolism in AA-induced responses,
cyanamide and Alda-1, ALDH inhibitor and ALDH2 activator, respectively, and an
aldose reductase (AR) null mouse model were used. Surprisingly, and despite
vasoactivity of their own, cyanamide (increased tension, 10-20%) and Alda-1
(decreased tension, 10-20%), neither compound had any significant effect on AAinduced relaxation in PE-precontracted SMA (Fig. 21A, B; Table 13). However,
the sensitivity of the AA-induced relaxation of SMA was rightward shifted
significantly in AR-null mice (EC50, 6.9±1.0 mM, n=3) although no effect on
maximal relaxation was observed (Emax, 78.1±4.0%). Despite lack of a strong effect
of ALDH modulators on AA’s vasoactivity, cyanamide significantly blocked the
relaxation of EtOH, and Alda1 slightly enhanced the EtOH relaxation (Fig. 21C, D;
Table 13). Similarly, cyanamide significantly blocked the relaxation of acetate,
although Alda1 was without effect on the relaxation of acetate (Fig. 21E, F; Table
13). These data support a potential regulatory role of ALDH activity in EtOH- and
acetate-induced relaxations in SMA (see Fig. 22).
Role of Transient Receptor Potential Ankyrin 1 (TRPA1):
Although formaldehyde induces a sensitive TRPA1- and endotheliumdependent relaxation in isolated SMA, AA-induced relaxation in PE-precontracted
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SMA was unaffected by addition of the TRPA1 antagonist (A967079, 1 µM)
(Tables 11, 12) indicating this pathway is not activated in a similar way by AA.

Nicotine and AA:
In tobacco users, EtOH, and thus, AA, may be present in blood
simultaneously with nicotine, so we also tested whether nicotine altered AAinduced relaxation in SMA. Nicotine alone (1 µM) had no effect in PE-contracted
SMA, and also had no effect on subsequent AA-induced vasorelaxation (Tables
11, 12).
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Table 9. Levels of urinary acetate following a daytime fast and overnight feeding
in (A) female and (B) male C57BL/6J mice.
A. Females
Condition
Urinary Metabolite

Daytime Fast

Overnight Feeding

Acetate (g/ml)

2.76±0.27

24.52±4.89*

Creatinine (mg/dl)

3.19±0.41

8.74±1.52

Acetate (g/mg
creatinine)

91.11±6.61

296.82±32.95*

B. Males
Condition
Urinary Metabolite

Daytime Fast

Overnight Feeding

Acetate (g/ml)

4.71±0.66

8.54±2.34*

Creatinine (mg/dl)

6.52±1.16

5.67±1.15

Acetate (g/mg
79.56±7.49
158.57±32.16*
creatinine)
Values = means ± SE. N = 11-12 per group. *, P<0.05 vs fasting.
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Table 10. The effective concentration inducing 50% relaxation (EC50; in mM) of
acetaldehyde-induced vasorelaxation in isolated murine superior mesenteric
artery (SMA; female and male) and thoracic aorta (male only) with different
contractile agonists.
Blood Vessel
(sex, time of
day)
SMA (f, day)
SMA (m, day)
SMA (m, day)
+LNAME
SMA (m, night)

EC50 by precontraction agonist
PE

U46,619

High K

6.0±0.6*
3.3±0.4

-14.9±1.5*

-17.7±0.5*

6.2±0.2*

17.2 ±0.2

18.4 ±0.4

4.3±0.8

--

--

Aorta (m)
15.9±3.0*
Values = means ± SE. Abbr.: PE, phenylephrine, [10 µM]; U46,619, thromboxane
A2 analog, [0.1 µM]; High K, high potassium solution, [60 mM K+]; --, did not
perform experiment. N=3-10 per group. *, P<0.05 vs EC50 of “SMA (male, day)”
PE agonist (i.e., baseline control).
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Fig. 16. Acetaldehyde (AA) induced relaxation in superior mesenteric artery
(SMA). A) Representative traces of concentration-dependent relaxation induced
by cumulative addition of AA (1-100 mM) in isolated SMA pre-contracted by one of
3 agonists: phenylephrine (PE); thromboxane A2 analog (U46,619); or, high
potassium (High K+). B) Summary data of the efficacy (Emax % relaxation) of AAinduced relaxation in isolated PE, U46,619 and High K+ pre-contracted SMA. C)
Summary data of the efficacy (Emax) and of the (D) sensitivity (EC50) of AA-induced
relaxation in isolated PE-precontracted SMA from male mice euthanized either
during day or night time. Values are means ± SE of SMA from 3-4 mice.
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Fig. 17. Role of the endothelium and nitric oxide (NO) in acetaldehyde-induced
(AA) relaxation of SMA. A, B) Representative traces and summary data of AAstimulated relaxation of PE-induced contraction in SMA with intact endothelium or
with endothelium impairment due to 15 min of air perfusion. C, D) Representative
traces and summary data of AA-stimulated relaxation of PE-induced contraction in
the absence of and presence of NOS inhibitor, L-NAME. E, F) Representative
traces and summary data of AA-induced relaxation of PE-induced contraction in
the absence of and presence of the guanylyl cyclase antagonist, ODQ (3 µM),
added to bath after PE-induced contraction stabilized and prior to cumulative
addition of AA. Values are means ± SE of SMA from 3-8 mice as indicated. *,
P<0.05 vs Control.
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Table 11. Efficacy (maximal relaxation, Emax) of acetaldehyde- (AA), EtOH- and
acetate-induced relaxations of PE-precontracted superior mesenteric artery
(SMA) and aorta without and with inhibitor treatments.
[mM]
Emax (% relaxation)
Treatment
SMA Aorta
SMA
Aorta
AA
1-30 1-100
Control
89.6±1.7
91.6±6.7
AA
1-30
-ED
83.5±3.4
-AA
1-30
-+LNAME
87.1±4.0
-AA
1-30
-+ODQ
90.8±1.8
-AA
1-30
-+A967079
90.6±4.0
-EtOH
1-30 1-100
Control
39.4±3.1
0
EtOH
1-30
-+LNAME
8.1±1.2*
-Acetate
1-30 1-100
Control
42.9±5.9
0
Acetate
1-30
-+LNAME
16.0±8.2*
-Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; ED, endothelial
dysfunction induced by mechanical air perfusion; LNAME, N -nitro-L-arginine
methyl ester hydrochloride, 100 M; A967079, TRPA1 antagonist, 3 M; ODQ, 1h[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. N=3-6 per group. *, P<0.05 vs untreated
and matched Control.
Compound
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Table 12. The effective concentration inducing 50% relaxation (EC50; in mM) of
acetaldehyde- (AA), EtOH- or acetate-induced vasorelaxation in isolated murine
superior mesenteric artery (SMA; male mice only) pre-contracted with PE in the
absence
and
presence
of
functional
endothelium
or
selective
inhibitors/compounds.
Compound
Control EC50
Treatment
Treatment EC50
[1-30 mM]
(vehicle)
12.4±2.1*
AA
3.9±0.6
+ED
AA
2.9±0.4
+LNAME
6.2±0.6*
AA
2.1±0.9
+ODQ
7.4±0.9*
AA
2.9±0.6
+A967079
2.8±0.6
+LNAME
EtOH
3.2±1.5
X
+LNAME
acetate
6.9±3.0
X
Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; ED, endothelium
dysfunction induced by mechanical air perfusion; LNAME, N -nitro-L-arginine
methyl ester hydrochloride, 100 M; ODQ, 1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin1-one; A967079, TRPA1 antagonist, 3 M; X, could not calculate due to low %
relaxation (see Table 3). N=3-6 mice used per group. *, P<0.05 vs Control
(vehicle).
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Fig. 18. Role of the nitric oxide (NO) in acetaldehyde-induced relaxations of SMA.
AA (1-100 mM) induced relaxation of isolated SMA pre-contracted by one of 3
agonists: phenylephrine (PE); thromboxane A2 analog (U46,619); or, high
potassium (High K+). Summary data of the (A) efficacy (% relaxation) and of the
(B) sensitivity of AA-induced relaxation in isolated PE-precontracted SMA in the
absence and presence of L-NAME. Values are means ± SE of SMA from 3-8 mice.
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Fig. 19. The vascular effects of ethanol (EtOH), acetaldehyde (AA) and acetate in
SMA. Role of the nitric oxide (NO) in ethanol- and acetate-induced relaxations of
SMA. A) Representative traces of EtOH-, AA- and acetate-induced relaxations in
PE pre-contracted SMA. Summary data of EtOH-, AA- and acetate-induced
relaxations in PE pre-contracted SMA plotted as measures of efficacy (B, % PE
contraction) and sensitivity (C, converted to 100 % response). Concentration
dependent relaxations induced by either (D) ethanol or (E) acetate of
phenylephrine (PE) pre-contracted superior mesenteric artery (SMA) in the
absence and presence of L-NAME. Values are means ± SE of SMA from 3 mice
as indicated. *, P<0.05 vs Control.
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Fig. 20. The vascular effects of ethanol (EtOH), acetaldehyde (AA) and acetate
in aorta. A) Representative traces of EtOH-, AA- and acetate-induced responses
in PE pre-contracted aorta. Summary data of AA-induced relaxations in PE precontracted aorta plotted as measures of efficacy (B, % PE contraction) and
sensitivity (C, converted to 100 % response). Values are means ± SE of aorta
from 5 mice as indicated.
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Fig. 21. Role of aldehyde dehydrogenase (ALDH) metabolism in vascular
responses to EtOH, AA and acetate. Representative traces and summary data,
respectively, of vasorelaxant effects of AA (A, B), EtOH (C, D) and acetate (E, F)
in PE pre-contracted SMA of WT mice in the absence and presence of either
cyanamide (ALDH enzyme inhibitor, 1 mM) or Alda1 (ALDH2 activator, 25 μM).
The vasorelaxant effects of AA in AR-null mice (A). Values are means ± SE of SMA
from 3-8 mice as indicated. *, P<0.05 vs Control.
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Fig. 22. Mechanisms of acetaldehyde-induced vasorelaxation and relationship to
aldehyde metabolism. A) Cartoon depicting the mechanisms by which
acetaldehyde

(AA)

induces

vasorelaxation

in

SMA

precontracted

with

phenylephrine (PE), thromboxane A2 analog (U46,619) and 60 mM potassium
solution (High K+). AA induces a sensitive endothelial cell-dependent mechanism
that begins with eNOS activation, NO formation, and GC activation leading to
VSMC hyperpolarization and vasorelaxation (Pathway designated “1.”). Several
steps were confirmed by direct antagonism of NOS (L-NAME), endothelium
(impaired by air perfusion) and guanylyl cyclase (GC; ODQ). A less sensitive yet
equally efficacious pathway of vasorelaxation included a voltage-insensitive
mechanism that similarly reversed U46,619- and High K+-induced contraction
implicating closure of VSMC Ca2+ channels (Pathway designated “2.”). B) Cartoon
depicting the metabolic pathways of ethanol, acetaldehyde and acetate. Ethanol
is oxidized to acetaldehyde by alcohol dehydrogenase (ADH) and/or catalase
activity. Acetaldehyde is oxidized to acetate by aldehyde dehydrogenases
(ALDH1/ALDH2) or reduced back to ethanol by aldose reductase (AR). Acetate is
converted to acetyl coenzyme A (CoA).
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Table 13. Role of aldehyde dehydrogenase (ALDH) in AA-induced relaxations of
PE-precontracted SMA. The efficacy (A; measured as the maximal relaxation,
Emax; %) and sensitivity (B; measured as the effective concentration inducing 50%
relaxation; EC50; in mM) or the of AA-, EtOH-, or acetate-induced vasorelaxation
in isolated murine superior mesenteric artery (SMA; male) pre-contracted with PE
in the presence of cyanamide or Alda1(ALDH2 activator).
A. Efficacy
SMA
Compound
(1-30 mM)
Acetaldehyde

Emax (%Relaxation of PE-precontraction)
Control (vehicle)

+Cyanamide

+Alda1

89.5±4.8

85.9±5.9

93.4±3.5

Ethanol

40.6±3.1

13.6±6.8*

52.2±4.4

Acetate

38.1±5.1

8.2±9.1*

43.1±8.0

B. Sensitivity
SMA
Compound
(1-30 mM)
Acetaldehyde

EC50, [in mM]
Control (vehicle)

+Cyanamide

+Alda1

2.5±0.4

3.7±0.7

Ethanol

1.5±0.2

X

2.0±0.3
1.2±0.4

Acetate
2.4±0.8
X
3.6±0.9
Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; X, could not calculate due
to low % relaxation. Cyanamide, 1 mM; Alda1, 25 µM. N=3-6 mice per group. *,
P<0.05 vs Vehicle Control.
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4. Discussion
The physiological vascular action of AA is unclear but our study provides
evidence for a potential contribution of AA in postprandial hyperemia in SMA via
an EDRF-mediated dilatory pathway. In support, we show that SMA is significantly
more sensitive than the aorta to AA, and importantly, the SMA is a known major
arterial blood supply to the GI tract that dilates postprandially in response of a
variety of stimuli e.g., nutrients, vago-vagal reflex, NO, substance P, etc... (Chou
& Coatney, 1994; Lucchini et al., 1996). Moreover, because rodents feed at night
and sleep (fast) during the day, we observed a circadian difference in urinary
acetate levels indicating endogenous AA level likely increases with feeding (see
Table 9). Although, AA is oft considered an inhaled toxicant, its natural abundance
in food, water and beverages (Aldehydes, 1981; D. J. Conklin, P. Haberzettl, et al.,
2011) and as an abundant metabolic product, e.g., EtOH, make it a plausible
stimulus for increasing GI blood flow. As this is the first suggestion of this specific
physiological role that we know of, more research will be needed to establish AA
as a bona fide stimulus of postprandial hyperemia in vivo.
We found there are two distinct pathways of AA-induced vasorelaxation in
SMA (Fig. 22A), and, we focused on the mechanism of the most sensitive pathway
as it is likely a physiological pathway. The sensitive AA-induced vasorelaxation
requires a functional endothelium, NOS (presumably eNOS) and guanylyl cyclase
(GC/cGMP). The endothelial cells likely contribute to the most sensitive
components, whereas the latter component is likely present in vascular smooth
muscle cells (VSMC). These components are also activated by formaldehyde in
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rat aorta and murine SMA (Jin, Jagatheesan, et al., 2019; Q. Zhang et al., 2018),
yet the TRPA1 channel is not stimulated by AA indicating a different ‘activating
step’ in the endothelium for AA. Functionally, L-NAME, the eNOS inhibitor,
significantly blocks the most sensitive component of the AA-induced relaxation and
shifts the EC50 to the right. But this shift is less strong than that of endothelium
disruption and ODQ (a GC inhibitor) suggesting a second endothelium-dependent
component likely is operative. We also cannot rule out the possibility that additional
components in the vascular wall (perivascular nerves, SubP, CGRP, etc...) may
contribute to the AA-induced relaxation (Nilius et al., 2012).
AA induced a much stronger relaxation in SMA (and aorta) than either an
upstream precursor, EtOH, or its downstream metabolite, acetate – both of which
stimulate vasorelaxation in SMA but not in aorta indicating important similarities
and differences with AA. EtOH-induced vasorelaxations have been welldocumented for over 4 decades, yet the complete mechanism of this phenomenon
is only now becoming clearer. EtOH induces vascular relaxation by acting on both
endothelial cells and VSMCs to dilate mesenteric and cutaneous blood vessels;
yet EtOH also contracts cerebral, coronary, pulmonary and renal vascular beds
and skeletal muscle arterioles (Altura & Altura, 1982, 1987; Altura, Altura, & Carella,
1983; Greenberg et al., 1993; Rocha et al., 2012; Ru et al., 2008; Toda, Konishi,
Miyazaki, & Komura, 1983). Our data show that EtOH (and acetate) relax SMA at
concentrations <100 mM after which there is an onset of contraction. In contrast,
EtOH and acetate only increase tension in precontracted aorta. Nonetheless, LNAME significantly blocks the most sensitive component of both EtOH- and
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acetate-induced relaxation in SMA reflecting NO-dependence (endothelium) -- as
observed for AA (see shared Pathway 1. in Fig. 22A). Because the relaxations
induced by EtOH and acetate in SMA are qualitatively similar to AA, this may reflect
a role of AA in both EtOH- and acetate-induced relaxations. As AA induces
relaxation in both SMA and aorta this likely reflects a shared yet less sensitive
pathway (#2.; see Fig. 22A) that extracellular AA but not EtOH or acetate.
The concentration of AA in human blood is kept very low due to fast acting
aldehyde dehydrogenase 2 (ALDH2) enzyme. The capacity of the liver to eliminate
AA formed from EtOH is so efficient that measurable levels of AA are typically
undetected in peripheral blood (Lindros, Stowell, Pikkarainen, & Salaspuro, 1980)
but AA is detected in saliva. In an alcohol drinking model, salivary AA concentration
was approximately 150 μM (maximum 260 μM) over the first 20 to 40 min followed
by a rapid decrease to 20 to 30 μM for the remainder of the follow-up period (350
min)(Salaspuro, 2017). Moreover, ALDH2*2 enzyme deficiency is present in 3545% of Asian people (8% of world’s population), and results from ALDH2*2 gene
mutation that decreases ALDH activity by 20% (heterozygous mutation) and 50%
(homozygous), and thus, people with ALDH2*2 gene mutation are susceptible to
facial flushing and nausea after alcohol consumption presumably due to high AA
levels (Chen, Ferreira, Gross, & Mochly-Rosen, 2014; Gross et al., 2015).
Consistent with epidemiological findings, alcohol drinking in ALDH2-deficient
subjects markedly elevates AA concentrations in saliva (Vakevainen, Tillonen,
Agarwal, Srivastava, & Salaspuro, 2000; Yokoyama et al., 2008) and in blood of
EtOH- or AA-injected ALDH2-deficient mice (Jamal et al., 2016). Interestingly, high
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levels of AA are associated with increased risk of GI tract cancers (Salaspuro,
2017) indicating that AA is likely elevated in the GI tract as well.
Although concentrations of salivary and blood AA and those used in our
study are difficult to compare, theoretically, consuming as little as one glass of wine
(5 oz or 150 ml) containing 15-20 g of EtOH (11-13% ABV) would increase blood
EtOH concentration up to 65 mM (assuming 5 l blood volume, 70 kg adult). As
EtOH is rapidly metabolized to AA by ADH in liver and in blood vessels, it is
plausible that AA levels increase quite quickly in endothelial cells and VSMC with
corresponding intracellular/membrane levels being likely in the bioactive range
described in our study (1-30 mM). Despite this theoretical calculation, there is little
evidence for circulating AA levels in the active dilation range presumably because
of rapid intracellular oxidative metabolism of AA by ALDHs to acetate (see Fig.
22B). To test the role of SMA-dependent ALDH metabolism on AA’s bioactivity,
we use an ALDH inhibitor, cyanamide, and an ALDH2 activator, alda-1, to
decrease and increase ALDH activity, respectively, and in turn, potentially
augment and diminish AA’s action. Interestingly, alda-1 (25 µM) and cyanamide (1
mM) are vasoactive in SMA with opposing effects: alda-1 relaxed; cyanamide
contracted (see Fig. 21E). Because of these opposing effects, we infer that the
pharmacological target – (ALDH2 enzyme activity) may be an active regulator of
SMA vascular tone. Perhaps more surprising, neither compound significantly alters
AA-induced relaxation, yet cyanamide effectively blocks both EtOH- and acetateinduced relaxations in SMA. In contrast to our hypothesis, wherein we expect
cyanamide (or AR-null) to enhance EtOH-induced relaxation by increasing AA
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level, we observe inhibition of EtOH-induced relaxation. Notably, this result is not
without precedent. For example, EtOH combined with cyanamide inhibits rather
than enhances EtOH-induced increases in blood flow (Carmichael et al., 1987).
Interestingly, AA alone did not increase portal blood flow either. Equally
provocative is our finding that alda-1 increases the relaxation of EtOH but does not
alter relaxation of either AA or acetate. Collectively, these data are both compelling
(ALDH activity likely is involved in vascular effects of EtOH and acetate.) and
vexing (Why are vascular effects of AA unaltered by modulators of ALDH activity?).
The latter may be a function of addition of extracellular addition of AA whereas
both EtOH and acetate need to be intracellular in order to be metabolized to
bioactive AA. The cyanamide-mediated inhibition of EtOH- and acetate-induced
relaxations further indicates dependence on ALDH activity for initiation of
relaxation. There is, of course, precedent for such a role of ALDH2 activity in
nitroglycerin-induced vasorelaxation (Beretta et al., 2012; Hink et al., 2007),
however, others show that cyanamide alone induces relaxation in isolated and
precontracted rabbit aorta (Fukuto, Gulati, & Nagasawa, 1994). Moreover, as
nicotine did not alter AA-induced SMA relaxation, we infer nicotine does not inhibit
vascular ALDH activity. To dissect out the complex biochemical interplay between
AA vascular action and ALDH activity will require further studies.
In conclusion, we describe a sensitive component of an AA-induced
vasorelaxation in SMA that is sequentially dependent on an EDRF/NO and a
GC/cGMP pathway. We suggest this relaxation is a likely contributor to a broader,
multifaceted postprandial hyperemic reflex that increases blood flow to the GI tract
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to augment digestion and nutrient absorption. Moreover, EtOH and/or acetate (a
short chain fatty acid metabolite of gut microbiota) may contribute to local vascular
AA levels (via ADH and ALDH activities) to further augment the reflex increase in
gut blood flow related to feeding (and drinking).
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CHAPTER V

CROTONALDEHYDE-INDUCED VASCULAR RELAXATION AND TOXICITY:
ROLE OF ENDOTHELIUM AND TRANSIENT RECEPTOR POTENYTIAL
ANKYRINE-1 (TRPA1)

Introduction: Crotonaldehyde (CR) is an electrophilic α,β-unsaturated
aldehyde present in foods and beverages, and as a minor metabolite of 1,3butadiene. CR is a product of incomplete combustion, and thus, it is measured at
relatively high levels (ppm) in cigarette smoke and structural fires. Exposure to CR
has been linked to cardiopulmonary toxicity and cardiovascular disease including
atherosclerosis. Objective: The purpose of this study was to examine the direct
effects of CR in isolated murine blood vessels (aorta and superior mesenteric
artery, SMA) in vitro, and dissect the underlying mechanisms. Method and
Results: CR induced concentration-dependent (1-300 μM) and equally robust
relaxations (75-80%) in phenylephrine (PE) precontracted aorta and SMA, yet the
SMA was 20x more sensitive than aorta to CR (SMA EC50 3.8±0.5 μM; aorta EC50
76.0±2.0 μM; p<0.05). To probe the mechanisms of CR-induced relaxation and
toxicity, we used the sensitive SMA. The CR-induced relaxation was inhibited in
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the presence of: 1) mechanically-impaired endothelium; 2) Nω-Nitro-L-arginine
methyl ester hydrochloride (L-NAME); 3) guanylyl cyclase (GC) inhibitor (ODQ); 4)
transient receptor potential ankyrin-1 (TRPA1) antagonist (A967079); and, 5) nonvasoactive level of nicotine (1 μM). Similarly, a known TRPA1 agonist, allyl
isothiocyanate (AITC; mustard oil) also stimulated SMA relaxation dependent on:
endothelium, TRPA1, NO, and GC. Moreover, TRPA1 was co-localized with
isolectin by positive immunofluorescent staining of the SMA endothelium. Thus,
CR (1-30 μM) induces relaxation in SMA via an endothelium-, NO-, GC-, and
TRPA1-dependent pathway. Additionally, CR was toxic at high concentrations
(100-300 μM) where it stimulated tension oscillations and significantly depressed
subsequent PE-induced contractions after washout. CR-induced vasotoxicity was
significantly enhanced in SMA with impaired endothelial function. Conclusions:
The sensitive relaxation of CR depends on a functional endothelium and TRPA1
whereas vasotoxicity was enhanced under conditions of endothelium dysfunction.
CR is both vasoactive and vasotoxic along a concentration continuum with
elevated CR likely encountered in smoke exposures.

1. Introduction
Crotonaldehyde (CR) is a highly reactive α,β-unsaturated aldehyde that is
environmentally ubiquitous, e.g., found in foods such as fish, meat, fruits and
vegetables and beverages such as wine and whiskey (Eder, Schuler, & Budiawan,
1999; IARC., 1995). Sources of CR exposure are mainstream and side-stream
tobacco smoke (IARC., 1995). CR is also formed endogenously during lipid
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peroxidation (Chung, Chen, & Nath, 1996; Chung et al., 1999; Duescher & Elfarra,
1993; Filser et al., 2001; Kawaguchi-Niida et al., 2006; Nair, Bartsch, & Nair, 2007;
Voulgaridou, Anestopoulos, Franco, Panayiotidis, & Pappa, 2011) and in the
metabolism of 1,3-butadiene (Duescher & Elfarra, 1993; Filser et al., 2001) and Nnitrosopyrrolidine (Hecht, Upadhyaya, & Wang, 1999; M. Y. Wang, Chung, & Hecht,
1988). CR can also be formed from acetaldehyde by aldol condensation and
dehydration (Tuma, Hoffman, & Sorrell, 1991). CR is an important industrial
chemical used in the synthesis of tocopherols, sorbitol, and 3-methylbutanol, but it
is also a contaminant and a byproduct of various chemical processes (IARC.,
1995).
CR can rapidly penetrate cell membranes and induce adverse biological
effects, such as inflammation in alveolar macrophages of smokers (Facchinetti et
al., 2007; Yang et al., 2013a; Yang et al., 2013b); oxidative stress and apoptosis
in epithelial cells (Liu, Yang, Pan, Zhu, & Xie, 2010a, 2010b); and toxicity to
respiratory tract tissues (Reddy et al., 2002). Glutathione S-transferase P (GSTP)
accelerates metabolism of short chain unsaturated aldehydes such as acrolein (3C) and CR (4-C) via conjugation with glutathione (GSH) (Berhane, Widersten,
Engstrom, Kozarich, & Mannervik, 1994; D. J. Conklin, Haberzettl, et al., 2015a).
The major metabolite of CR and a urinary biomarker of CR exposure is 3-hydroxy1-methylpropyl mercapturic acid (HPMMA) (Gray & Barnsley, 1971). Urinary levels
of HPMMA are significantly increased after cigarette smoking and are significantly
higher (3x) in U.S. cigarette smokers than in non-smokers (Jain, 2015; Lorkiewicz
et al., 2019). Moreover, levels of both HPMMA and 3HPMA (major metabolite of
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acrolein) are similar in smokers yet as well as in non-smokers indicating similar
levels of these two aldehydes are found in the environment, derived from
endogenous metabolic processes and in cigarette smoke (Jain, 2015).
CR is chemically similar to acrolein, and thus, the lung toxicity of cigarette
smoke has been attributed in part to both acrolein and CR. It has been listed as
one of nine constituents recommended for disclosure and monitoring by the World
Health Organization (WHO) study group on tobacco product regulation
(Haussmann, 2012). Moreover, because the primary acrolein metabolite, 3HPMA,
is associated with cardiovascular and pulmonary disease risk (DeJarnett et al.,
2014; Srivastava et al., 2011; Zhang et al., 2018), it is expected that CR also
contributes to disease risk. Similarly, occupational exposure to 1,3-butadiene, a
precursor of CR, is associated with cardiovascular disease, and in an animal model,
exposure to 1,3-butadiene increases arteriosclerotic plaque development in
cockerels (Penn & Snyder, 1996b). Nonetheless, little research has been
dedicated to assess the direct vascular actions of CR.
Because CR and acrolein are known to activate the transient receptor
potential ankyrin 1 (TRPA1) channel and because TRPA1 is present in the
vasculature, we explored the TRPA1-dependence of CR vasoreactivity in isolated
blood vessels. TRPA1 is widely distributed in the nervous and cardiovascular
systems especially sensory neurons (unmyelinated C-fibers) (Anand et al., 2008;
Nagata, Duggan, Kumar, & Garcia-Anoveros, 2005), endothelial cells (Earley et
al., 2009a), and heart and cardiomyocytes (Andrei, Sinharoy, Bratz, & Damron,
2016; D. J. Conklin, Y. Guo, et al., 2019). Activation of TRPA1 by a variety of
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agonists including acrolein, CR and allyl isothiocyanate (AITC, mustard oil) leads
to pain (Trevisan et al., 2016), neurogenic tissue inflammation (Schwartz et al.,
2011), pulmonary edema and airway hyper-reactivity (Andre et al., 2008; D. J.
Conklin, Haberzettl, Jagatheesan, Kong, & Hoyle, 2016), vasodilation (Jin,
Jagatheesan, et al., 2019) and hypotension (Earley, 2012; Pozsgai et al., 2010).
Thus, TRPA1 could be important in the vasoactive effects of CR.
Consistent with our hypothesis, our research showed that CR induced a
robust, concentration-dependent relaxation that in superior mesenteric artery
(SMA) was dependent on: 1) a functional endothelium; 2) NO formation; 3)
guanylyl cyclase (GC); and, 4) TRPA1 activation. High concentrations of CR,
however, led to tension oscillations and irreversible suppression of subsequent
contractility reflecting acute vasotoxicity. These data indicate that CR is vasoactive
with TRPA1 at low concentrations and vasotoxic at high concentrations.

2. Material and Methods
Chemicals and Solutions.
Reagent grade chemicals were purchased from Sigma-Aldrich or other
commercial sources as indicated: A967079 (AdooQ); acetylcholine chloride (ACh);
crotonaldehyde (CR); allyl isothiocyanate (AITC); 1h-[1,2,4]oxadiazolo[4,3a]quinoxalin-1-one (ODQ); N-nitro-L-arginine methyl ester hydrochloride (LNAME); L-phenylephrine hydrochloride (PE); sodium nitroprusside (SNP).
Animals.
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Male or female wild type C57BL/6J (WT), TRPA1-null and GSTP-null mice
(12-20 weeks old; 25-35g) were purchased (The Jackson Laboratory, Bar Harbor,
ME) or used from in house breeding (D. J Conklin et al., 2017; D. J. Conklin,
Haberzettl, et al., 2009b). Mice were treated according to American Physiological
Society Guiding Principles in the Care and Use of Animals, and all protocols were
approved by University of Louisville Institutional Animal Care and Use Committee.
Mice were housed under pathogen-free conditions in the University of Louisville
vivarium under controlled temperature and 12h light:12h dark cycle. Mice were
provided water and a standard chow diet ad libitum (Rodent Diet 5010, 4.5% fat
by weight, LabDiet; St. Louis, MO).
Urine Collection and CR Metabolite Analysis
Urine Collection. To measure total urine HPMMA, mice were exposed to HEPAfiltered air or mainstream cigarette smoke (MCS; KY Reference 3R4F cigarettes:
50% of smoke of 12 cigarettes over 6h) and then placed singly per metabolic cage
with glucose/saccharin solution (w/v; 3.0%/0.125%) to collect urine (without food)
up to 3h post-exposure followed by urine collection overnight (O/N; with food).
Urine samples were centrifuged in cold immediately after collection (600×g, 5 min;
to pellet any feces and food particles), decanted, and stored at -80 °C (D. J. Conklin
et al., 2018).
CR Metabolite Analysis. The major urine metabolite of CR, 3-hydroxy-1methylpropylmercapturic acid (HPMMA), was quantified by ultrafast performance
liquid chromatography-mass spectrometry (UPLC-MS) as described (D. J. Conklin
et al., 2018). Briefly, urine (25 µl) was mixed with 15 mM ammonium acetate (975
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µl) containing HPMMA-d3 standard (667 ng) and filtered through a 0.2 mm PTFE
membrane. Samples (2 µl) were applied on UPLC and the eluate was analyzed for
the MRM traces by MS. To account for urinary dilution, all values for urinary
metabolites were normalized to urinary creatinine (mg/dl) (D. J. Conklin et al.,
2018).
CR-Induced Vasoreactivity in Isolated Aorta and Superior Mesenteric Artery (SMA)
Isolation and Organ Bath Conditions. After removal and cleaning of the aorta and
SMA, thoracic aorta rings (3-4 mm) were hung on stainless steel hooks in organ
baths and SMA rings (2 mm) were hung on tungsten wire in 5-ml heated organ
baths (MultiWire Myograph System 620M, DMT, Denmark) in PSS bubbled with
95% O2:5% CO2 at 37 °C. After 10 min without tension, aorta and SMA rings were
equilibrated to respective loading tension over 30 min (aorta, 1g; SMA, 0.25g). All
rings were stimulated with High K+ (60 mM) to test for viability, washed 3 times
with PSS over 30 min, and re-equilibrated to appropriate resting tension (Jin,
Jagatheesan, et al., 2019). Krebs physiological salt solution (PSS) for SMA was
(in mM): NaCl, 119; KCl, 4.7; CaCl2, 2; MgCl2, 1.2; KH2PO4, 1.2; NaHCO3, 24;
glucose, 7; pH 7.4. Krebs PSS for aorta was (in mM): NaCl, 119; KCl, 4.7; CaCl2,
1.2; KH2PO4, 1.2; MgSO4, 1.2; NaHCO3, 25; glucose, 5.5; pH 7.4. High K+ PSS
(High K+; 60 mM) substituted equimolar K+ for Na+ in SMA PSS.
Crotonaldehyde (CR) Experimental Series:
CR-Induced Relaxation. Crotonaldehyde (1, 3, 10, 30, 100, and 300 µM) was
added to organ bath containing uncontracted and pre-contracted (PE, 10 µM; PE1)
aorta and SMA. Following exposure to the highest concentration of CR, organ
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baths were washed (3x) with fresh PSS over 30 min, and then vessels were
precontracted again with PE (PE2) and relaxed sequentially with ACh (10 µM) and
then SNP (100 µM) to test for endothelium-dependent and -independent
relaxations, respectively. The efficacy of CR-induced relaxation was calculated as
the % reduction in agonist-induced contraction. The sensitivity of CR-induced
relaxation was the effective concentration producing 50% response (EC50), i.e.,
cumulative concentration responses normalized to 100% with interpolation of EC 50
(Jin, Jagatheesan, et al., 2019). EC50 values were calculated only if total relaxation %
exceeded 50% of PE1. Contractile toxicity was quantified as the PE2/PE1 tension
ratio (as %) by dividing PE-induced tension post-CR-exposure (PE2) by PEinduced tension pre-CR (i.e., PE1) multiplied by 100. Tension oscillations were
quantified by their frequency (oscillations/min) and their amplitude (mN) as
averaged after high CR concentration exposure (300 µM) (D. J. Conklin, Boyce,
Trent, & Boor, 2001a).
Role of the Endothelium, Nitric Oxide Synthase (NOS), and cGMP. The role of the
endothelium in CR-induced vasorelaxation was studied in SMA with intact and
injured endothelium. The endothelium was mechanically injured by air perfusion
and damage confirmed by near complete abolition (>95%) of ACh-induced dilation
of PE pre-contracted SMA (Jin, Jagatheesan, et al., 2019). To evaluate the role of
NOS, L-NAME (100 µM) was added after addition of PE (10 µM; 15 min), and, precontracted SMA were then relaxed with cumulative concentrations of CR (1, 3, 10,
30, 100 and 300 µM). To assess whether cGMP was involved in CR-induced
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vasorelaxation, PE-precontracted SMA were exposed to ODQ (3 µM) to inhibit
guanylyl cyclase (GC) and subsequent formation of cGMP (Jiang et al., 2015).
Role of TRPA1. The role of the TRPA1 channel was assessed by incubation of
SMA with TRPA1 antagonist (A967079, 1 µM) followed by cumulative addition of
CR (1-300 µM). Similarly, effects of CR in SMA of TRPA1-null mice were measured
without and with the TRPA1 antagonist (A967079, 1 µM) present. Likewise, effects
of a known TRPA1 agonist, allyl isothiocyanate (AITC, 1-300 µM), were measured
in PE-precontracted SMA.
Role of GSTP on CR Relaxation. Because CR is primarily metabolized by
glutathione S-transferase P (Berhane et al., 1994), we assessed whether GSTP
deficiency could enhance effects of CR in isolated blood vessels of GSTP-null mice.
Blood vessels were PE-precontracted and exposed to increasing concentrations
of CR (1-300 µM) as described above.
Role of Nicotine. Because exposure to CR via tobacco smoke also will necessarily
contain nicotine, we tested whether a super-pharmacological level of nicotine (1
µM) would affect CR-induced relaxation in PE-precontracted SMA.
Histology and TRPA1 Immunofluorescence. Thin sections (4 µm) of formalin-fixed,
paraffin-embedded SMA, aorta and dorsal root ganglia (DRG; positive control) of
WT mice were stained with H&E or TRPA1 antibody (1:200; Alomone Labs, Israel;
Cat. #: ACC-037). To label endothelial cells, blood vessel sections were co-stained
with isolectin GS-IB4 Alexa Fluor 594 conjugate (1:200 dilution; Invitrogen; Cat. #:
I21413). Images of H&E-stained sections were made using a digital Spot camera

134

mounted on an Olympus microscope. Immunofluorescence microscopy was
performed with rabbit polyclonal antibody against TRPA1 without or with a blocking
peptide of the TRPA1 antibody and Alexa Fluor 647 goat anti-rabbit secondary
antibody (1:400 dilution; Invitrogen; Cat. #: 21244). Slides were covered with DAPI
containing Slow Fade® Gold anti-fade reagent (Invitrogen; Cat. #: S36938), and
fluorescence was visualized on a Nikon eclipse Ti fluorescence Microscope using
NIS-Elements (Nikon; Japan) at 200X. A DAPI filter was used for nuclear staining
and a Cy5 Red filter for TRPA1 staining (D. J. Conklin, Y. Guo, et al., 2019; Jin,
Jagatheesan, et al., 2019).
Statistical Analyses. Data are expressed as means ± SE. When comparing two
groups, a t-test was used (paired or unpaired as appropriate). Multiple group
testing was done with One-Way ANOVA with Bonferroni post hoc. If either equal
variance or normality test failed, One-Way ANOVA on Ranks (Kruskal-Wallis) and
Dunn’s post hoc was used (SigmaPlot, ver. 12). Statistical significance was
assumed where P<0.05.

3. Results
Urinary CR Metabolite, HPMMA, is Elevated in Mice Exposed to Mainstream
Cigarette Smoke (MCS).
The total urinary HPMMA (μg) excreted from C57BL/6 (WT) mice exposed
to KY Reference cigarette MCS (3R4F) was increased 2.5x over that in urine of
air-exposed mice (Fig. 23A). As expected, urinary nicotine level also was
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increased significantly after MCS exposure (Fig. 23A). Baseline excretion of
HPMMA (about 1.8 μg/16h) is equivalent to 0.025 μmol CR (MW = 70.07), and as
blood volume of a 25g mouse is about 2 ml, this amount of CR approximates to
12.5 μM in blood. Moreover, as the HPMMA level was increased 2.5x after MCS
exposure, a potential blood level of CR >30 μM was estimated. So, we tested for
direct vascular effects of CR from 1-300 μM to cover a broad systemic
concentration range.

Concentration-Dependent Effects.
CR (1-300 μM) produced robust (around 75-80%) concentration-dependent
relaxations in precontracted aorta and SMA (Fig. 23B-C), but relaxations did not
reach 100% in SMA due to a consistent reversal of relaxation and induction of
tension oscillations (“spasms”) at 300 μM (Fig. 23B). CR induced equally robust
vasorelaxation in both isolated aorta and SMA, but the SMA was significantly more
sensitive (20x) than aorta to CR (SMA EC50 3.8±0.5 μM; aorta EC50 76.0±2.0 μM;
p<0.05) (Fig. 23D; Tables 14-15). Tension oscillation frequencies were low
(<2/min) and of modest amplitude (<2.5 mN) (Fig. 23B; Table 16). Endothelial
impairment abolished CR induction of oscillations, and L-NAME treatment
decreased oscillation frequency by 35% and amplitude by 60% although neither
reduction was statistically significant (Table 16).
CR (1-300 μM) added to uncontracted SMA had no effect on basal tension
(myogenic tone; data not shown) nor on PE2-generated tension (84.0±12.8% of
PE1; n=3) nor on ACh-induced relaxation (-91.1±1.3%; n=3) in the continued
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presence of CR. However, after 3 bath exchanges over 30 min, CR-treated SMA
were largely refractory to PE3-induced tension by 74.4±15.0% of PE1 (n=3;
P=0.0666); yet, retained functional ACh-induced relaxation (-84.6±2.4%; n=3).
Mechanisms of CR-Induced Vasorelaxation.
The most sensitive component of CR-induced vasorelaxation (1-30 μM)
was significantly inhibited in PE-pre-contracted SMA by a mechanically disrupted
endothelium (>90% loss of ACh-induced relaxation) (Fig. 24A-B; Tables 14-15).
Similarly, CR-induced vasorelaxation in pre-contracted SMA was equally inhibited
in the presence of L-NAME, and the EC50 shifted rightward (less sensitive) (Fig.
24C-D; Tables 14-15). This L-NAME effect indicated a role of NO (likely eNOS)
as critical in the most sensitive part of the CR-induced relaxation in PEprecontracted SMA. Similarly, ODQ treatment, an irreversible guanylyl cyclase
(GC) inhibitor, significantly blocked only the most sensitive part of the CR-induced
relaxation (Fig. 24E-F; Tables 14-15). Collectively, these data show that the
sensitive portion of the CR-induced relaxation was dependent on the endothelium,
NOS (likely eNOS) and NO-mediated activation of GC (and formation of cGMP in
VSMC). The female SMA was marginally less sensitive to CR than male SMA
(Table 15).

Role of TRPA1 channel in the CR-induced relaxation.
Because CR is a known agonist of TRPA1, we hypothesized that the
TRPA1 channel contributes to endothelium-dependent CR-induced vasorelaxation
in SMA. In support, the TRPA1 antagonist, A967079 (1 µM), significantly inhibited
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the most sensitive part (<10 µM) of the CR-induced relaxation in PE-contracted
SMA (Fig. 25A-B; Tables 14-15). We also tested CR-induced relaxation with or
without A967079 (1 µM) in PE-contracted SMA of male TRPA1-null mice (Fig.
25C-D; Tables 14-15). In contrast, presence of A967079 appeared to enhance
slightly the relaxation of CR in TRPA1-null SMA (Fig. 25D). Because CR is a
substrate of GSTP, we tested for a metabolic role of GSTP in SMA treated with
CR. There was no difference in the CR-induced relaxation in PE-contracted SMA
of GSTP-null mice compared with WT SMA (Fig. 25E-F; Tables 14-15), and there
was no difference in the CR-induced relaxation with or without ezatiostat which
was a GSTP inhibitor (Fig. 25G-H; Tables 14-15). Because AITC is a known
TRPA1 agonist, it, unsurprisingly, induced a concentration- and TRPA1-dependent
relaxation in SMA (Fig. 26A). This relaxation, as with CR, was inhibited by the
TRPA1 antagonist (A976709), and the AITC-induced relaxation was similarly
shifted rightward in SMA of TRPA1-null mice (Fig. 26B), supporting the idea that
TRPA1 mediates this sensitive vasorelaxation (see EC50s in Table 15).
In immunofluorescent-stained cross-sections of mouse SMA, TRPA1
(green; Fig. 26D) was co-localized with isolectin (red) in the endothelium (see
yellow in Fig. 26E). Modest yet specific TRPA1 staining also was present in the
media:adventitia border of SMA (green; Fig. 26D). Although aorta (Fig. 26F-H)
had positive TRPA1 staining localized in the media (green; Fig. 26G), there was
no staining observed in the endothelium. Positive TRPA1 staining was confirmed
by use of a TRPA1 blocking peptide in aorta (Fig. 26H) and in dorsal root ganglion
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(DRG; Fig. 27), which also served as a positive control for TRPA1 (D. J. Conklin,
Y. Guo, et al., 2019).

Vascular smooth muscle toxicity of CR.
The PE2/PE1 tension (%) was significantly decreased after CR exposure
(CR PE2/PE1: 27.0±2.2%) compared with the untreated control group (PE2/PE1:
133.6±12.3%) (Fig. 28A, Table 17). The PE2/PE1 tension (%) was further
decreased in endothelial dysfunction (ED) and ODQ treatment groups compared
with the CR only exposed group (Fig. 28A) but there were no differences with any
other treatment group. Although CR treatment alone depressed PE 2 contraction, it
had no effect on subsequent ACh-induced relaxation (Fig. 28B, Table 16). In fact,
the only 2 groups with impaired ACh-induced relaxation following CR exposure
were by design: ED and L-NAME treatments (Fig. 28B, Table 17) suggesting that
CR did not induce acute endothelial cell injury despite causing VSMC dysfunction.

Nicotine and CR.
In users of combustible tobacco, CR and nicotine exposure occur
simultaneously; therefore, we tested whether nicotine altered CR-induced
relaxation in SMA. Nicotine (>10 µM) induced robust relaxation in SMA (Fig. 29A).
Nicotine alone (1 µM) had no effect on tension in PE-contracted SMA, yet
decreased slightly and significantly efficacy of subsequent CR-induced
vasorelaxation (Table 14; Fig. 29B).
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Fig. 23. Crotonaldehyde-induced (CR) relaxation in aorta and superior
mesenteric artery (SMA). A) Cumulative quantification of mass spectrometry
analyses

of

primary

crotonaldehyde

(CR)

metabolite

(3-hydroxy-1-

methylpropylmercapturic acid; HPMMA) and nicotine in urine of mainstream
cigarette smoke-exposed (MCS; 12 cigarettes/6 h) male mice 16h post-exposure.
(Graph derived from data in Conklin et al., 2018). B) Representative trace of CRstimulated (1-300 µM) relaxation and tension oscillations of phenylephrine (PE)contracted SMA, and post-CR exposure vasoreactivity. C) Representative trace of
CR-stimulated (1-300 µM) relaxation of phenylephrine (PE)-contracted aorta, and
post-CR exposure toxicity (no contraction to PE). D) Summary sensitivity data of
CR-induced relaxation in PE pre-contracted SMA and aorta. Values = means ± SE
of 3-4 preparations. *, P<0.05 vs aorta.
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Table 14. Efficacy (maximal relaxation, Emax) of crotonaldehyde-induced
relaxations of PE-precontracted superior mesenteric artery (SMA; male and
female) without and with inhibitor treatments.
SMA
(+treatment, N)
WT+ED

Emax
(Control, PE+vehicle)
-74.3±6.6

Emax
(ED or PE+inhibitor)
-63.6±7.1

WT+L-NAME

-62.7±5.3

-66.8±2.4

WT+ODQ

-73.4±6.9

-54.7±15.2

WT+A967079

-57.2±3.5

-61.6±6.8

TRPA1-null+A967079

-70.5±6.4

-79.0±4.2

WT+Ezatiostat

-56.5±7.2

-61.5±2.5

GSTP-null

-52.6±2.9

--

WT+Nicotine

-67.0±4.2

-55.0±6.5#

WT (f)

-59.8±3.9

--

Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; ED, endothelial
dysfunction induced by mechanical air perfusion; L-NAME, N-nitro-L-arginine
methyl ester hydrochloride, 100 µM; A967079, TRPA1 antagonist, 1 µM; ODQ, 1h[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, 3 µM; Ezatiostat 1µM; Nicotine 1 µM; --,
experimental group not performed; (f), female. All SMA were from male mice
except where indicated female, (f). N=3-6 per group. *, P<0.05 vs matched Control
(PE+vehicle); #, 0.05<P<0.10 vs matched Control (PE+vehicle).
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Table 15. The sensitivity (effective concentration inducing 50% relaxation; EC50;
in µM) of crotonaldehyde (CR)-induced vasorelaxation in PE pre-contracted
murine superior mesenteric artery (SMA) in the absence and presence of
functional endothelium or selective inhibitors.
SMA
(+treatment, N)
WT+ED

EC50
(Control, PE+vehicle)
5.7±1.0

EC50
(ED or PE+inhibitor)
68.2±13.9*

WT+L-NAME

6.0±2.0

43.6±17.9*

WT+ODQ

3.9±1.6

35.3±1.6*

WT+A967079

7.2±2.3

12.1±2.1*

TRPA1-null

17.9±7.4

14.1±2.7

WT+Ezatiostat

4.3±0.7

4.2±0.6

GSTP-null

5.9±0.8

--

WT+Nicotine

3.3±0.8

5.7±1.2

WT (f)

6.6±0.3*

--

Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; ED, endothelial
dysfunction induced by mechanical air perfusion; L-NAME, N-nitro-L-arginine
methyl ester hydrochloride, 100 µM; A967079, TRPA1 antagonist, 1 µM; ODQ, 1h[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, 3 µM; Ezatiostat 1µM; Nicotine, 1 µM; --,
experimental group not performed; (f), female. All SMA were from male mice
except where indicated (f). N=3-6 per group. *, P<0.05 vs matched Control
(PE+vehicle).
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Table 16. Characteristics of tension oscillations induced by a high concentration
of crotonaldehyde (CR; 300 µM) in PE-precontracted superior mesenteric artery
(SMA).
SMA (+treatment)

Amplitude (mN)

WT+CR

Frequency
(oscillations/min)
2.0±0.4

WT+CR+ED

0*

--

WT+CR+L-NAME

1.3±0.2

0.9±0.1

WT+CR+ODQ

2.1±0.6

1.2±0.5

WT+CR+A967079

1.7±0.3

1.9±0.5

TRPA1-null+CR

1.7±0.3

2.0±0.2

WT+CR+Ezatiostat

1.9±0.1

2.1±0.2

GSTP-null+CR

1.9±0.6

3.4±0.5

WT+Nicotine

1.8±0.2

1.6±0.3

WT (f) +CR

1.4±0.6

2.9±0.6

2.0±0.3

Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; WT, wild type; ED,
endothelial dysfunction; L-NAME, N-nitro-L-arginine methyl ester hydrochloride,
100 µM; ODQ, 1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, 3 µM; A967079,
TRPA1 antagonist, 1 µM; Ezatiostat 1µM; Nicotine, 1 µM; (f), female. All SMA were
from male mice except where indicated (f). N=3-10 per group. *, P<0.05 vs WT+CR.
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Fig. 24. Mechanisms of crotonaldehyde-induced (CR) relaxation in superior
mesenteric artery (SMA). A) Representative traces of CR-stimulated relaxation
of PE-induced contraction without and with endothelium impairment due to 5 min
of air perfusion. B) Summary data of CR-induced relaxation in isolated SMA precontracted with PE in the presence and absence of functional endothelium. C)
Representative traces of CR-stimulated relaxation of PE-induced contraction in the
absence and presence of L-NAME (100 µM). D) Summary data of CR-induced
relaxation in isolated SMA pre-contracted with PE in the absence and presence of
L-NAME. E) Representative traces of CR-stimulated relaxation of PE-induced
contraction in the absence and presence of the guanylyl cyclase (GC) antagonist,
ODQ (3 µM), added to bath after PE-induced contraction plateaued and prior to
cumulative addition of CR. F) Summary data of CR-induced relaxation in isolated
SMA pre-contracted with PE in the absence and presence of ODQ. Values =
means ± SE of 3-4 preparations. *, P<0.05 vs control.
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Fig. 25. Role of the TRPA1 channel in crotonaldehyde (CR)-induced
relaxation in superior mesenteric artery (SMA). A) Representative traces of
CR-stimulated relaxation of phenylephrine (PE) pre-contracted SMA in the
absence (Control) and presence of the TRPA1 antagonist, A967079 (1 µM) added
after PE-induced contraction plateaued and prior to cumulative addition of CR in
wild type (WT) SMA. B) Summary data of CR-induced relaxation in isolated SMA
pre-contracted with PE in the absence and presence of TRPA1 antagonist. C)
Representative traces of CR-stimulated relaxation of PE pre-contracted SMA in
the absence (Control) and presence of the TRPA1 antagonist, A967079 (1 µM)
added after PE-induced contraction plateaued and prior to cumulative addition of
CR in TRPA1-null SMA. D) Summary data of CR-induced relaxation in PE precontracted TRPA1-null SMA in the absence and presence of TRPA1 antagonist.
E) Representative traces of CR-stimulated relaxation of PE pre-contracted SMA of
WT and GSTP-null mice. F) Summary data of CR-induced relaxation in PE precontracted WT and GSTP-null SMA. G) Representative traces of CR-stimulated
relaxation of phenylephrine (PE) pre-contracted SMA in the absence (Control) and
presence of the GSTP antagonist, Ezatiostat (1 µM) added after PE-induced
contraction plateaued and prior to cumulative addition of CR in wild type (WT)
SMA. H) Summary data of CR-induced relaxation in isolated SMA pre-contracted
with PE in the absence and presence of GSTP antagonist. Values = means ± SE
of 3-4 preparations. *, P<0.05 vs Control.
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Fig. 26. Role of TRPA1 in AITC-induced relaxation of superior mesenteric
artery (SMA), and localization in SMA and aorta. A) Representative traces of
AITC-stimulated, concentration-dependent relaxation of PE-contracted SMA. B)
Summary data of AITC-induced relaxation in PE-contracted SMA of WT and
TRPA1-null mice in the absence (DMSO) and presence of TRPA1 antagonist,
A967079 (1 µM). Formalin-fixed, paraffin-embedded, cross-sections of murine
SMA (C-E) and aorta (F-H) stained with H&E (C, F). Immunofluorescent
localization of TRPA1 alone in SMA (green, D) or with isolectin (red, endothelium)
and DAPI (E). Immunofluorescent localization of TRPA1 alone in aorta (green, G)
or with isolectin (red) and a TRPA1 blocking peptide and DAPI (H). All images were
taken at 200x magnification (scale bar = 100 µm). Values = means ± SE of 3-4
preparations. *, P<0.05 vs Control. Abbr.: L, lumen.
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Fig. 27. Immunofluorescent localization of TRPA1 in dorsal root ganglion
(DRG). Formalin-fixed, paraffin-embedded sections of murine DRG were stained
with H&E (A); DAPI only (blue) (B); TRPA1 antibody (red) and DAPI (C); or, TRPA1
antibody, TRPA1 blocking peptide, and DAPI (D). All images were imaged at 200x
magnification (scale bar = 100 µm).
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Fig. 28. Toxicity of crotonaldehyde (CR) exposure in superior mesenteric
artery (SMA). A-B) Ratio of PE2 (PE-induced tension post-CR [300 µM] exposure)
to PE1 (PE-induced tension pre-CR) (as %) across treatment groups with untreated
control group for comparison. B) Effects of CR and treatments on ACh-induced
relaxation. Values = means ± SE of 3-6 preparations. *, P<0.05 vs untreated
Control or vs CR control (B only). Abbr.: ED, endothelial dysfunction.
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Table 17. Vasotoxicity of crotonaldehyde (CR) in superior mesenteric artery (SMA).
SMA (+treatment)

PE2/PE1 (%)

ACh (%)

WT (control)

133.6±12.3

-95.4±1.6

WT+CR

27.0±2.2*

-92.6±2.5

WT+CR+ED

10.0±2.5*#

-16.7±3.3*

WT+CR+L-NAME

21.0±1.7*

-64.2±4.8*

WT+CR+ODQ

9.5±3.2*#

-83.9±2.4

WT+CR+A967079

34.0±2.4*

-89.9±2.3

TRPA1-null+CR

34.0±4.7*

-97.1±1.8

WT+CR+Ezatiostat

43.5±4.5*#

-91.9±3.4

GSTP-null+CR

37.5±2.5*

-95.1±1.3

WT+CR+Nicotine

26.6±4.5*

-87.3±2.9

WT (f) +CR

26.1±6.2*

-93.9±3.3

Values = means ± SE. Abbr.: PE, phenylephrine, 10 µM; ACh, acetylcholine
chloride, WT, wild type; ED, endothelial dysfunction; L-NAME, N-nitro-L-arginine
methyl ester hydrochloride, 100 µM; ODQ, 1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin1-one, 3 µM; A967079, TRPA1 antagonist, 1 µM; Ezatiostat 1 µM; Nicotine, 1 µM,
(f), female. The PE2/PE1 tension (%) was calculated by dividing PE-induced
tension post-CR-exposure (PE2) by PE-induced tension pre-CR (i.e., PE1) and
multiplied by 100. ACh-induced relaxation was calculated as the % reduction in
PE2-induced tension. All SMA were from male mice except where indicated (f).
N=3-10 per group. *, P<0.05 vs WT (male) (control). #, P<0.05 vs WT+CR.
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Fig. 29. Effects of nicotine on CR-induced relaxation in SMA. A)
Representative trace of concentration dependent (0.1 µM – 1 mM) nicotineinduced relaxation of PE pre-contracted SMA. B) Nicotine at 1 µM had no effect
on tension of PE-precontracted SMA yet significantly decreased efficacy (10, 30
and 100 µM) of subsequent CR-induced vasorelaxation (Table 1). Values = means
± SE of 6 preparations. *, P<0.05 vs matched Control; #, 0.05<P<0.10 vs matched
Control.
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4. Discussion
To our knowledge, this is the first study to show the vasoreactivity of CR
and its mechanisms of action that include TRPA1. The mechanisms of CR-induced
vasorelaxation are similar to formaldehyde, including dependence on TRPA1,
endothelium, NO formation and guanylyl cyclase activation (Jin, Jagatheesan, et
al., 2019). The robust and sensitive relaxation is reminiscent of actions described
for acrolein at low concentrations in perfused rat mesenteric bed (Awe et al., 2006),
isolated rat coronary artery (D. J. Conklin et al., 2001a), and isolated mouse aorta
(D. J. Conklin, Haberzettl, et al., 2009a). Moreover, we show that, also like acrolein
(D. J. Conklin et al., 2001a), CR at higher concentrations induces tension
oscillations (“spasms”) and suppresses contractility (toxicity) in SMA. This
continuum from potent relaxation to vascular toxicant belies the importance of
studying these responses as CR is abundant in foods, beverages, occupational
settings, and especially in combustion-derived smoke, i.e., tobacco smoke,
wildfires, etc... Thus, appreciating the avidity of unsaturated aldehydes for altering
vascular wall function is a first step toward understanding how exposure to CR
may increase cardiovascular disease risk.
It is unsurprising that vascular TRPA1 is involved in CR-induced
vasorelaxation. Activation of TRPA1 can lead to release of vasoactive peptides,
substance P (SubP) and CGRP (Trevisan et al., 2016) that can induce vasodilation
and inflammatory responses (Achanta, Chintagari, Brackmann, Balakrishna, &
Jordt, 2018; D. J. Conklin, 2016). The mechanism of CR-induced TRPA1-mediated
relaxations in SMA, however, appears to be dependent largely on endothelium159

localized TRPA1 as we show that endothelial impairment either by air perfusion or
L-NAME shifts the sensitivity of the CR response rightward to a degree similar to
that of either TRPA1 antagonist treatment or by use of TRPA1-null SMA. This is
mirrored by relaxation of known TRPA1 agonist AITC that is equally shifted by both
A967079 and TRPA1 deletion. Nevertheless, we cannot fully rule out that other
cells in the isolated SMA, e.g., perivascular nerves, contribute to CR’s mechanism
of relaxation. Moreover, there are at least 2 mechanisms mediating the full
relaxation of CR (see Fig. 30): 1) endothelium; and, 2) time-dependent, irreversible
change in VSMC contractile machinery, e.g., closure of VSMC calcium channels.
Although the latter conclusion has limited experimental support, we infer it because
PE contraction is significantly impaired both pre- and post-CR exposure and
washouts; endothelium is intact because ACh-induced relaxation is unaffected
post-CR exposure (no endothelium dysfunction); and, previous experience with
similar vascular toxicity of acrolein led to findings consistent with a role of external
calcium (D. J. Conklin et al., 2006).
Cigarette smoke is a major source of exogenous CR (Goniewicz et al., 2017;
Lorkiewicz et al., 2019). We show that exposure of mice to MCS increases
excretion of the CR metabolite, HPMMA, by 2.5x, indicating there is a fair amount
of CR produced endogenously in mice. Our estimation of circulating blood levels
of CR puts it in the low end of the vasoactive range - a novel consideration. Given
that acrolein and CR are highly reactive unsaturated aldehydes, it is hard to fathom
these molecules floating as free aldehydes in the blood, and we do not think that.
However, the metabolites of CR and acrolein certainly are carried in the blood, and
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we hypothesize that these metabolites may be vasoactive, and this possibility
should be investigated further. Nonetheless, many unsaturated aldehydes are
noted potent vasodilators including acrolein (Awe et al., 2006), 4-hydroxynonenal
(4HNE) (Martinez et al., 1994; Romero et al., 1997) and cinnamaldehyde (Pozsgai
et al., 2010; Yanaga et al., 2006), and now CR -- all these are known ligands of
TRPA1. These potent dilatory effects may contribute to a variety of physiological
processes such as postprandial hyperemia or flow-mediated dilation (FMD) or
response to injury/infection, but too much of any of these aldehydes may lead to
pathological changes including vasospasm, atherosclerosis and vascular toxicity
(Boor & Conklin, 2008; D. J. Conklin et al., 2006; D. J. Conklin et al., 2001a).
Although these parent aldehydes can covalently modify intracellular aminoterminus free cysteines to activate TRPA1 (Macpherson et al., 2007), it is unclear
if their metabolites can do this as well or if there are other mechanisms of activating
TRPA1 channels.
Nicotine is also an important component of tobacco smoke, and nicotine
activates the sympathetic nervous system that can increase cardiovascular
disease risk factors such as heart rate and blood pressure and decrease heart rate
variability (HRV). These changes, in turn, affect myocardial remodeling, impair lipid
metabolism, and stimulate inflammation (Benowitz & Burbank, 2016; Dutta et al.,
2012). The plateau concentration of nicotine in the blood of smokers throughout
the day averages 40 μg/L (0.25 µM) (Moyer et al., 2002), and thus, we tested
whether effects of super-pharmacological level of nicotine (1 µM) could alter CR
effects in PE pre-contracted SMA. Although nicotine induces relaxation at high
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concentrations (≥10 µM), it is inactive at 1 µM (see Fig. 29A); yet, it modestly
suppresses CR-induced relaxation. The mechanism of this effect is unclear, but
inhaled nicotine at a high concentration (1 mM) is thought to activate sensory
TRPA1 channel and stimulate airway constriction reflex (Talavera et al., 2009).
Our previous studies show that nicotine (1 µM) has no effect on formaldehyde- or
acetaldehyde-induced relaxations in PE-contracted SMA (Jin, Jagatheesan, et al.,
2019; Jin, Lorkiewicz, et al., 2019), indicating this effect appears specific for CR.
Inhibition of CR vasorelaxation may promote the sympathomimetic effects of
nicotine

alone,

e.g.,

increased

blood

pressure,

perhaps

counteracting

vasodepressor effects of CR.
In conclusion, this study describes a sensitive mechanism of CR-induced
vasorelaxation that is sequentially dependent on endothelium-localized TRPA1
channel, NO, and a VSMC GC pathway in SMA (but not in aorta), which may play
an important role in regulating blood flow/blood pressure at low endogenous levels
of CR. Smooth muscle impairment at high concentrations (300 μM) of CR evokes
tension oscillations reminiscent of “spasms” observed with acrolein in vitro –
another vasotoxic and TRPA1 agonist compound. Future studies of the in vivo
contribution of CR and TRPA1 to cardiovascular physiology and pathophysiology
are required to better understand how exposure to these reactive aldehydes confer
increased cardiovascular disease risk.
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Fig. 30. Cartoon depicting the mechanisms of crotonaldehyde (CR) induced
vasorelaxation in SMA. CR induces a sensitive and sequential mechanism
dependent on activation of Transient Receptor Potential Ankyrin 1 (TRPA1) cation
channels, endothelial cell-based eNOS, NO-mediated GC activation leading to
VSMC hyperpolarization and relaxation. These steps were significantly impaired
by a selective antagonist or treatment, including endothelium impairment (by air
perfusion), eNOS inhibition (L-NAME), guanylyl cyclase inhibitor (GC; ODQ), and
TRPA1 inhibitor (A967079). An additional, but less sensitive pathway of CRmediated relaxation likely involves closure of VSMC calcium channels. Potential
role of VSMC-localized TRPA1 channel activation (dashed line) in CR-induced
relaxation, tension oscillations or vascular toxicity is uncertain. Glutathione Stransferase P (GSTP) deletion had no effect on CR actions in SMA.
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CHAPTER Ⅵ

VASCULAR EFFECTS OF INHALED ALDEHYDES IN VIVO:
ROLE OF ENDOTHELIUM- AND TRANSIENT RECEPTOR POTENYTIAL
ANKYRINE-1 (TRPA1) - DEPENDENT MECHANISM

Introduction Formaldehyde (FA) and acetaldehyde (AA) are small, saturated
aldehydes, and crotonaldehyde (CR) is a highly electrophilic α, β-unsaturated
aldehyde, they are all abundant in the environment and in the aerosols of
tobacco as well as in many foods and beverages. Because of high-level
exposures in users of tobacco products and are well-known associated with the
development of cardiovascular disease (CVD), including atherosclerosis. We
explored the effects of FA, AA and CR exposures in isolated murine blood
vessels. Objective The purpose of this study was to explore the acute and
chronic cardiovascular toxicity of inhaled aldehydes in mice in vivo; and explore
the possible mechanisms. Method and Results C57BL/6J (wild type, WT) mice
were chronically exposed to CR or filtered room air for 12 weeks (1 ppm, 5
d/week). Blood pressure was significantly lower in the CR group than in the air
control group, while heart rate was unchanged. Hemodynamic changes

165

were accompanied by changes in aortic vasoreactivity ex vivo. Following 12-wk
CR chronic exposure, there was no change in aortic response to phenylephrine
(PE), however, the sensitivity of acetylcholine- (ACh) and sodium nitroprussideinduced relaxation were significantly altered in the CR-exposed mice. To dissect
the mechanism of CR-induced vascular changes, we performed acute 4-day CR
exposures (1 and 3 ppm). Acute CR exposures also altered aortic responses to
ACh and SNP. Based on these findings, we tested for the role of the transient
receptor potential ankyrin 1 (TRPA1) channel. In CR-exposed TRPA1-null mice
(4-days, 1ppm), there were no changes in aortic responses to any agonist (PE,
ACh, and SNP) compared with air group, indicating a distinct role of TRPA1.
Interestingly, there also were no differences in aortic responses in acutelyexposed female C57BL/6J mice (1 ppm, 6h/day, 4days), indicating sexdependence. WT mice were exposed to FA or AA gas (5ppm, 6h/day) for 4days,
FA from 30-1,500 Μm or AA from 1-100 mM strongly and reversibly inhibited
agonist-induced contractions. There was no difference in the sensitivity and
relaxation of acetylcholine (ACh) and sodium nitroprusside (SNP). So, short-term
inhalation exposure to FA or AA at levels present in tobacco product aerosols did
not alter the direct effects of these aldehydes. Conclusions These consistent
vascular effects indicate that CR is vasoactive at low concentrations and chronic
exposure to CR may lead to compensatory changes in the vasculature to offset
excessive smooth muscle relaxation and hypotension, which may lead to
vascular disease. Future studies are required to better understand the
mechanisms by CR exposure modifies cardiovascular pathophysiology, and the
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specific role of TRPA1 and sex in CVD such as atherosclerosis. Those two
saturated aldehydes, FA and AA, have limited direct toxicity in large arteries –
prior inhalation exposure indicating these agents may not be involved in tobaccorelated endothelium dysfunction.

1. Introduction
Smoking is the most significant preventable factor in the development of
cardiovascular disease (CVD) (Association., 2014; Bhatnagar, 2006), has been
shown to increase the risk of myocardial infarction, coronary artery disease,
atherosclerosis and stroke (Ambrose & Barua, 2004). Tobacco use is
responsible for an estimated 7 million global deaths each year (Organization.,
2017), most deaths due to CVD (Haussmann, 2012). Extensive evidence
demonstrates that exposure to both mainstream cigarette smoke (MCS)
(Administration., 2012; U.S. Department of Health and Human Services, 2014) or
second-hand tobacco smoke (Prevention., 2017; U.S. Department of Health and
Human Services, 2014) releases high concentration of aldehydes and increases
the risk for CVD.
More than 90% of the non-cancer health risk associated with smoking
(i.e., cardiovascular and pulmonary disease risk) is attributable to aldehydes
(Haussmann, 2012). The unsaturated aldehydes (Administration., 2012; Smith &
Fischer, 2001; van Andel I, 2017), including acrolein and crotonaldehyde (CR),
some studies showed that MCS contains acrolein (50-70 ppm) and
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crotonaldehyde (CR) (1-53 µg/cigarette), these units are very different (Alwis,
deCastro, Morrow, & Blount, 2015; Pazo et al., 2016), though they are classified
as the most significant toxins in tobacco smoke (Haussmann, 2012; Stabbert et
al., 2017). Our previous study showed that e-cigarette contains very high
concentrations of FA and AA (Ogunwale et al., 2017). Aldehyde also generated
by burning coal and gasoline, FA and AA approximately 71.4% of the gasoline
exhaust from cars (Committee on, 1981). As we know, it’s very difficult to
measure aldehyde directly since it’s highly reactive. So, even if it is formed in
relatively small amounts, are likely to be of greater toxicological because of their
high toxicity.
Because CR is physically and chemically similar to acrolein, we expected
that the cardiovascular toxicity of CR in vivo may be similar to acrolein exposure,
but surprisingly there are limited data on CR toxicity in vivo. CR has been shown
to induce inflammation, oxidative stress and apoptosis in epithelial cells (Liu et
al., 2010a, 2010b) and to cause cardiomyocyte dysfunction (Pei et al., 2014), but
CR inhalation studies have not been performed. Both acute and chronic
inhalation exposure to acrolein has been shown and induce endothelium
dysfunction in mice (D. J. Conklin, Haberzettl, Lesgards, et al., 2009). Acrolein
ingestion promotes pro-atherosclerotic changes and atherosclerosis (D. J.
Conklin et al., 2010; Srivastava et al., 2011). Similarly, inhalation exposure to
1,3-butadiene, an upstream precursor of CR, accelerates arteriosclerotic plaque
development in cockerels (Penn & Snyder, 1996b). Another epidemiological
study expressed nearly 50% increase in the standardized mortality ratio (SMR)
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for atherosclerotic heart disease that was associated with environmental
butadiene exposure (Matanoski et al., 1990). However, whether CR could
promote the atherosclerotic effects of 1,3-butadiene exposure has not been
studied.
The direct vascular toxicity of CR inhalation remains unexplored, not to
mention about the mechanisms by which inhaled CR may induce cardiovascular
effects. From our previous studies, we show that the transient receptor potential
ankyrin 1 (TRPA1) receptor is a pulmonary irritant receptor, mediate responses
to inhaled compounds such as tobacco smoke and acrolein and blocked the
relaxation of FA in vitro (D. J. Conklin, 2016; D. J Conklin et al., 2017; Jin,
Jagatheesan, et al., 2019). Furthermore, the negative cardiovascular effects of
inhaled acrolein (at levels in cigarette smoke) are TRPA1-dependent
(Kurhanewicz, Ledbetter, Farraj, & Hazari, 2018; Kurhanewicz et al., 2017). Yet
the role of TRPA1 in potential cardiovascular toxicity of inhaled CR is unknown.
To address these gaps in knowledge regarding potential cardiovascular toxicity
(and its mechanisms) of CR, healthy adult male and female C57BL/6 mice were
exposed acutely or chronically (12 weeks; 1 ppm) by inhalation to CR, and
biomarkers of cardiovascular system harm were measured. To probe the role of
TRPA1, we performed select CR exposures in TRPA1-null mice (D. J. Conklin et
al., 2017).
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2. Material and Methods
Chemicals and Solutions.
Reagent grade chemicals were purchased from Sigma-Aldrich (St. Louis,
MO) or other commercial sources as indicated: A967079 (AdooQ); acetylcholine
chloride (ACh); 4-aminopyridine (4-AP); crotonaldehyde (CR); allyl isothiocyanate
(AITC); 1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ); N-nitro-L-arginine
methyl ester hydrochloride (L-NAME); L-phenylephrine hydrochloride (PE);
sodium nitroprusside (SNP).
Krebs physiological salt solution (PSS) for aorta was (in mM): NaCl, 119;
KCl, 4.7; CaCl2, 1.6; MgSO4•7H2O, 1.2; KH2PO4, 1.2; NaHCO3, 25; glucose, 5.5;
pH 7.4. High K+ PSS (60 mM) substituted equimolar K+ for Na+.
Mice and Crotonaldehyde Exposure
Mice.
Male and female C57BL/6 mice were obtained from The Jackson
Laboratories (Bar Harbor, ME). Male TRPA1-null mice (on a C57BL/6 background)
were from a breeding colony at the Univ. Louisville (D. J Conklin et al., 2017). All
mice were treated according to the Guiding Principles for the Care and Use of
Animals in Research and Teaching as adopted by the American Physiological
Society, and all protocols were approved by the Univ. Louisville Institutional Animal
Care and Use Committee. Before and during exposures, mice were housed under
pathogen-free conditions, controlled temperatures, and a 12h:12h light:dark cycle.
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Mice were maintained on a standard chow diet (Rodent Diet 5010, 4.5% fat by
weight, LabDiet; St. Louis, MO).
Aldehydes exposures.
To parallel our previous study of chronic acrolein toxicity in mice at 1 ppm
exposure in mice (Daniel J. Conklin et al., 2017), we used 1 ppm CR. Mice were
exposed to either HEPA- and charcoal-filtered air or CR (1 or 3 ppm, 6h/day) for 4
days or 12 weeks (1 ppm; 6h/day, 5 days/week) using a custom exposure system
and certified permeation tubes (Kin-Tek; LaMarque, TX) as previously described
(Daniel J. Conklin et al., 2017). Immediately following the final exposure, mice
were anesthetized with sodium pentobarbital (≈150 mg/kg, i.p.) followed by ventral
thoracotomy and exsanguination via cardiac puncture for blood collection in EDTAcoated syringes. Organs were removed, weighed, and snap frozen in N 2 and
stored at -80°C until further analysis. Mice were exposed to either HEPA- and
charcoal-filtered air, FA or AA (1 or 5 ppm, 6h/day) for 4 days using the same
exposure system and methods.
Non-invasive blood pressure.
Blood pressure was measured in male mice using the CODA tail-cuff blood
pressure system (Kent Scientific; Torrington, CT) as described (Daniel J. Conklin
et al., 2019). Mice were acclimated for 5 consecutive days to the CODA system
prior to collecting data.

During the chronic exposure study, blood pressure

measurements were made immediately following an exposure period once per
week beginning in the second week of exposure and continuing for the remainder
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of the study. Briefly, mice (n=15 in both control and exposure groups) were put in
a holding chamber on a warming platform, and 25 measurement cycles were
performed on each mouse with a five second interval between each cycle (approx.
30 min).
Hemodynamics by telemetry.
To measure blood pressure and heart rate real-time in CR exposure, mice
were implanted with pressure cannula in aortic arch for radiotelemetry (PA-C10;
DSI, St. Paul, MN). Naïve mouse was given 1-week post-surgery to recover before
being placed in an exposure chamber for 15 min of baseline recording prior to
onset of CR exposure (9 min; 1 ppm; 2x over 1h), and systolic blood pressure
(mmHg), diastolic blood pressure (mmHg), mean blood pressure (mmHg), pulse
pressure (mmHg), and heart rate (bpm) were continuously recorded (1 kHz).
Echocardiography.
Echocardiography was performed in chronically-exposed male C57BL/6
mice using a Vevo-770 echocardiography system (FUJIFILM Visual Sonics;
Toronto, Canada). Body temperature was maintained (36.5-37.5°C) using a rectal
thermometer interfaced with a servo-controlled heat lamp. Mice were anesthetized
with 2% isoflurane and maintained under anesthesia with 1.5% isoflurane during
the procedure. The 707-B (30MHz) scan head was used to obtain 2D images (100
fps) of the parasternal long axis. M-modes were taken from the same anatomical
position. An apical four-chamber view of the heart was obtained, and pulse wave
Doppler readings were taken of the mitral valve. Pulse wave Doppler readings
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were also taken in the ascending aorta, the innominate artery, and the left common
carotid artery and in the descending aorta distal the left subclavian artery.
Additional pulse wave Doppler readings were taken at the branches of the
descending aorta and both the right and left renal arteries. Pulse wave velocity
was calculated by dividing the distance (mm) between the left subclavian artery
and the right and left renal arteries by the pulse wave travel time (ms).
Vascular Reactivity
Aorta isolation and preparation. Exposed mice were anesthetized (sodium
pentobarbital, ≈150 mg/kg, i.p.) and the aorta was removed via mid-ventral
thoracotomy. Aortas were cleaned of perivascular adipose tissue and cut into rings.
Thoracic aorta rings (3-4 mm) were hung on stainless steel hooks in 15-ml waterjacketed organ baths or in 5-ml heated organ baths of a MultiWire Myograph
System 620M (DMT; Hinnerup, Denmark). The organ baths contained PSS
bubbled with 95% O2: 5% CO2 at 37°C. After 10 min without tension, aorta rings
were equilibrated to ≈1g loading tension over 1h. All rings were stimulated with
High K+ to test for viability, washed three times with PSS over 30 min, reequilibrated to 1g (aorta) of resting tension. The rings were then stimulated again
with High K+ followed by three bath changes and re-equilibration to resting tension.
Transducer signals were recorded using LabChart software.
Post-aldehydes exposure evaluation. To test whether CR exposure altered
vascular reactivity, the following responses were measured: 1) contractions
induced by High K+; 2) concentration-dependent contractions of phenylephrine
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(PE); 3) concentration-dependent relaxations of acetylcholine (ACh) in PEprecontracted rings; and, 4) concentration-dependent relaxations of sodium
nitroprusside (SNP; nitric oxide donor) in PE-precontracted rings. Measures of
efficacy (Emax: contractions normalized to aortic length; percentage relaxation of
PE contraction)(Jin, Lipinski, & Conklin, 2018) and sensitivity (EC50, effective
concentration producing 50% response, i.e., cumulative concentration responses
normalized to 100% with interpolation of EC50) were calculated (Conklin et al.,
2009).
Histology and TRPA1 Immunofluorescence.
Thin sections (4 µm) of formalin-fixed, paraffin-embedded SMA, aorta and
dorsal root ganglia (DRG; positive control) of WT mice were stained with H&E or
TRPA1 antibody (1:200; Alomone Labs, Israel; Cat. #: ACC-037). To label
endothelial cells, blood vessel sections were co-stained with isolectin GS-IB4
Alexa Fluor 594 conjugate (1:200 dilution; Invitrogen; Cat. #: I21413). Images of
H&E-stained sections were made using a digital Spot camera mounted on an
Olympus microscope. Immunofluorescence microscopy was performed with rabbit
polyclonal antibody against TRPA1 without or with a blocking peptide of the TRPA1
antibody and Alexa Fluor 647 goat anti-rabbit secondary antibody (1:400 dilution;
Invitrogen; Cat. #: 21244). Slides were covered with DAPI containing Slow Fade®
Gold anti-fade reagent (Invitrogen; Cat. #: S36938), and fluorescence was
visualized on a Nikon eclipse Ti fluorescence Microscope using NIS-Elements
(Nikon; Japan) at 200X. A DAPI filter was used for nuclear staining and a Cy5 Red
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filter for TRPA1 staining (D. J. Conklin, Y. Guo, et al., 2019; Jin, Jagatheesan, et
al., 2019).
Statistics
Data are presented as mean ± standard error of mean (SEM). MannWhitney U Rank sum tests were used for the data comparison between two groups,
and two-way Repeated Measures ANOVA with Bonferroni’s post-test was used
when comparing more than two groups with repeated measures (SigmaPlot, ver.
12.5; Systat Software, Inc., San Jose, CA). Statistical significance was set at
p<0.05.

3. Results
Crotonaldehyde and Hemodynamics
Non-invasive blood pressure and heart rate were measured in both air- and
CR-exposed male mice once a week during the chronic study (Figs. 31A, B).
Compared with the air-exposed control group, CR-exposed mice had significantly
lower systolic, mean, and diastolic blood pressures at the 7 th, 8th, and 10th weeks
of exposure.

Diastolic and mean blood pressures also were decreased

significantly in the CR-exposed mice in the fifth week compared with the baseline
measurements made during the second week of exposure (Fig. 31A). Heart rate
was significantly higher in CR- than in air-exposed mice by echocardiography
(under isoflurane anesthesia; Table 18). In addition to HR change, isovolumic
relaxation time (IVRT) was significantly decreased in CR-exposed mice compared
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with air controls (Table 18). There was no effect, however, of chronic CR exposure
on aortic stiffness as indexed by pulse wave velocity (PWV) measured by
ultrasound (Table 18).
Chronic Exposure to Crotonaldehyde and Vascular Reactivity
Because chronic exposure to CR lowered blood pressure but not pulse
wave velocity, we investigated potential acute CR-induced blood pressure
changes. For this a naïve mouse with an indwelling blood pressure cannula in the
aortic arch and acutely exposed to CR (1 ppm) for a 9-min session. Onset of CR
exposure was followed by a delayed yet robust decreases in diastolic blood
pressure (15 mm Hg) and heart rate (100 bpm) – both effects returned to baseline
within 10 min after CR exposure ended and filtered air returned (Figs. 32 A, B).
These data provide plausibility that even an acute and brief CR exposure at 1 ppm
can rapidly and reversibly depress systemic arterial blood pressure.
Although the aorta does not directly regulate blood pressure, the aorta is an
important marker of systemic vascular dysfunction especially of endothelial
dysfunction and atherosclerosis risk. CR had no effect on the efficacy of PE, ACh
or SNP action in the aorta of chronically-exposed male mice (Table 19) and there
also were no differences in aortic sensitivity or contractility to PE between
exposure groups, however the ACh-induced, endothelium-dependent relaxations
were significantly stronger (% relaxation; Fig. 32A) and more potent (i.e.,
enhanced sensitivity; EC50 shifted to right; Fig. 32B) in the CR group vs air group
(Table 20). By comparison, the endothelium-independent relaxations of SNP were
not different between groups (Fig. 32C, D; Table 20) indicating a preferential CR
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effect on the endothelium. Interestingly, this effect may have contributed to the
lower overall arterial blood pressure measured in the CR-exposed group compared
with air group.
Acute Exposure to Crotonaldehyde and Vascular Reactivity
Because of the endothelium-dependent changes seen in the aortas of
chronic CR-exposed WT male mice, vascular function was also measured postexposure in isolated aorta of WT male mice after 4 days of CR exposure (1 and 3
ppm). In the aorta of CR-exposed mice after both 1 and 3 ppm, there was a
significant increase in relaxation and a slight increase in sensitivity of aorta in
response to ACh (Fig. 33A, B; Fig. 34A, B). Similarly but, modestly there was also
an increased relaxation (Fig. 33C; Fig. 34C) and sensitivity (Fig. 33D; Fig. 34D)
in response to SNP that resulted in a significantly decreased EC50 (at 3 ppm only;
Table 20).
Acute Exposure to Crotonaldehyde and Role of TRPA1
Because of the known relationship between the TRPA1 channel and
neurogenic inflammation induced by MCS or acrolein, we performed acute
exposures to CR (4 days; 1 ppm) in TRPA1-null male mice. In contrast to the WT
mice, measures of vascular reactivity in TRPA1-null mice showed no significant
changes in relaxation or sensitivity in response to ACh or SNP (Fig. 35), nor was
there was a significant change in any EC50 (Table 20). These data indicate that
the vascular responses observed in male WT mice in response to CR were likely
mediated by TRPA1.
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Acute Exposure to Crotonaldehyde and sex dependence
Because acrolein-induced toxicity showed protective in female mice in our
previous study. We performed acute exposures to CR (4 days; 1 ppm) in female
mice. In contrast to the WT mice, measures of vascular reactivity in female mice
showed no significant changes in relaxation or sensitivity in response to ACh or
SNP (Fig. 36), nor was there was a significant change in any EC50 (Table 20).
These data indicate that the vascular effects of CR at 1 ppm were sex-dependent.
Acute Exposure to Formaldehyde or Acetaldehyde and Vascular Reactivity
We also measured vascular function in isolated aorta of WT male mice after
4 days of FA (5 ppm), there was no difference in the relaxation and the sensitivity
in response to ACh or SNP (Fig. 37). Mice were exposed to 2 weeks of AA (5 ppm),
there was no difference in the relaxation and the sensitivity in response to ACh or
SNP (Fig. 38). These results indicated that there was limited vascular dysfunction
after acute FA or sub-acute AA exposure.
Compare the vascular toxicity of aldehydes
The PE2/PE1 tension (%) which was calculated by dividing PE-induced tension
post-CR-exposure (PE2) by PE-induced tension pre-CR (i.e., PE1) and multiplied
by 100. The PE2/PE1 tension (%) was significantly inhibited after CR exposure in
vitro compared to FA or AA exposure (Fig. 39). The effective concentration
inducing 50% relaxation (EC50) of CR-induced vasorelaxation was significantly
lower than FA and AA in PE precontracted superior mesenteric artery (SMA)
(Table 21). The unsaturated aldehyde (i.e., CR) caused more toxic to vascular
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smooth muscle than saturated aldehydes (i.e., FA and AA). However, both FA
(0~300 μM), AA (0~30 mM) and CR (0~300 μM) showed limited endothelial
dysfunction after exposure in vitro.
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Fig.31. Hemodynamic effects of inhaled crotonaldehyde (CR) in mice. Blood

pressure was measured non-invasively by tail cuff method in C57BL/6J male mice
weekly (within 1h after exposure) during the chronic air and CR exposures (1 ppm;
6h/d, 5 d/week, 12 weeks) (A). Blood pressure (mm Hg) was significantly lower in
CR-exposed mice compared with air-exposed control mice over several weeks of
the latter half of the exposure (A), but there was no consistent change in heart rate
(HR, bpm) throughout (B). Aortic arch blood pressure was measured via invasive
radiotelemetry in a male C57BL/6J mouse during an acute CR exposure (9 min, 1
ppm). Diastolic blood pressure (DBP; C) and HR (D) fell rapidly upon onset of CR
exposure, and both parameters recovered quickly to baseline levels within 10-12
min after ceasing CR exposure. Aortic arch blood pressure was measured via
invasive radiotelemetry in male C57BL/6J mice during an acute CR exposure (3h,
1 ppm; 3h, 3 ppm) to simulate our acute and chronic exposure conditions.
Although only modest drops in DBP (E) and HR (F) were observed upon beginning
1 ppm CR exposure, there were much more noticeable drops in DBP (E) and HR
(F) when the CR level was increased to 3 ppm. As with brief CR exposure (9 min,
1 ppm), HR recovered quickly to baseline levels within 5 min of ceasing the CR
exposure, however, DBP was slow to recover and did not reach baseline levels
after 15 min. Summary data of two mice exposed to CR (1 and 3 ppm, 3h each)
showed that all blood pressures (systolic, mean, diastolic; G) were suppressed
equally by CR exposure whereas mean HR was not (H). Values = mean ± SE (n=910 mice per group, A, B; n=2, G, H); a, p<0.05 vs air control; b, p<0.05 vs baseline.
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Table 18. Echocardiography measures in male mice chronically exposed to air or
crotonaldehyde.
Exposure
Measurement

Air Control (5)

1 ppm CR (5)

Body Weight (g)

29.1 ± 0.5

28.6 ± 0.5

HR (bpm)

476 ± 20

536 ± 13*

EDV (µL)

42 ± 7

41 ± 2

ESV (µL)

12 ± 2

11 ± 1

SV (µL)

30 ± 4

30 ± 2

EF (%)

72 ± 1

74 ± 2

CO (mL/min)

13.9 ± 1.4

16.2 ± 0.7

LVIDd (mm)

3.7 ± 0.1

3.4 ± 0.1

LVIDs (mm)

2.1 ± 0.1

1.9 ± 0.2

LVPWd (mm)

0.8 ± 0

1.0 ± 0.1

LVPWs (mm)

1.3 ± 0.1

1.4 ± 0.1

LVAWd (mm)

1.1 ± 0.1

1.1 ± 0

LVAWs (mm)

1.6 ± 0.1

1.6 ± 0

LVM (mg)

105.4 ± 6.9

103.6 ± 6.8

IVRT (ms)

13.3 ± 0.9

9.6 ± 1.2*

Aortic AVG

2587.0 ± 698.8

1806.8 ± 71.0

Innominate AVG

1209.8 ± 78.6

1216.0 ± 67.1

LCC_AVG

744.6 ± 69.8

770.8 ± 95.4

2.8 ± 0.1

2.9 ± 0.1

0.46 ± 0.03

0.56 ± 0.05

PWV (Right & Left; mm/s)
RWT (mm)

Values = mean±SE. (n), number of mice; *, p<0.05 compared to air control; #,
0.05≤p≤0.10 compared to air control. Abbr.: CO, cardiac output; CR,
crotonaldehyde; EDV, end-diastolic volume; EF, ejection fraction; ESV, endsystolic volume; HR, heart rate; IVRT, isovolumic relaxation time; LCC, left
coronary cusp; LVAWd, left ventricular anterior wall thickness at end-diastole;
LVAWs, left ventricular anterior wall thickness at end-systole; LVIDd, left
ventricular internal dimension at end-diastole; LVIDs, left ventricular internal
dimension at end-systole; LVM, left ventricular mass; PWV, pulse wave velocity;
RWT, relative wall thickness; SV, stroke volume.
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Fig. 32. Vascular toxicity of chronic crotonaldehyde (CR) inhalation exposure in
mice. Aortic function was measured ex vivo in male C57BL/6J mice following 12

weeks of exposure to CR (1 ppm, 6h/d, 5 d/week, 12 weeks). Acetylcholine (ACh)
was used to assess aortic endothelium-dependent relaxation efficacy (%
relaxation; A) and sensitivity (EC50; B) in phenylephrine (PE)-precontracted aortic
rings by isometric myography. CR exposure significantly enhanced ACh sensitivity
(B). There were, however, no changes in aortic efficacy (% relaxation; C) and
sensitivity (EC50; D) to the endothelium-independent vasorelaxant sodium
nitroprusside (SNP). Values = mean ± SE (n=10 mice per group); *, p<0.05 vs air
control.
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Fig. 33. Vascular toxicity of acute crotonaldehyde (CR) inhalation exposure
in C57BL/6 mice. Aortic function was measured ex vivo following 4 days of
exposure of male C57BL/6J mice to either air or CR (1 ppm, 6h/d, 4 days).
Acetylcholine (ACh) was used to assess aortic endothelium-dependent relaxation
efficacy (% relaxation; A) and sensitivity (EC50; B) in phenylephrine (PE)precontracted aortic rings by isometric myography. CR exposure significantly
enhanced ACh efficacy (A) and slighted shifted sensitivity (B). There were,
however, no changes in aortic efficacy (% relaxation; C) and sensitivity (EC50; D)
to the endothelium-independent vasorelaxant sodium nitroprusside (SNP). Values
= mean ± SE (n=8-10 mice per group); *, p<0.05 vs air control. #, 0.05≤p≤0.10 vs
air control.

186

187

Fig. 34. Vascular toxicity of acute crotonaldehyde (CR) inhalation exposure
in C57BL/6 mice. Aortic function was measured ex vivo following 4 days of
exposure of male C57BL/6J mice to CR (3 ppm, 6h/d, 4 days). Acetylcholine
(ACh) was used to assess aortic endothelium-dependent relaxation efficacy (%
relaxation; A) and sensitivity (EC50; B) in phenylephrine (PE)-precontracted aortic
rings by isometric myography. CR exposure significantly enhanced ACh efficacy
(A) and slighted shifted sensitivity (B). There was no change in aortic efficacy (%
relaxation; C) but there was an enhanced sensitivity (EC50; D) in response to the
endothelium-independent vasorelaxant sodium nitroprusside (SNP). Values =
mean ± SE (n=10 mice per group); *, p<0.05 vs air control. #, 0.05≤p≤0.10 vs air
control.
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Table 19. Effects of either air or crotonaldehyde (CR; 1 or 3 ppm) exposure on
efficacy responses of isolated thoracic aorta of C57BL/6J (wild type, WT) and
TRPA1-null mice to pharmacological agents in the absence and presence of nitric
oxide synthase inhibitor (L-NAME).
Exposure Conditions
Strain
(sex)

Level
(ppm)

Duration

WT

1

4 days

TRPA1null

1

4 days

WT

3

4 days

WT

1

12
weeks

WT (f)

1

4 days

Exposure Conditions
Strain
(sex)

Level
(ppm)

Duration

WT

1

4 days

TRPA1null

1

4 days

WT

3

4 days

WT

1

12
weeks

WT (f)

1

4 days

PE, Emax
[mN/mm]
Air

CR

4.1 ±
3.9 ±
0.7
0.6
2.4 ±
2.1 ±
0.5
0.3
4.0 ±
3.7 ±
0.7
0.7
3.2 ±
3.6 ±
0.6
0.7
3.5 ±
4.0 ±
0.6
0.6
PE Ratio, +LNAME

ACh, Emax [%]
Air

CR

-53.8 ± -65.2
4.4
± 5.2*
-64.6 ± -59.8
3.4
± 4.0
-49.3 ± -57.8
4.6
± 4.4
-51.2 ± -62.6
5.6
± 3.8
-76.4 ± -77.4
3.8
± 4.6
ACh, [%], +LNAME

SNP, [%], +LNAME

Air

CR

Air

CR

Air

CR

1.3 ±
0.03
1.8 ±
0.1
1.4 ±
0.04
1.5 ±
0.1
1.5 ±
0.1

1.5 ±
0.05*
2.0 ±
0.2
1.5 ±
0.04#
1.5 ±
0.1
1.5 ±
0.05

-1.4 ±
0.5
-1.7 ±
1.1

-0.9 ±
0.5

0±0

0±0

-0.3 ±
0.2
-0.5 ±
0.4

-0.8 ±
0.5
-1.9 ±
1.5

-96.9 ±
0.7
-99.7 ±
0.2
-98.6 ±
1.3
-97.3 ±
1.3
-99.4 ±
0.5

-98.4 ±
0.6
-99.6 ±
0.2
-99.1 ±
0.7
-98.3 ±
0.6
99.3 ±
0.3

0±0

Values = mean ± SE (n=10-11 mice per group); Abbr.: ACh, acetylcholine; CR,
crotonaldehyde; EC50, half maximal effective concentration; PE, phenylephrine;
SNP, sodium nitroprusside; TRPA1, transient receptor potential ankyrin 1; *,
p<0.05 compared with air control based on Bonferroni’s or Dunn’s post-test;
#, 0.05≤p≤0.10 compared with air control based on Bonferroni’s or Dunn’s
post-test; †, p<0.05 for WT vs TRPA1-null based on Dunn’s post-test; ¶,
0.05<p<0.10 for WT vs TRPA1-null based on Dunn’s post-test.
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Table 20. Effects of either air or crotonaldehyde (CR; 1 or 3 ppm) exposure on
sensitivity responses of isolated thoracic aorta of C57BL/6J (wild type, WT) and
TRPA1-null mice to pharmacological agents.
Exposure Conditions
Strain
(sex)

Leve
l
(ppm
)

Durati
on

PE, EC50 [nM]

Air

CR

ACh, EC50 [nM]

Air

CR

SNP, EC50
[nM]1
Air

CR

128 ±
201 ±
285 ±
135 ± 11.5 ±
9.2 ±
30
55
79
31#
0.7
0.9#
TRPA1198 ±
252 ±
156 ±
296 ±
9.9 ±
9.9 ±
1
4 days
null
34
61
30
124
0.4
0.5
139 ±
167 ±
236 ±
102 ± 18.8 ± 12.7 ±
WT
3
4 days
31
26
100
9
2.3
2.8*
12
108 ±
231 ±
238 ±
78 ±
12.0 ±
8.6 ±
WT
1
weeks
26
109
53
8*
2.0
0.6
157 ±
234 ±
100 ±
68 ±
8.5 ±
7.5 ±
WT (f)
1
4 days
45
70
15
13
1.9
1.0
Values = mean ± SE (n=9-11 mice per group); all values are of male mice except where
(f) = female mice. 1, SNP EC50 measured in presence of L-NAME, 100 µM. Abbr.: ACh,
acetylcholine; CR, crotonaldehyde; EC50, half maximal effective concentration; PE,
phenylephrine; SNP, sodium nitroprusside; TRPA1, transient receptor potential ankyrin 1;
*, p<0.05 compared with air control based on Bonferroni’s or Dunn’s post-test; #,
0.05≤p≤0.10 compared with air control based on Bonferroni’s or Dunn’s post-test.
WT

1

4 days
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Fig. 35. Vascular toxicity of acute crotonaldehyde (CR) inhalation exposure

in TRPA1-null mice. Aortic function was measured ex vivo following 4 days of
exposure of male TRPA1-null mice to CR (1 ppm, 6h/d, 4 days). Acetylcholine
(ACh) was used to assess aortic endothelium-dependent relaxation efficacy (%
relaxation; A) and sensitivity (EC50; B) in phenylephrine (PE)-precontracted aortic
rings by isometric myography. CR exposure had no effect on efficacy (A) or
sensitivity (B) of ACh-induced relaxations. Similarly, there were no CR-induced
changes in aortic efficacy (% relaxation; C) or sensitivity (EC50; D) in response to
the endothelium-independent vasorelaxant sodium nitroprusside (SNP). Values =
mean ± SE (n=10-11 mice per group).
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Fig. 36. Vascular toxicity of acute crotonaldehyde (CR) inhalation exposure
female mice. Aortic function was measured ex vivo following 4 days of exposure
of female mice to CR (1 ppm, 6h/d, 4 days). Acetylcholine (ACh) was used to
assess aortic endothelium-dependent relaxation efficacy (% relaxation; A) and
sensitivity (EC50; B) in phenylephrine (PE)-precontracted aortic rings by isometric
myography. CR exposure had no effect on efficacy (A) or sensitivity (B) of AChinduced relaxations. Similarly, there were no CR-induced changes in aortic efficacy
(% relaxation; C) or sensitivity (EC50; D) in response to the endotheliumindependent vasorelaxant sodium nitroprusside (SNP). Values = mean ± SE (n=911 mice per group).
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Fig. 37. The changes of aorta function after 4 days of exposure of FA 5ppm. A)
The relaxation of aorta to ACh. B) The relaxation of aorta to SNP. C) The
sensitivity of aorta to ACh. D) The sensitivity of aorta to SNP. *, P<0.05 vs
Control.
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Fig. 38. The changes of aorta function after 2 weeks of exposure of AA 5ppm. A)
The relaxation of aorta to ACH. B) The relaxation of aorta to SNP.

C) The

sensitivity of aorta to ACH. D) The sensitivity of aorta to SNP. *, P<0.05 vs Control.
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4. Discussion
Aldehydes are ubiquitous pollutants and toxic. Extensive epidemiological
and experimental data show that aldehyde affect cardiovascular system. However,
the processes by which aldehydes impair cardiovascular function and accelerate
the cardiovascular disease are not known. This study especially show the vascular
toxicity of CR in vivo and the possible mechanisms that would help us to study the
toxicity of tobacco smoking and environmental pollution, and could also help
government regulate the policies.
Crotonaldehyde is a hazardous air pollutant of significant human concern,
especially as a component of cigarette smoke (IARC., 1995), which could induce
apoptosis and necrosis in epithelial cells (Liu et al., 2010a, 2010b), oxidative stress,
inflammation in alveolar macrophages (Facchinetti et al., 2007). In spite of these
well-recognized toxicity of crotonaldehyde, the mechanisms underlying adverse
effects of CR inhalation are not well understood. To our knowledge, this is the first
study to evaluate the cardiovascular effects of CR exposure in vivo and propose
that CR may contribute to vasodilation via a TRPA1- and endothelium-mediated
pathway.
Isovolumic relaxation time (IVRT) is an interval in the cardiac cycle, from
the aortic component of the second heart sound, that is, closure of the aortic valve,
to onset of filling by opening of the mitral valve. The IVRT likely decreased with
CR exposure because of the increased of heart rate or the decreased of the
afterload as a result of low blood pressure (see Table. 18). We measure the blood
pressure of the chronically-exposed mice immediately following an exposure
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period once a week for the duration of the study. The blood pressure significantly
decreased in CR group compared with air group, although there was no difference
in heart rate between these two groups (see Fig. 32); this might be the reason of
decreased IVRT. Many studies have showed that shear stress is critically
important in regulating the vascular physiology and pathobiology of the vessel wall
by modulating endothelial cell (EC) function (C. Cheng et al., 2004; Malek, Alper,
& Izumo, 1999). In particular, low and oscillatory shear stress, but not increased
shear stress, contributes to the development of atherosclerotic lesions (C. Cheng
et al., 2006). Shear stress and stretch could also modulate EC functions by
activating mechano-sensors and signaling pathways. Low shear stress in vitro can
downregulate endothelial nitric oxide synthase (eNOS) and upregulate endothelin1 [Ziegler et al., 1998] and adhesion factors (Chappell, Varner, Nerem, Medford,
& Alexander, 1998), which results in an increase in the adhesion of monocytes. Of
course, strong irritation in the airways can cause airway hyperresponsiveness and
respiratory depression, and which are associated with systemic hypotension,
though hypotension may also be caused by systemic cardiovascular depression
due to parasympathetic vagal reflexes (B. P. Lee, Morton, & Lee, 1992; Polverino
et al., 2012).
Regardless of the mechanism, coronary vasospasm or peripheral
vasodilation can cause ischemia and heart attack or hypotension and syncope,
and/or even death and thus could be responsible for the drop in blood pressure
after CR exposure. Furthermore, in isolated aorta of 4-day 3 ppm exposed mice,
the sensitivity and relaxation of aorta to SNP increased significantly in CR group,
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and there was a trend that the sensitivity and relaxation of ACH also was increased
in CR group (see Table 19; Fig. 34). We thus decreased the dose of CR to 1ppm
to test for the effects at a lower level of exposure. In isolated aortas of 4-day and
12-week 1 ppm exposed mice, the sensitivity and relaxation of aorta to ACh
significantly increased in CR group. What’s more, there was a trend that the
sensitivity and relaxation of SNP increased in the exposed CR group after 4 days
of exposure (see Table 19 and Fig. 32). These data show that the vasculature
becomes more sensitive to both direct additions and chronic exposures to CR, with
the resulting effects being augmented smooth muscle relaxation. These consistent
vascular effects indicate that chronic exposure to CR may lead to compensatory
changes in the vasculature to offset excessive smooth muscle relaxation and
hypotension.
Endothelium is important regulation of vascular tone through the production
of a variety of mediators such as nitric oxide, reactive oxygen species, prostanoids,
and endothelin. It not only acts as a barrier but also acts as an active signal
transducer (Vita & Keaney, 2002). Alteration in endothelial function precedes the
development of morphological atherosclerotic changes and also contributes to the
initiation and evolution of prothrombotic, proinflammatory and proliferative states.
Endothelial

dysfunction

refers

to

impairment

of

endothelium-dependent

vasodilatation and implies widespread abnormalities in endothelial integrity and
homeostasis; this dysfunction might occur at an early stage of hypertension
(Deanfield et al., 2007). Evaluation of endothelial function has been critical to our
understanding of the significance of endothelium to cardiovascular system.
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Exposure to FA (5 ppm), AA (5 ppm) and CR 1 ppm showed limited endothelial
effect in our study, but, CR exposure showed significant difference between WT
mice and TRPA1-null mice.
TRPA1 is a cationic (calcium) channel and a promiscuous receptor
concentrated in sensory fibers (unmyelinated C-fibers) that mediates pain
reception/transmission (nociceptors). The distribution of TRPA1 receptors has
expanded to non-neuronal system, such as heart, endothelium, urothelium and in
the vasculature (Bautista et al., 2006; Bessac et al., 2008; Earley et al., 2009a;
Sinharoy et al., 2017). Activation of peripheral sensory fiber TRPA1 leads to pain
signaling and release of vasoactive peptides, substance P (SubP) and cGRP
(Russell, King, Smillie, Kodji, & Brain, 2014; Trevisan et al., 2016), which may
contribute to increased vasodilation and inflammatory response such as increased
blood flow, increased vascular permeability (edema), increased white blood cell
binding, and extravasation and pain (D. J. Conklin, 2016). TRPA1 is in the
pulmonary airways and it plays a role in the protective physiological maneuver
called “respiratory braking” elicited by inhaled toxins. Our previous study showed
that TRPA1-null mice are more sensitive than WT mice to acrolein exposure and
that TRPA1 antagonist injection post-acrolein exposure reduces acrolein-induced
mortality (D. J Conklin et al., 2017; D. J. Conklin et al., 2017). This is consistent
with the results that combined with TRPA1 antagonists (HC-030031) and TRPV1
antagonists (AMG 9810) can prevent pain and inflammation in pancreatic cancer
mice (Schwartz et al., 2011). Interestingly, compared to the augmentation
vasodilation in WT mice after CR exposure, there was no difference both in the

203

sensitivity and relaxation of ACh and SNP in CR group and air group in TRPA1null mice after CR exposure (see Table 19 and Fig. 36). This disappearance of
augmented smooth muscle relaxation in the vasculature indicate that TRPA1 plays
an specific role in the toxicity of CR. Future study still needs to make clear whether
TRPA1 plays an protective function or induces impairment to the blood vessels.
The study of sex difference is very important in the exposure-related
cardiovascular effects. Our previous study showed that female mice exposed to a
high level of acrolein showed both pulmonary and systemic protection compared
to the male mice, demonstrating reduced morbidity and a significantly lower
sensitivity to acrolein-induced mortality (D. J Conklin et al., 2017). Although both
acute and chronic exposure to CR induced vascular changes in male mice,
females showed no changes in aortic sensitivity or reactivity in response to CR
exposure in vivo (see Fig. 36). These differences between males and females
post-CR exposure seem to support our previous findings that females are
somewhat protected against α,β-unsaturated aldehyde-induced toxicity and injury.
An aldehyde is a compound containing a functional group with the structure
−CHO, which is a carbon double-bonded to oxygen. Numerous studies show that
unsaturated

aldehydes

are

more

toxic

than

saturated

aldehydes

in

Pharmacodynamics. Our study also show that the concentrations of aldehydes
cause relaxation of SMA is much higher in saturated aldehydes than in unsaturated
aldehydes in vitro (see Chapter Ⅲ , Ⅳ , Ⅴ ). The PE2/PE1 tension (%) was
significantly inhibited after CR exposure compared to FA or AA exposure in vitro
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(see Fig. 39). The effective concentration inducing 50% relaxation (EC50) of CRinduced vasorelaxation was significantly lower than FA and AA in PE
precontracted superior mesenteric artery (SMA) (see Table 22). CR induce more
toxic to vascular smooth muscle than FA or AA. However, both FA (0~300 μM),
AA (0~30 mM) and CR (0~300 μM) didn’t cause endothelial dysfunction after
exposure in vitro. Future studies are needed to show the mechanism and
pathology of aldehydes-induced endothelial dysfunction in vasculature.
In conclusion, this study indicates that chronic exposure to CR may lead
to compensatory changes in the vasculature to offset excessive smooth muscle
relaxation and hypotension that may lead to vascular disease. Because the
vascular changes were not seen in TRPA1-null or in female WT mice, we conclude
that these CR-induced changes within the vasculature are TRPA1- and sexdependent. However, additional studies are needed to further clarify these findings
as well as to provide a better mechanistic understanding of CR-induced
cardiovascular pathophysiology. As exposure to CR through both ambient and
personal means continues to be a potential health threat to the global population,
our current results provide novel insights into the cardiovascular effects of CR and
implicate chronic low levels of exposures as a potential inducer of CVD. Future
studies are required to test the mechanisms and the toxicology of aldehydes.
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Table 21. The effective concentration inducing 50% relaxation (EC50) of aldehydeinduced vasorelaxation in isolated murine (male) superior mesenteric artery (SMA)
with different contractile agonists in the absence and presence of the nitric oxide
synthase (NOS) inhibitor, LNAME.
EC50
(SMA)
Formaldehyde
(μM)
Acetaldehyde
(mM)
Crotonaldehyde
(μM)
Cinnamaldehyd
e
(μM)
AITC
(μM)

PE（10-5M）
+L-NAME

U46619(10-7M)

High K+(60mM)

+L-NAME

+L-NAME

52.4±13.9

206.9±10.4

514.5±74.4

568.9±56.6

1093.2±50.4

984.1±52.8

3.3±0.3

6.2±0.6

14.9±1.5

17.2±0.2

17.5±0.5

18.4±0.4

3.8±0.5

43.9±17.7

11.9±3.1

327.6±96.4

3.9±1.0
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Fig.39. Vascular smooth muscle toxicity of aldehydes (A) and endothelium
function change after aldehydes exposure (B). PE, phenylephrine; the PE2/PE1
tension (%) was calculated by dividing PE-induced tension post-CR-exposure
(PE2) by PE-induced tension pre-CR (i.e., PE1) and multiplied by 100.
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CHAPTER Ⅶ

SUMMARY AND CONCLUSIONS

A. Major findings in this dissertation
1. Aldehydes exposure and vascular response in vivo and in vitro
Aldehydes could be delivered either via inhalation, oral gavage, or
intravenous injections. All these pathways would increase the concentration of
aldehydes in the blood, which cause vasorelaxation of the blood vessels,
including the blood vessels in the gastrointestinal (GI) tract (D. J. Conklin et al.,
2004; Jin, Jagatheesan, et al., 2019). Although the effects of aldehydes have
been studied for several decades, the vascular effects of aldehydes are still
unclear. This study mainly focuses on the vascular toxicity of inhaling aldehydes
(FA, AA, and CR) and the underlying mechanisms.
Mice were exposed to CR (1 ppm) for 12 weeks, in the isolated aortas of
exposed mice, the efficacy and sensitivity of ACh significantly increased in PEprecontracted aortic rings by isometric myography (see Chapter Ⅵ, Fig. 32;
Table 19). In isolated aortas of 4-days CR 1 ppm exposed mice, CR exposure
significantly enhanced Ach efficacy and slightly shifted sensitivity. However, no
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changes in aortic efficacy and sensitivity to SNP (see Chapter Ⅵ, Fig. 33; Table
19). These data show that the vasculature becomes more sensitive to both
direct additions and chronic exposures to CR, with the resulting effect being
augmented smooth muscle relaxation. Acute exposure to CR 1 ppm significantly
decreased the blood pressure during CR exposure by telemetry, did not recover
shortly after CR exposure stop; these results were very robust and consistent
(see Chapter Ⅵ, Fig. 31). Our study showed that inhalation of low
concentrations of CR might affect the function of smooth muscles and induce
hypotension. Many studies showed that hypotension could affect the quality of
life and also induce cardiovascular diseases, such as myocardial infarction,
syncope, heart failure, etc. (Duschek, Hoffmann, & Reyes Del Paso, 2017;
Owens & O'Brien, 1999; Shibasaki, Ogawa, Yamada, Ouchi, & Akishita, 2018;
Tsujimoto & Kajio, 2018), mice might also be hurt by hypotension. Chronic
exposure to CR may lead to compensatory changes in the vasculature to offset
excessive smooth muscle relaxation and hypotension, which might promote the
release of neuronal hormones to increase blood pressure that would cause
disease. We could not rule out that inhalation of CR might induce cardiovascular
disease after long exposure.
FA and AA are contained in cigarette smoke. Our previous study showed
that the levels of aldehydes were high in cigarettes (Lorkiewicz et al., 2019;
Schick et al., 2017). In our study, after acute exposure to FA or subacute
exposure to AA, there were no differences in the sensitivity or relaxation of ACh
and SNP in response to isolated aortas between the control and exposed groups
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(see Chapter Ⅵ, Fig. 38). The effect of FA or AA exposure on endothelium
function is very limited at this exposure level. Many studies showed that FA is a
carcinogen and an irritant, and we could not exclude the possibility that cancer
would present an earlier risk than cardiovascular impairment (Nielsen, Larsen, &
Wolkoff, 2017; Tyihak, Bocsi, Timar, Racz, & Szende, 2001). However, the risks
of chronic inhalation of FA or AA at the levels found in tobacco or e-cigarette
aerosols are still unknown.
An aldehyde is a compound containing a functional group with the
structure −CHO, which is a carbon double-bonded to oxygen, and unsaturated
aldehydes are more active than saturated aldehydes. Our study shows that the
concentrations of aldehydes required to cause relaxation of SMA is much higher
in saturated aldehydes than in unsaturated aldehydes in vitro (see Chapter Ⅲ,
Ⅳ, Ⅴ); FA and AA relaxed agonist-induced tension by >90% in SMA and aorta.
The PE2/PE1 tension (%) was significantly inhibited after CR exposure
compared to FA or AA exposure in vitro (see Chapter Ⅵ, Fig. 39A). The
effective concentration inducing 50% relaxation (EC50) of CR-induced
vasorelaxation was significantly lower than FA and AA in PE-precontracted SMA
(see Chapter Ⅵ, Table 22). Future studies are needed to show the mechanism
and pathology of aldehyde-induced toxicity in the vasculature. CR stimulated
isometric tension oscillations at high concentrations (≥300 μM) (see ChapterⅤ,
Fig.23B), though FA and AA did not, the mechanism of the oscillations is thus
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unclear. It might be dependent on the toxicity since it only showed in unsaturated
aldehydes.
In conclusion, this study indicates that CR is more toxic to vasculature in
vitro than FA and AA. Chronic exposure to CR may lead to compensatory changes
in the vasculature to offset excessive smooth muscle relaxation and hypotension
that may lead to vascular disease. However, additional studies are needed to
further clarify these findings as well as to provide a better mechanistic
understanding of CR-induced cardiovascular pathophysiology. As exposure to CR
through both ambient and personal means continues to be a potential health threat
to the global population, our current results provide novel insights into the
cardiovascular effects of CR and implicate chronic low levels of exposures as a
potential inducer of CVD.

2. Aldehydes and endothelium function
It is well known that the endothelium is very important in the regulation of
vascular tone in the blood vessels (Furchgott & Zawadzki, 1980; Palmer, Ferrige,
& Moncada, 1987). Endothelial dysfunction refers to impairment of endotheliumdependent vasodilatation, which implies widespread abnormalities in endothelial
integrity and homeostasis and might occur at an early stage of hypertension
(Deanfield et al., 2007), and it is the precursor of atherosclerosis and
inflammation (Vanhoutte, Shimokawa, Feletou, & Tang, 2017; Versari, Daghini,
Virdis, Ghiadoni, & Taddei, 2009). Our previous study showed that acrolein
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feeding increased atherosclerotic lesion formation in the aorta (Srivastava et al.,
2011), and 5ppm of acrolein derived from tobacco smoke induced endothelium
dysfunction in GSTP-null mice (D. J. Conklin, Haberzettl, et al., 2009b).
In contrast to the idea that FA induces oxidative stress in endothelial cells
(Yu, 1998), our data indicate that in our endothelial dysfunction model in vitro,
endothelial dysfunction blocks only the physiological (sensitive) component of
FA-induced vasorelaxation. We did not observe FA-, AA-, or CR-induced
endothelial dysfunction even after exposing SMA to 1,000 μM FA, 300 mM AA or
300 μM CR. The relaxation of ACh was not different from vehicle group after CR
exposure (see ChapterⅥ, Fig. 39B). This is consistent with our previous study:
in isolated human coronary artery bypass graft (CABG) blood vessels with
endothelial dysfunction, FA still induces relaxation, but in a far less sensitive
manner (EC50, 315 ± 0 mM) (D. J. Conklin et al., 2004) than that present in
healthy mice as seen in our study.
Acute exposure to FA or CR, subacute exposure to AA, and chronic
exposure to CR showed limited endothelial dysfunction in the isolated aortas.
This could because the length and dose of exposure were not enough to see an
effect or because arteries other than the aorta are more sensitive to aldehydes
exposure in vivo study. It is well known that the effect of aldehydes is time- and
dose-dependent (D. J. Conklin et al., 2004). The velocity of blood flow in the
aorta is so fast that the amount of time the aldehydes affect endothelial cells in
aorta is limited, or the little damaged endothelial cells might be repaired very fast.
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3. Aldehydes and postprandial hyperemia
Our study showed that urinary levels of the metabolites of FA and AA
increase with feeding such that FA and AA likely contribute to the physiological
reflex of post-prandial hyperemia via SMA vasodilatation. The SMA is a major
arterial blood supply to the GI tract, and it dilates postprandially in response to
many stimuli e.g., nutrients, vago-vagal reflex, NO, and substance P (Chou &
Coatney, 1994; Lucchini et al., 1996). These aldehydes are often considered to
be toxicants, but they are naturally abundant in food, water, and other beverages
(Aldehydes, 1981; D. J. Conklin, P. Haberzettl, et al., 2011) and their abundant
metabolic products make them plausible stimuli for increasing GI blood flow. This
is the first suggestion of these physiological roles; more research will be needed
to establish these aldehydes as bona fide contributors to postprandial hyperemia
in vivo.

4. The mechanisms of vasodilation of aldehydes
L-NAME, an NO inhibitor, totally blocked the relaxation of the aorta (about
90%), but the relaxation of the SMA is much less (approximately 15%) (data not
shown). We conclude that endothelium-derived hyperpolarizing factor (EDHF) is
the dominant mechanism in the relaxation of the SMA, which is consistent with a
previous study showing that EDHF is much more important in the relaxation of
smaller blood vessels than in large conduit vessels (Tomioka et al., 1999).
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Testing the function changes in SMA is therefore a good way to study the smaller
blood vessels as well as resistance arteries. Although the aorta does not directly
regulate blood pressure, the aorta is an important marker of systemic vascular
dysfunction, especially of endothelial dysfunction and atherosclerosis risk. We
thus test the changes of aorta function in our in vivo studies and explore the
mechanisms of vasodilation in SMA in our in vitro studies. The mechanisms of
the vascular effects of aldehydes have been studied for several decades, but the
complex mechanisms of this phenomenon are only now becoming clear.
We show that there are 3 distinct pathways of FA- and CR-induced
vasorelaxation in SMA and 2 distinct pathways of AA-induced vasorelaxation in
SMA (see Chapter Ⅲ, Fig. 15; Chapter Ⅳ, Fig. 22; Chapter Ⅴ, Fig. 29) and
while this is fascinating in its own right, we focused on the mechanism of the
most sensitive, and thus, most likely physiological pathway. The sensitive FA-,
AA- and CR-induced vasorelaxations require a functional endothelium, NOS
(presumably eNOS), and guanylyl cyclase (GC/cGMP). The endothelial cells
likely contribute to the most sensitive components, whereas the latter component
is likely present in vascular smooth muscle cells (VSMC). We propose a model
for each of these three aldehydes featuring a stepwise sequence of events that is
quite typical of agonists that elicit EDRF/NO. However, we also cannot rule out
the possibility that additional components in the vascular wall (perivascular
nerves, SubP, CGRP, etc...) may contribute to the AA-induced relaxation (Nilius
et al., 2012).
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The EC50 of FA, AA and CR are 52.4 ± 13.9 μM, 3. 3± 0.3 mM and 3.8 ±
0.5 μM, respectively, which show that CR is much more toxic than FA and AA in
the vasculature. As we know, it is very difficult to test the actual concentrations of
aldehydes in the blood and in the cells since the aldehydes are so active and
metabolism of aldehydes occurs quickly. One study showed the concentration of
FA was in the range of 1.27 ×10-2 to 2.28 μg/mL in the blood (Y. S. Wang et al.,
2011), which looked much lower than the EC50 of relaxation in our study. The
sensitivity of FA- and AA-induced relaxation (but not efficacy) was agonistdependent (PE<U46,619=High K+) (see Chapter Ⅵ, Table 22) and indicated K+
channel plays an important role in the relaxation of FA and AA. What’s more, we
show that Kir channel regulate the relaxation of FA.

5. Aldehydes and TRPA1 Receptor
Our study show several distinct pathways of FA-, AA-, and CR-induced
vasorelaxation in SMA (see figures in Chapter Ⅲ, Ⅳ, Ⅴ). We focus on the
mechanism of the most sensitive, and thus, most likely, physiological pathway.
FA-, AA-, and CR-induced vasorelaxation requires a functional endothelium,
NOS (presumably eNOS), and guanylyl cyclase (GC/cGMP), and what’s more,
FA- and CR- induced vasorelaxation in a similar pathway via the TRPA1 channel.
It is likely that the TRPA1 and NOS components are in endothelial cells, whereas
the latter is also present in vascular smooth muscle cells (VSMC).
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In addition, several unsaturated aldehydes including acrolein,
cinnamaldehyde, and 4HNE induce sensitive and robust vasodilation in
mesenteric arteries (Awe et al., 2006; Romero et al., 1997) and other blood
vessels (Yanaga et al., 2006) as well as tracheal smooth muscle (Cheah et al.,
2014), perhaps indicating a shared (universal) aldehyde-TRPA1 pathway.
TRPA1 is a cation (calcium) channel and a promiscuous receptor concentrated in
sensory fibers (unmyelinated C-fibers) that mediate pain reception/transmission
(nociceptors), and it is also present in the vasculature (Earley et al., 2009a;
Sinharoy et al., 2017). It is a well-known target of unsaturated aldehydes, such
as acrolein and crotonaldehyde (Andre et al., 2008; Bessac et al., 2008; D. J.
Conklin, 2016) and cinnamaldehyde (Pozsgai et al., 2010), but its activation by
FA is somewhat surprising given the proposed mechanism of unsaturated
aldehyde-mediated activation via conjugation with TRPA1 N-terminal free
cysteines (Macpherson et al., 2007). Activation of peripheral sensory fiber
TRPA1 leads to pain signaling and release of vasoactive peptides, substance P
(SubP), and cGRP (Trevisan et al., 2016), which may contribute to increased
vasodilation. We confirmed localization of TRPA1 in mouse dorsal root ganglion
(DRG) and showed Immunofluorescent staining in the endothelium of murine
SMA but not in aorta.
In our in vivo study, compared to the augmentation vasodilation in WT
mice after CR exposure, there was no difference in the sensitivity or relaxation of
ACh and SNP in CR group and air group in TRPA1-null mice after CR exposure;
the compensatory changes in the vasculature were missing in TRPA1-null mice
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(see Chapter Ⅵ, Table 19,20 and Fig. 35). This disappearance of augmented
smooth muscle relaxation in the vasculature indicates that TRPA1 plays a
specific role in the toxicity of CR.
TRPA1 is found in the pulmonary airways, and it plays a role in the
protective physiological maneuver called “respiratory braking” elicited by inhaled
toxins. Our previous study showed that TRPA1-null mice are more sensitive than
WT mice to acrolein exposure because of its “respiratory braking”, and that
TRPA1 antagonist injection post-acrolein exposure reduces acrolein-induced
mortality (D. J Conklin et al., 2017; D. J. Conklin et al., 2017). Our results show
that TRPA1 receptor plays a much more important role in the vascular toxicity of
the unsaturated aldehydes than saturated aldehydes. Future studies are needed
to make clear whether TRPA1 plays a protective function or induces impairment
to the blood vessels.
In our in vitro study, SMA is the main artery in the GI system, and food is a
main source of endogenous aldehydes. Cho et al. showed that TRPA1 is present
in sensory nerve endings and in some gastrointestinal enteroendocrine cells in
the mouse gastrointestinal tract (Cho, Callaghan, Bron, Bravo, & Furness, 2014).
Our study also showed the immunofluorescence staining of TRPA1 present in the
endothelium of the blood vessels in SMA. The specific TRPA1 antagonist,
A967079 (IC50 = 289 nM), significantly blocked the most sensitive component of
the FA- and CR-induced relaxation and shifted the EC50 to the right quantitatively
like that of endothelium disruption but less so than L-NAME treatment (see
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Chapter Ⅲ, Fig. 11; Chapter Ⅴ, Fig. 25). At high concentrations of FA and
CR—likely at unphysiological levels of FA and CR—the TRPA1 antagonist did
not affect relaxation, reflecting a non-TRPA1 pathway(s), perhaps via TRPV1 or
TRPV4 channels (Ma et al., 2008). We cannot rule out the possibility that
additional components in the vascular wall (perivascular nerves, SubP, CGRP,
etc.) also may contribute to overall FA- and CR-induced relaxation (Nilius et al.,
2012).

6. Aldehydes and Nicotine
Nicotine is an important component of tobacco smoke, and extensive
research has shown nicotine is a main reason for increased cardiovascular
events via activation of the sympathetic nervous system, increased myocardial
remodeling, impaired lipid metabolism, and induction of inflammation (Benowitz &
Burbank, 2016; Dutta et al., 2012) . However, some papers show that nicotine is
a double-edged sword which promotes angiogenesis and arteriogenesis on the
contrary (Heeschen, Weis, & Cooke, 2003; J. Lee & Cooke, 2012).
Few studies show the interaction between nicotine and aldehydes in vivo,
especially the effect of nicotine on the cardiovascular effects of aldehydes.
Nicotine could metabolize to methylamine and then metabolize to FA by
semicarbazide-sensitive amine oxidase (SSAO) (D. J. Conklin et al., 2004; Yu,
1998). Previous studies have shown a dose-related interaction between nicotine
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and AA in conditioned taste-aversion (CTA) paradigm (Kunin, Latendresse,
Gaskin, Smith, & Amit, 2000).
One purpose in our study is to investigate the effect of nicotine on the
function of aldehydes. The plateau concentration of nicotine in the blood
averaging 40 μg/L throughout the day in smokers (Moyer et al., 2002). In this
study, we aim to mimic the vascular effect of nicotine and aldehydes when
smoking or smoking as well as drinking. Our study showed that low
concentrations of nicotine as well as 1 µM does not affect the relaxation of FA,
AA, or CR in SMA (see Chapter Ⅲ, Chapter Ⅳ, Table 11,12; Chapter Ⅴ, Fig.
29). Nicotine does not affect the vascular function of aldehydes in vitro.

Nicotine mainly binds and activates nicotine acetylcholine receptor
(nAChR), but it is also a sensory agonist that activates TRPA1 and is responsible
for the airway constriction reflex (Talavera et al., 2009). TRPA1 is a well-known
target of acrolein, cinnamaldehyde, FA, and other aldehydes (Andre et al., 2008;
Bessac et al., 2008; D. J. Conklin, 2016; Pozsgai et al., 2010). However, the
function of TRPA1 in nicotine exposure and the effect of nicotine on aldehydes in
vivo are still unclear.

7. Aldehydes and sex difference
This data in our study was consistent with our previous study, in which
female mice exposed to a high level (210-250 ppm) of acrolein showed both
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pulmonary and systemic protection compared to their male counterparts,
demonstrating reduced morbidity and a significantly lower sensitivity to acroleininduced mortality female mice showed a protective effect under acrolein
exposure (D. J Conklin et al., 2017). Although both acute and chronic exposure
to CR induced vascular changes in male mice, females showed no changes in
aortic sensitivity or reactivity in response to CR exposure in vivo (see Chapter
Ⅵ, Fig. 36). These differences between males and females post-CR exposure
seem to support our previous findings that females are somewhat protected
against α,β-unsaturated aldehyde-induced toxicity and injury. This is consistent
with the human studies, rodent studies have also found that females are less
sensitive than males in tobacco-induced atherosclerotic damage in part because
of protective effects of female hormones (Bolego, Poli, & Paoletti, 2002).
Females had greater pain in some inflammatory conditions than males, which is
under the control of prolactin (Patil, Green, Henry, & Akopian, 2013). Prolactin
receptor regulates transient receptor potential (TRP) channels in neurons
including TRPA1, TRPV1, and TRPM8 and has a sex difference (Patil, Ruparel,
Henry, & Akopian, 2013). The mechanism of female-dependent protection in
mice is not clear. Future studies are needed to explore the sex-dependent
differences in respiratory, cardiovascular, and systemic toxicity in electronic
cigarette aerosols or aldehyde exposures.

8. Normalization of aorta contractility in testing vascular function
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Vascular function measurements are widely used in the study of
pathogenesis of cardiovascular, cerebrovascular, pulmonary vascular, and
kidney diseases (D. J. Conklin, 2016; D. J. Conklin et al., 2004; Earley,
Gonzales, & Crnich, 2009b; Jin, Jagatheesan, et al., 2019; Jin et al., 2018). In
our in vitro studies, isolated vascular rings were hung on the organ bath systems
and were in the Krebs-Henseleit equilibrium solution bubbling with a mixture of
gases (95% O2 + 5% CO2) to mimic physiological conditions. The blood vessels
were given a certain preload by pulling by two wires to mimic a physiological or
pathological condition in vivo. We then studied the contractility and relaxation of
the blood vessels. Our method proved to be a reliable method for the comparison
of contractility outcomes from different studies. We developed a simple 2-step
aorta normalization method: (1) measure blood vessel segment length (mm),
area (mm2) and calculate volume (mm3); then, (2) normalize isometric
contraction (mN) by segment length and volume. We recommend that aortic
contractions be normalized to segment length and/or volume to reduce variability,
enhance efficiency, and to foster universal comparisons across isometric
myograph platforms, laboratories, and experimental settings.

B. Strength
First, we show that the vascular toxicity of aldehydes in vivo exposure,
which are absolutely associated with cigarette smoking. Second, this is the first
study to show the vascular effects of CR exposure in vivo exposure, although the
effect of endothelium dysfunction is limited. We also test the vasodilation of CR in
vitro and showed the possible mechanism. Third, FA and AA are all very
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sensitive to the vasodilation of aorta and SMA. However, FA and AA at our
exposure levels showed limited toxicity to blood vessels in vivo exposure or the
direct effect to the blood vessels in vitro even at very high concentrations. Fourth,
we tested the direct vascular effects of three aldehydes from low concentrations
to high concentrations in vitro, which help us study the real biological changes to
aldehydes exposure in life. Fifth, we show a good pharmacological model of
endothelial dysfunction which is caused by air perfusion. Sixth, since the 85%
vasorelaxation of SMA is EDHF dependent, it is a good choice to select SMA as
a representative to study the function of small arteries, and it is the most
important artery to control the blood flow to GI system. Seventh, we show the
function of TRPA1 receptor in the mediation of cardiovascular toxicity of CR.
And, we show TRPA1 staining in the endothelium. TRPA1 might be the target for
medical treatment after aldehydes exposure.

C. Limitations
There are important caveats to consider in this study. First, mice are
obligate nose breathers and are “involuntary smokers,” meaning that they
decrease breathing rate and depth to reduce the inhalation of toxins such as
acrolein (D. J Conklin et al., 2017). This reflex is known as the “respiratory
braking response” (Alarie, 1973). The nose is very sensitive to aldehydes
exposure, it would be swelling because of edema, and the mice even die of
hypoxia because nose congestion. Second, low levels of FA, AA, and CR did not
induce endothelial dysfunction, even in the chronic exposure of CR. This could
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be because the level of exposure was too low and/or because and the length of
exposure was not sufficient to see significant changes. It is difficult to decide the
exposure time for these inhalation experiment as several factors can complicate
our desired outcomes. As we know, aldehydes are carcinogenic as well as
irritants, and it is possible that cancer could develop before the development of
negative cardiovascular effects during exposure. Third, we only tested the
vascular function changes in aorta and SMA; we have not tested functional
changes in other arteries such as the pulmonary artery and the third or fourth
segments of mesenteric artery that might more sensitive to inhalation exposure.
Fourth, we did not test whether TRPA1 antagonist had protective yet nonspecific
effects, especially in the chronic exposure of CR. Testing the function of TRPA1
antagonist is needed in order to further explore the function of TRPA1 receptor.
Fifth, perivascular adipose tissue (PVAT) is very important to the function of
blood vessels, and there is a lot of TRPA1 receptor staining in the PVAT. We
have not yet tested the effect of TRPA1 on the PVAT on the relaxation of blood
vessels. Sixth, in vivo exposure study, the concentrations of aldehydes are
continuous though the real smoking is intermittent since it’s hard to prudence
intermittent pattern during aldehyde exposure in our exposure system. Seventh,
aldehydes are very active and the metabolisms of aldehydes are very fast. It’s
difficult to measure the concentration of aldehyde in the blood.

D. Future direction
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Additional studies are still needed to further explore the toxicity of ecigarettes and cigarettes. We still have not identified the actual constituent that is
responsible for the toxicity of smoking or how to cure the toxicity of smoking. We
could test other possible mechanisms that mediate cardiovascular toxicity of
aldehydes. In the future, we could increase the dose of aldehydes or the length
of exposure to test whether it induces endothelial dysfunction. We could also test
the vascular function changes of other arteries such as the pulmonary artery and
smaller arteries such as the third or fourth segments of mesenteric artery.
Additional studies could also be performed to determine the effect of TRPA1
antagonists during aldehydes exposure in mice as well as the effect of PVAT on
the relaxation of blood vessels, including testing the function of TRPA1 receptor
in PVAT. We could test CR exposure in atherosclerosis models to test whether
TRPA1 could block atherosclerosis. We could test CR exposure in TRPA1-null
mice. Finally, more studies are still needed to examine the effect of e-cigarette
flavors on cardiovascular function such as testing blood pressure, heart rate, and
body temperature changes during flavor exposures in mice.

E. Conclusion
These studies indicate that short-term exposures of mice to FA or AA
have limited direct toxicity in aorta. However, CR exposures (acute and chronic)
lead to altered vascular function that may lead to cardiovascular disease.
Moreover, we describe direct effects of FA, AA, and CR that are dependent on
an EDRF/NO and VSMC GC/PKG pathway in SMA, with FA- and CR-induced
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relaxations also dependent on an endothelium-localized TRPA1 receptor. From
our in vitro study, we conclude that aldehydes play a key role in the regulation of
blood flow in the gastrointestinal (GI) tract to augment digestion and nutrient
absorption and induce postprandial hyperemia, what’s more, the TRPA1 receptor
plays an important role in the aldehyde-induced vasodilation. Future studies are
required to better understand how CR exposure modifies cardiovascular
pathophysiology and the specific roles that TRPA1 and sex play in contributing to
the burden of tobacco-related CVD including pathophysiological processes of
atherosclerosis.
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ABBREVIATIONS

AA

Acetaldehyde

ACh

Acetylcholine chloride

ADH

Alcohol dehydrogenase

AITC

Allyl isothiocyanate

ALDH2

Acetaldehyde dehydrogenase 2

ALT

Alanine transaminase

ANOVA

Analysis variation

AR

Aldose reductase

AST

Aspartate transaminase

BaCl2

Barium chloride

CACs

Circulating angiogenic cells

CK

creatinine kinase

CR

Crotonaldehyde

CVD

Cardiovascular disease

CO

Cardiac output

EC

Endothelial cell

EC50

Half maximal effective concentration
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EDHF

Endothelium-Derived Hyperpolarizing Factor

EDRF

Endothelium-Derived Relaxing factor

EPC

Endothelial progenitor cell

FA

Formaldehyde

FALDH2

Formaldehyde dehydrogenase

GC

Guanylyl cyclase

GI

Gastrointestinal

GSH

Glutathione

GSTP

Glutathione S-transferase P

GTT

Glucose tolerance test

HbA1c

Whole blood hemoglobin A1c

HPMMA

3-hydroxy-1-methylpropylmercapturic acid

3-HPMA

3-hydroxypropyl mercapturic acid

4HNE

and 4-hydroxynonenal

HR

Heart rate

IL-6

Interleukin 6

IVRT

Isovolumic relaxation time

LDH

Lactate dehydrogenase

LDLR-KO

Low-density lipoprotein receptor deficient
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L-NAME

N&-Nitro-Larginine methyl ester hydrochloride

MCS

Mainstream cigarette smoke

NO

Nitric oxide

NOS

Nitric oxide synthase

ODQ

1 h-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one

PE

L-phenylephrine hydrochloride

PKG

Protein Kinase G

PMAs

Platelet-monocyte aggregates

PSS

Phosphate-buffered solution

PWV

Pulse wave velocity

SMA

Superior mesenteric artery

SNP

Sodium nitroprusside

TEA

Tetraethylammonium chloride

TNFα

tumor necrosis factor alpha

TRPA1

Ttransient receptor potential ankyrin 1

VSMC

Vascular smooth muscle cells

WT

Wild type
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